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Abstract 
 
Resorcylic acid lactones (RALs) are a biologically important and structurally interesting 
class of natural products.i Recently the Barrett group has developed a novel, biomimetic 
strategy to access RALs that bypasses many common inefficiencies inherent to more 
classical synthetic approaches. The focus of this thesis consists of a synthetic study of the 
RALs radicicol (X) and paecilomycin B (XIX) that utilised this methodology. 
The first part of the thesis focuses on the synthesis of radicicol (X), a potent and selective 
Hsp90 inhibitor. Key intermediate III was formed via the known aldehydeii II in ten steps. 
Compound VI was synthesised from β-propiolactone IV in seven steps.  
 
 
By way of a Suzuki coupling, key building blocks VI and III were joined to give the 
cis, trans-diene moiety, which was oxidised to aldehyde VII. After addition of keto-
dioxinone VIII and oxidation, diketo-dioxinone IX was obtained. This furnished the carbon 
framework required for radicicol (X).iii 
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The second part of this thesis consists of work towards the total synthesis of paecilomycin B 
(XIX). The tetrahydropyran unit XIII was synthesised in ten steps from 1,6-anhydro-β-D-
glucose XI.  
 
During the course of this work we developed an improved procedure for the C-acylation of 
dioxinone XIV with acid chlorides. This new protocol permitted the synthesis of diketo-
dioxinone XV. The ketene derived from XV was then trapped with alcohol XVI and 
subsequently aromatised to give the resorcylate in a one-pot procedure. After methylation 
and chemoselective removal of the para-bromobenzyl group, oxidation of the primary 
alcohol gave the advanced intermediate XVIII. 
 
 
i) Winssinger, N.; Barluenga, S. Chem. Commun. 2007, 22–36. 
ii) Robert M. Garbaccio; Shawn J. Stachel; Daniel K. Baeschlin, and; Danishefsky, S. J. J. Am. Chem. Soc. 
2001, 123, 10903−10908. 
iii) Cookson, R.; Pöverlein, C.; Lachs, J.; Barrett, A. G. M. European J. Org. Chem. 2014, 2014, 4523–4535. 
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1. GENERAL INTRODUCTION 
  Resorcylic Acid Lactones (RALs) 1.1
 
Resorcylic acid lactones (RALs) are a class of natural products isolated from a variety of 
fungal strains and have been known for several decades. Radicicol (1) was first isolated in 
1953 from Monocillium nordinii,1 followed by zearalenone (2) in 1962 which was isolated 
from the microfungus Fusarium gramiearum.2 Some examples are shown below with each 
containing the 6-alkyl-2,4-dihydroxybenzoic acid or β-resorcylate unit (4) as a key part of 
the macrocycle (Figure 1). Many members of the RAL family show significant biological 
activities and as a result these compounds have received much attention over the years.3,4 
However initially, radicicol (1) was thought to solely possess mildly sedative and antibiotic 
activity and was therefore, with the rest of the RALs, left relatively unstudied in the years 
following its discovery.1,5 It was not until the 1990s that the selective inhibition of the heat 
shock protein 90 (Hsp90) by radicicol (1) was reported. Such inhibition prevented the 
proliferation of cancer cells.6,7 This was shortly followed by further reports of kinase 
inhibitors within the family which revived interest in the RALs. Thus radicicol (1) became a 
promising anticancer target.8,9 Zearalenone (2) is known to be an estrogen agonist. In 
addition, it also exhibits anabolic properties, which have been used for bovine growth 
stimulation. As a result this natural product, with its analogues, have been extensively 
studied over the years.10 Other examples within the RALs exhibit antimalarial, kinase 
inhibitors and antifungal activity.3,4 Their unique and interesting structures coupled with 
desirable biological properties render them appealing targets for total synthesis, while acting 
as attractive scaffolds to showcase current and innovative synthetic methodologies.  
   18 
 
Figure 1: Biologically Active Resorcylic Acid Lactones 
 
  Biosynthesis of RALs 1.2
 
RALs are mycotoxins produced via polyketide biosynthesis from polycarbonyls. Many such 
aromatic and alternatively non aromatic compounds found in nature are a result of a series of 
condensations between acetate and malonate units.11 Collie first proposed the synthesis of 
such polycarbonyls in 1907.12 Then in the 1940s and 1950s Birch and Robinson investigated 
this further through administering isotopically-labelled acetate units to an appropriate 
polyketide organism, establishing the theory still believed today.13–15 The initiation of the 
polyketide chain occurs with the condensation of coenzyme A ester 9 and malonyl coenzyme 
A ester 10 with the extrusion of carbon dioxide giving β-keto-thioester 11 (Scheme 1). 11 
will then undergo additional Claisen-type condensations, which are entropically driven 
through the loss of carbon dioxide, with malonyl ester 10 to elongate the polyketide chain. 
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Scheme 1: Biosynthesis of a Polyketide Chain 
For the biosynthesis of RALs, large, multidomain enzymes known as type I fungal 
polyketide synthases (PKS) iteratively catalyse the condensation of nine units of thioacetate 
or malonate groups. The proposed biosynthesis of the generic RAL 15 utilises two PKSs 
(Scheme 2). An initial enzyme assembles the first five acetate units and manipulates them 
into the correct oxidation state. The second constructs the final three condensations without 
reduction of the carbonyl moiety to give triketo-thioester 14. This readily undergoes 
aromatisation and subsequent transesterification to yield the 6-alkyl-2,4-dihydroxybenzoic 
acid structure 15.3,4  
 
Scheme 2: Proposed Generic Biosynthesis of RALs 
 
  Traditional Syntheses of RALs 1.3
 
Over the years many syntheses of RALs have been reported.3,4 By far the most common 
route to RALs and other resorcylate natural products proceed by the stepwise derivatisation 
of aromatic starting materials such as resorcylic acid (16) and orsellinic acid (17) shown 
below (Figure 2).  
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Figure 2: Common Starting Materials for the Synthesis of RALs 
 
1.3.1 Zearalenone 
 
Zearalenone (2) was first synthesised in 1967 by Wender, the key disconnections of which 
are outlined below (Scheme 3).16 The group utilised a Wittig reaction to generate the alkene 
moiety. Macrolactonisation was achieved through formation of a mixed anhydride with 
trifluoroacetic anhydride. Finally, ether cleavage with boron tribromide furnished 
(±) zearalenone (2). 
 
Scheme 3: First Total Synthesis of Zearalenone (2) in 1967 
 
1.3.2 Aigialomycin D 
 
Pan reported the enantioselective total synthesis of aigialomycin D (3) in 2006, the 
retrosynthetic analysis of which is outlined in Scheme 4.17 A Yamaguchi macrolactonisation 
formed the macrocycle and the two alkenes were derived from Kocienski modified Julia 
olefinations.  
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Scheme 4: Total Synthesis of Aigialomycin D (3) by Pan in 2006 
The synthesis began with alkylation of propargyl alcohol 24. Its subsequent partial reduction 
to the alkene followed by a Sharpless asymmetric epoxidation gave alcohol 25 (Scheme 5). 
Ring opening of the epoxide and ensuing protecting group manipulations followed by a 
Mitsunobu reaction and oxidation formed fragment 23. 
 
Scheme 5: Synthesis of Fragment 23 
Aldehyde 21 was formed through a regioselective bromination and oxidation of benzyl 
alcohol 28, while sulfone 22 was formed in a similar fashion to sulfone 23 (Scheme 6). 
 
Scheme 6: Generation of Fragments 21 and 22 
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With the key fragments in hand, these were coupled under Kocienski-Julia conditions to give 
the diene (Scheme 7). Carboxylation with carbon dioxide afforded acid 32 and the lactone 
was formed through a Yamaguchi macrolactonisation. Finally cleavage of the protecting 
groups gave aigialomycin D (3). 
 
Scheme 7: Synthesis of Aigialomycin D (3) 
 
1.3.3 Pochonin D  
 
Winssinger utilised polymer-supported reagents in the synthesis of pochonin D (34) and the 
retrosynthesis shows the key disconnections (Scheme 8). These included a Mitsunobu 
esterification, C-acylation and an alkene metathesis to form the macrocycle.18 
 
Scheme 8: Retrosynthesis of Pochonin D (34) 
The synthesis began with Weinreb amide 38, which was S-alkylated and then added to 
Merrifield resin in one pot (Scheme 9). Oxidation, alkylation and sulfoxide elimination 
furnished diene 37. Chlorination of acid 42 and a Mitsunobu reaction with polymer-
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supported diethyl azodicarboxylate provided the resorcylate which was phenol protected to 
give intermediate 43. In this example it was found that (m-ClPh)3P was necessary to 
suppress generation of the ether at the para-phenol position. Deprotonation and acylation at 
the benzylic position with Weinreb amide 37 gave a triene. The resorcylate was cyclised 
with second generation Grubbs’ catalyst to give a 1:4 mixture of the cis/trans product. When 
the reaction was left to equilibrate under thermodynamic conditions, this resulted in >95% 
selectivity to form the trans product. Deprotection of the phenol groups gave pochonin D 
(34). 
 
Scheme 9: Synthesis of Pochonin D (34) 
Moderate yields, difficult macrolactonisation or esterification steps and the need for phenol 
protecting groups, which often have associated difficulties with their removal, frequently 
limits these syntheses. Macrolactonisation and esterification transformations are repeatedly 
found to be low yielding due to the low reactivity of resorcyloyl electrophiles. While 
methods have been developed to address this issue such as the Mitsunobu esterification,18 
Mukiayama macrocyclisation19 and Corey-Nicolaou thioester macrolactonisation20 there is 
no general method appropriate to all syntheses. As a result, a new and general synthesis of 
RALs, overcoming these limitations, was attractive. In order to achieve this it would be 
particularly beneficial to find a route that introduced the aromatic portion at a late stage and 
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would therefore not require phenol protecting groups. It would also include a highly 
electrophilic species that would readily form the ester moiety in all syntheses. 
 
  Biomimetic Synthesis of Resorcylates 1.4
 
Biomimetic syntheses are often of great significance in natural product synthesis, such as the 
Johnson polyene cyclisation in the generation of steroids.21,22 They are frequently succinct, 
practical and provide sophisticated routes to complex targets while often negating the need 
for protecting groups. In 1970 Harris and Harris developed a biomimetically inspired 
synthesis of resorcylate compounds whereby upon treatment of polyketides with acid or 
base, these could be aromatised to give their respective resorcylate.23 The example given 
below is for the formation of resorcylate 46 from β,δ,ζ-triketo ester 45, which itself is the 
result of the self-condensation of methyl acetoacetate 44 (Scheme 10). 
 
Scheme 10: Self-condensation and Aromatisation of Methyl Acetoacetate 44 
Barrett et al. further optimised these conditions in 1980 and was able to produce resorcylate 
46 in 72% yield using buffered conditions at pH 9.2 (Scheme 11).24 
 
Scheme 11: Barrett Optimisation of the Synthesis of Resorcylate 46 
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While this research showed that simple resorcylates could be formed in a biomimetic 
fashion, the methodology was restricted to unfunctionalised compounds due to the harsh 
conditions required at the time. 
Chan further advanced this area through the use of silyl reagents. An example is his 
synthesis of lasiodiplodin (54) from methyl triacetate 49 (Scheme 12).25  
 
Scheme 12: Chan’s Synthesis of (±)-Lasiodiplodin (54)  
Tris silyl ether 51 was formed in two steps from triacetate 49 and subsequently condensed 
with imidazole 52 under Lewis acidic conditions to generate resorcylate 53. This was further 
manipulated to give lasiodiplodin (54). This methodology remained limited due to the labile 
nature of the silyl enol ethers. 
 
  Barrett Group Synthesis of Resorcylates 1.5
1.5.1 The Use of Dioxinones in Synthesis 
 
In 1984 Hyatt showed that upon thermolysis dioxinone 55 reacted with nucleophiles such as 
alcohols, amines and thiols to give the aceto-acetate derivatives 57 (Scheme 13).26 He 
proposed that dioxinone 55 underwent a retro-Diels Alder reaction to give acetyl-ketene 56, 
which was subsequently trapped by the nucleophile. 
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Scheme 13: Generation of Acetyl-ketene 56 from Dioxinone 55 
The acetyl-ketene 56 was first proposed as long ago as 1907, for what in fact turned out to be 
the structure of diketene (58) (Figure 3). When the true structure of diketene was 
subsequently suggested in 1940 and widely accepted in 1950, acetyl-ketene 56 remained 
proposed as an intermediate for the reactions of diketene.27 Evidence for its presence did not 
arrive until the 1980s and in 1989 Witzeman and Clemens published a detailed study into its 
existence as a result of the pyrolysis of dioxinone 55 (Figure 3).28 They found that upon 
pyrolysis of dioxinone and trapping of the products in an argon matrix they could detect the 
presence of acetone and acetyl-ketene 56 through the strong ketene absorption in the IR at 
2135 and 2142 cm-1. The authors suggested these stretching frequencies were from the cis 56 
and trans 59 isomers.  
 
Figure 3: Diketene (58) and the Cis and Trans Acetyl-ketene (56 and 59 Respectively) 
Pyrolysis of dioxinone 55 in the absence of a nucleophile gave the dimerised product 60 of 
acetyl-ketene 56 through a [4+2] cycloaddition (Scheme 14).  
 
Scheme 14: Pyrolysis of Dioxinone 55 in the Absence of a Nucleophile 
Additionally, kinetic studies on the thermolysis of dioxinone with different nucleophiles 
(1-butanol, phenol and di-n-butylamine) showed the reaction to be first order and the rates 
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independent of nucleophile concentration. The rate constants were also identical for the three 
different nucleophiles. This data is consistent with a unimolecular, rate-limiting generation 
of a reactive species, such as the acetyl-ketene 56. 
Due to the high reactivity of acetyl-ketenes, dioxinones have since been utilised in many 
syntheses.29,30 The 4 π component of the acetyl-ketene can be exploited in inverse electron 
demand hetero-Diels Alder transformations. Coleman and Fraser utilised this reaction in 
their synthesis of 2,6-dideoxy pyranosides, a structural motif found in many natural products 
and antibiotics.31 A representative example is the synthesis of the arabino-hexapyranoside 
natural product olivoside (62) outlined in Scheme 15. The Diels-Alder reaction occurred 
between the in-situ generated acetyl-ketene and n-butyl vinyl ether in 84% yield. 
 
 Scheme 15: The Use of Dioxinone 55 in a Hetero-Diels Alder Reaction 
Alternatively, dioxinones have been used to form β-keto-esters and β-keto-amides, as can be 
seen in the synthesis of (−)-carlosic acid (67), reported by Sakaki in 1990 (Scheme 16).32  
 
Scheme 16: Utilisation of Dioxinone 64 to Form β-Keto-ester 65 
Dioxinone 64 and alcohol 63 were heated in toluene to afford β-keto-ester 65, which upon 
treatment with tetrabutylammonium fluoride initiated a Dieckmann cyclisation to form 
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tetronic acid 66 (74% over two steps). Finally acid hydrolysis returned the natural product 
(67) in 42% yield and just three steps. 
 
1.5.2 Boeckman Macrolactonisation 
 
As has been shown, dioxinone can be used as an excellent route to β-keto-esters and amides. 
Boeckman performed these transformations in an intramolecular fashion to form 
macrolactones and macrolactams, which gave access to macrocycles that were previously 
very difficult to synthesise. The first use of this in synthesis was in 1989 for (+)-diplodialide 
(69), containing the 10-membered ring.33 The trans double bond of diplodialide (69) had 
previously hindered traditional lactonisation methods and yields were achieved in 25-
45%.34–36 By contrast, Boeckman showed that by utilising the inherent reactivity of acetyl-
ketene he could accomplish this transformation in 68% yield with low concentrations 
necessary to avoid polymeric by-products (Scheme 17).  
 
Scheme 17: Boeckman’s Use of Dioxinone in Macrolactonisation Reactions 
Boeckman then described the use of the methodology in the more complex natural product 
(−)-kromycin (71) (Scheme 18).33 Here the macrolactone was formed in 70% yield which 
concurrently generated the natural product. They found no other isolable products from this 
transformation. 
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Scheme 18: The Use of Dioxinone in the Synthesis of (−)-Kromycin (71) 
This methodology has since been utilised by many groups in the synthesis of a variety of 
natural products.29,37–40 Paquette and co-workers used dioxinone in the synthesis of (+)-
ikarugamycin (75) to form the lactam functionality.41 Through heating of the advanced 
intermediate 72 in toluene, the resulting ketene 73 was trapped intramolecularly with the 
pendant secondary amine in 94% yield to form the complex macrolactam 74 (Scheme 19). 
(+)-Ikarugamycin (75) was formed in a further five steps. 
 
Scheme 19: Intramolecular Trapping of Acetyl-ketene 73 to Give Macrolactam 74 
 
1.5.3 Barrett Group Proposed Route to Resorcylates 
 
Inspired by the pioneering work of Harris, Hyatt and Boeckman, the Barrett group have 
sought to develop this into a mild and reliable, biomimetic synthesis of resorcylate products 
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from β,δ-diketo-dioxinone precursors 76 (Scheme 20). Work has focused on the generation 
of these β,δ-diketo-dioxinones 76 from the dioxinone 55 starting material and their retro-
Diels-Alder reactions to form acetyl-ketene intermediates 77. Trapping of these reactive 
intermediates with the appropriate alcohol both intra- and intermolecularly gives β,δ,ζ-
triketo esters 78 and the concluding aromatisation of these esters generates resorcylates 79 in 
a biomimetic manner (see section 1.2). The dioxinone functionality serves to mask the 
inherently unstable triketo-ester that can then be revealed later at the required moment. It 
additionally generates the acetyl-ketene intermediate, a highly electrophilic species, that 
readily generates the ester or lactone functionality present in RALs that so often, through 
previous methods, has proved difficult to form. Finally aromatisation at a late stage in the 
synthesis, as is the case for the biosynthesis of RALs, enables the limited or altogether 
unnecessary use of phenol protecting groups. In reality, diketo-dioxinones 76 and triketo-
esters 78 exist as a mixture of their enolic forms. However for clarity they have been drawn 
solely as the keto-tautomer throughout this thesis. 
 
Scheme 20: Barrett Group Synthesis of Resorcylates 79 
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1.5.4 The Use of Keto-Dioxinones in Synthesis 
 
Keto-dioxinones have been used in synthesis since 1990 when Kaneko reported the reaction 
of the lithium anion of dioxinone 55 with acetyl chloride (R = Me; Scheme 21). The 
dioxinone unit in the resulting keto-dioxinone 80 was used as a labile group that could be 
removed at a later stage. Enantioselectivity for the reduction of the ketone was achieved with 
baker’s yeast. This transformation gave the (S)-alcohol 81 (44%, 90% ee).42 Kaneko later 
formed keto-dioxinone 80 (R = Ph) in 48% using two equivalents of the lithium enolate. 
This strategy reduced competitive O-acylation, presumably as a result of transacylation.43 
Reduction of 80 (R = Ph) with sodium borohydride gave the racemic hydroxyl-dioxinone 81 
in 87% yield. The acylation of dioxinone with acetyl chlorides has since been utilised by 
other groups.44,45  
 
Scheme 21: Kaneko’s Generation of Keto-Dioxinones 80 
Over a decade later, in 2003, Tadano used a vinylogous Mukaiyama aldol reaction with 
ensuing oxidation to form keto-dioxinone 84 (Scheme 22).  
 
Scheme 22: Tadano’s Synthesis of Macquarimicin A (86) 
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A boron mediated chelation-controlled diastereoselective reduction gave cis-diol 85, a 
precursor for macquarimicins A (86), B and C.46,47 The Mukaiyama aldol and oxidation 
approach to keto-dioxinones has subsequently been used by other groups.45,48,49 
In 2005 Katritzky treated 1-acylbenzotriazole derivatives, acting as enhanced electrophiles, 
with the enolate derived from dioxinone 55 to generate keto-dioxinones 80 (Scheme 23).50 
The thermolysis of these products gave 6-substituted-4-hydroxy-2-pyrones 87. 
 
Scheme 23: Katritzky’s Synthesis of Pyrones 87 
Omura formed keto-dioxinone 89 through an aldol reaction between dioxinone 88 and 
acetaldehyde with a subsequent Swern oxidation to form the keto-functionality. Reaction 
with sodium methoxide gave pyrone 90, which was converted into verticipyrone (91) and its 
analogues (Scheme 24).51 
 
Scheme 24: Omura’s Synthesis of Verticipyrone (91) 
There have been no reported syntheses of β,δ-diketo-dioxinones prior to those generated in 
the Barrett group, which shall be discussed later. However in 2000, Kiegel showed that 
under controlled conditions keto-ester 93 could be formed from double dioxinone 92 and 
t-butanol at 65 °C (Scheme 25).52 Heating to 130 °C gave the di-ester.  
 
Scheme 25: Kiegel’s Synthesis of Keto-ester 93 
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The Barrett group has since sought to extend these studies to the synthesis of β,δ-diketo-
dioxinones. These have subsequently been used in the total synthesis of a diverse range of 
resorcylic acid lactones and esters.53 Of particular note throughout these syntheses, some of 
which will now be described, is their potential to access many structurally modified 
analogues. Due to the important biological activities displayed by the RALs this allows for 
investigation into the improvement of these properties. By contrast, as is often the case for 
previous total syntheses, it can be seen that the synthesis of analogues would not be 
straightforward.  
 
  Previous Work in the Barrett Group on the Synthesis of Resorcylic 1.6
Acid Lactones 
1.6.1 Model Studies 
 
Initial model studies by Bassett and Barrett showed that β,δ-diketo-dioxinone 96 could be 
formed through the acylation of dioxinone 55 with acyl-benzotriazole 95 (Scheme 26). 
Resorcylate 46 was generated through heating of diketo-dioxinone 96 in methanol to give 
the triketo-ester 45, which readily aromatised either through base catalysed aldol 
condensation and acid promoted dehydration (87%) or directly through heating in methanol 
alone (82%). It was also found that resorcylate 97 could be generated in the presence of 
triethylamine via a non-ketene pathway (96%). Alternatively heating of diketo-dioxinone 96 
alone in toluene gave pyrone 98 in 85% yield.54 
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Scheme 26: Model Studies on Diketo-Dioxinone 96 
 
1.6.2 Zearalenone  
 
For the synthesis of zearalenone (2), a Mukaiyama aldol and oxidation sequence was used to 
form diketo-dioxinone 103 (Scheme 27).55 Alcohol 100 was prepared from (±)-hexanolide 
with a lipase-mediated kinetic resolution as a key step to introduce chirality. Heating of both 
fragments in toluene, followed by the successive addition of cesium carbonate and Dowex 
resin gave resorcylate 104 in 87% yield. Macrocyclisation was achieved with Hoveyda-
Grubbs II catalyst (105) to form zearalenone (2) in 71% yield, without the need for phenol 
protecting groups. 
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Scheme 27: Synthesis of Zearalenone (2) 
 
1.6.3 15G256 π, ι and β 
 
A mild route to diketo-dioxinones, suitable for polyfunctional resorcylates, was developed 
for the synthesis of antibiotics 15G256 π, ι and β.55 A double Claisen condensation of 
dioxinone 101 with acyl chlorides 106 and 107 gave allyl ester 108 (Scheme 28). Palladium 
mediated deallylation and decarboxylation afforded diketo-dioxinone 109 (89% yield). 
Heating of diketo-dioxinone 109 with alcohol 110 gave the triketo-ester, which was 
aromatised by the sequential addition of potassium carbonate and methanolic hydrogen 
chloride. Benzyl protection of the phenols gave resorcylate 111 and in turn resorcylate 112 
was formed, which was transformed into 15G256 π (113), ι (114) and β (7).  
O O
TBSO
OTBS
H
O
i) BF3•OEt2
ii) DMP O O
O
O O
OH OO
OH
HO
O
O
O
Hoveyda-Grubbs 
II Catalyst (105)
+
zearalenone (2)
O
O OOOH
HO
71%
28%
Cs2CO3; 
Dowex 50WX8-400
iii) HF, H2O
iv) DMP
Ru
O
NN MesMes
Cl
Cl
Hoveyda-Grubbs
 II Catalyst (105)
O
O
5 steps
PhMe, 110 °C;
101 102 103
104
100
99
87%
   36 
 
Scheme 28: Synthesis of Antibiotics 15G256 π (113), ι (114) and β (7) 
 
1.6.4 Cruentaren A 
 
This highly complex natural product (126), containing eight stereocentres, was synthesised 
in 23 linear steps and incorporated the use of a Weinreb amide to form the diketo-dioxinone 
fragment (Scheme 29).56 Two groups, Maier and Fürstner, had previously completed the 
total synthesis of cruentaren A with both initially derivatising a pre-formed aromatic core.57–
59 Both groups also used an esterification to install the ester functionality, a step which had 
the inherent problems of low reactivity (see section 1.3). They additionally had to overcome 
a side reaction that was formation of the undesired six membered lactone, which could be 
formed under either acidic or basic conditions. Both these problems were avoided in the 
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Barrett group synthesis of cruentaren A, which additionally showcased the range of 
functionalities tolerated by the methodology.  
Weinreb amide 116 was formed in nine steps with a Brown crotylation, hydroboration and 
Seyferth-Gilbert acetylene synthesis as key steps (Scheme 29). Amide 116 was reacted with 
the enolate of keto-dioxinone 117 to give diketo-dioxinone 118 in 67% yield. This cross 
Claisen condensation approach gave diketo-dioxinone 118 on a gram scale in ten steps. The 
alcohol fragment 121 was formed in 13 steps with a Lindlar reduction, Evans aldol reaction 
and asymmetric propargylation as key transformations. 
 
Scheme 29: Formation of Key Fragments 118 and 121 
Thermolysis of diketo-dioxinone 118 and alcohol 121 gave the corresponding triketo-ester, 
which was subsequently aromatised to give the expected resorcylate 122a and the 
methylated analogue 122b (Scheme 30). It was presumed that 122b was formed as a result 
of intermediate 127. The Fürstner molybdenum nitride precatalyst 124 was used to achieve 
the ring-closing alkyne metathesis in 75% yield and generate macrocycle 125. Cruentaren A 
(126) was formed in a further seven steps, which included a Mitsunobu azide synthesis, 
Staudinger reaction and amide synthesis. 
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Scheme 30: Synthesis of Cruentaren A (126) 
 
1.6.5 Zearalenone via an Intramolecular Ketene Trapping Pathway 
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macrocycle providing a convenient alternative to the typically used ring-closing metathesis 
approach. Ester 129 was formed in four steps from (±)-norbornene-2-carboxylic acid (128). 
This was transformed into the benzotriazole derivative, which was used in a Claisen 
condensation with dioxinone 55 to form keto-dioxinone 130 in 63% yield. Cross metathesis 
of keto-dioxinone 130 with alcohol 100 gave the E-alkene without the need for phenol 
protection. Thermolysis of keto-dioxinone 132 gave the macrolactone and upon removal of 
the ketal protecting group to give triketo-ester 133 this readily aromatised to give (S)-(−)-
zearalenone (2). 
 
Scheme 31: Second Synthesis of Zearalenone (2) 
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steps and is notable, like the two syntheses of zearalenone (2) (see section 1.6.2 and 1.6.4), 
in that it shows that there can be no need for phenol protection (Scheme 32). Weinreb amide 
136 was formed in five steps from 2-deoxy-D-ribose via aldehyde 135. Lindlar reduction of 
the alkyne to the Z-alkene, acylation of the Weinreb amide with the enolate of keto-
dioxinone 117 and alcohol deprotection gave diketo-dioxinone 137 in 40% yield over the 
three steps. Diethylzinc was used as an additive in the acylation as it was found to suppress 
formation of the Michael addition product while attaining total consumption of the Weinreb 
amide. Thermolysis of diketo-dioxinone 137 followed by aromatisation through the 
successive addition of cesium carbonate and acetic acid gave resorcylate 138 in 55% for the 
one-pot sequence. The total synthesis of LL-Z1640-2 (8) was achieved in a further three 
steps. 
 
Scheme 32: Synthesis of LL-Z1640-2 (8) 
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resorcylates 143 and dihydroxyisoindolines 144 were formed using the groups methodology 
and were shown to have activities against receptors and kinases that included CDK2 and 
CDK7 in the MCF7 breast cancer cell line.61 Diketo-dioxinone intermediates 141 were 
prepared from keto-dioxinone 117 and imidazoles 140 or Weinreb amides 139 through 
Claisen condensations (Scheme 33). Diethylzinc was again found to be a necessary additive 
in these transformations to keep reaction yields high for the crossed Claisen coupling. It was 
presumed this was a result of the reduced basicity of the zinc dienolates relative to their 
lithium equivalents. Aromatisation with triethylamine gave resorcylates 142 and 
transacylation gave in turn the aminoalkyl resorcylates 143 (R  = tertiary amine) or the 
dihydroxyisoindolines 144 (R = secondary amine). 
 
Scheme 33: Synthesis of Novel o-Aminoalkyl Resorcylates Derivatives and Isoindolines 
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  Aims of this Project 1.7
 
The aim of this project was to extend the Barrett group methodology to even more complex 
RALs, to explore just how sensitive the functionalities that could be tolerated by it were. The 
first target was the Hsp90 kinase inhibitor radicicol (1), which has received significant 
interest due to its important biological activity (Figure 4). Radicicol was chosen as a result of 
its highly sensitive conjugated epoxide-enone moiety. The project was also driven by the 
prospect of being to able form a general route that would allow the facile synthesis of 
analogues for biological testing.  Previous work in the group had investigated an 
intermolecular ketene trapping approach to the synthesis of radicicol (1). However 
unfortunately they failed to reach a total synthesis for reasons that shall be explained (see 
section 2.3.3). This project looked to investigate whether the recently developed 
intramolecular ketene trapping approach could be applied to the synthesis of radicicol (1) in 
order to achieve its total synthesis. The second natural product investigated was the recently 
isolated and structurally interesting paecilomycin B (5) whose tetrahydropyran unit within 
the macrocycle is unique to the RALs (Figure 4). At the time the project was started there 
were no reported syntheses of this compound.  
 
Figure 4: Radicicol (1) and Paecilomycin B (5) 
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CHAPTER 2 
RADICICOL
 2. RADICICOL 
2.1 Isolation and Structure 
 
As mentioned previously, radicicol (1) was first isolated in 1953 and named monorden, 
however the proposed structure for this later turned out to be incorrect.1 In 1964 it was 
independently isolated from Netricia radicicola and named radicicol. The suggested 
structure in this case was determined to be correct and as a result the name radicicol 
prevailed (Figure 5).62  
Radicicol (1) contains the β-resorcylate fragment within a 14 membered macrolactone, 
which is a common feature of the RALs. Alongside this, there is the unusual conjugated 
epoxide-enone functionality, which makes this natural product such a challenging and 
appealing target. The natural product monocillin I (145), which omits the chlorine atom but 
is otherwise structurally identical is also known and was isolated in 1980.63  
 
Figure 5: Structures of Radicicol (1) and Monocillin I (145) 
 
  Biological Activity of Radicicol 2.2
 
The Hsp90 protein is one of the most abundant proteins expressed in cells. It has multiple 
roles within these cells. Examples include its upregulation in response to stress, assistance in 
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protein folding and the stabilisation of several proteins. Hsp90 has two binding sites within 
the protein, one for ATP at the N-terminus and another for proteins at the C-terminus.64 
However within many cancer cells Hsp90 is found to be over-expressed and has several 
important functions in the maintenance and growth of the cancer.65 Primarily this is through 
the stabilisation and maturation of several oncogenic proteins such as mutant forms of p53, 
BCR-ABL, C-RAF and MET, which promote the survival and development of cancer 
cells.65–68 It has been shown that the inhibition of Hsp90 results in its clients being targeted 
for proteosomal degradation and ultimately to cell apoptosis.69 It is therefore clear why 
inhibitors of Hsp90 are such attractive targets. 
Pearl and others reported the co-crystal structure of binding between Hsp90 and radicicol (1) 
and reported that radicicol (1) had a nanomolar binding affinity (Kd = 19 nM).70 Radicicol 
(1) inhibits the ATPase activity of Hsp90 by binding non-covalently in the ATP site, despite 
the lack of similarity structurally to ATP. 
Following the discovery that radicicol (1) was a potent kinase inhibitor in vitro it was found 
that in vivo it displayed no activity, which was most likely due to its rapid metabolism into 
inactive compounds.71 It has been shown that thiols, such as dithiothreitol (DTT), take part 
in a 1,6-Michael addition rendering the product inactive.72,73 As a result, research into the 
analogues of radicicol (1) has become a new area of interest in the hope that one can be 
found which enhances the stability of the molecule while retaining its anticancer 
properties.71,74 There is therefore the need for a general route allowing easy access to these 
compounds.  
It has been shown that the chlorine is necessary for the biological activity of radicicol and 
therefore monocillin I (145) has received less attention over the years. Radicicol (1) can 
adopt three low energy conformations of the macrocycle, however just one of these is 
responsible for successful Hsp90 inhibition.18 There is a notable reduction of activity in 
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monocillin I (145) which is thought to be due to the removal of the chlorine leading to an 
alteration in the macrolactone ring conformation. This could be due to the loss of 1,3-allylic 
strain present from the chlorine in radicicol (1). It is also evident from the co-crystal 
structure of radicicol (1) and Hsp90 that the chlorine can fill a hydrophobic pocket. 
 
  Previous Syntheses of Radicicol 2.3
2.3.1 Lett 
 
Lett et al., reported the first total synthesis of radicicol (1) in 1992 in 18 steps for its longest 
linear sequence. The completion of this work allowed the authors to confirm the absolute 
stereochemistry of the compound (Scheme 34). 75  
 
Scheme 34: The first Total Synthesis of Radicicol (1) by Lett 
The sensitive allylic epoxide and acidic benzylic proton, which could form the enolate and 
react to yield the isocoumarin, proved to be the most challenging aspects to the synthesis. 
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However Lett was able to use this to his advantage and incorporated an isocoumarin (150) 
into the synthetic pathway.  The synthesis began from propargylic alcohol, which was 
converted into alkyne 146 over four steps. Reduction of the alkyne to the alkene allowed the 
epoxide to be installed through a Sharpless asymmetric epoxidation (SAE). An ensuing 
Swern oxidation gave aldehyde 147. Addition of stanane 148 to aldehyde 147, MOM 
protection and silyl deprotection gave the key intermediate 149. Isocoumarin 150 was 
formed from the dimethyl-protected analogue through the removal of the methyl ethers and 
reprotection as the silyl ethers. A Stille coupling76 was then used to join fragments 149 and 
150 in 75% yield. The isocoumarin 151 was opened with diisobutylaluminium hydride and 
following oxidation to the acid, a Mitsunobu reaction joined the macrolactone to give 152. It 
was found in previous syntheses of related compounds that having the ortho-phenol 
unprotected gave much higher yields for this Mitsunobu transformation.77 Conveniently, the 
ortho-phenol was selectively deprotected during isocoumarin cleavage. Phenol re-protection 
as the silyl ether was then necessary prior to elimination of the MOM group (25-30%).  A 
final chlorination and deprotection gave radicicol (1). The silyl phenol protecting groups 
were necessary as it was found that when these were substituted with the methyl ethers, it 
was not possible to remove these at the end of the synthesis. This highlights the problems 
that can arise from requiring phenol protecting groups in the generation of RALs. Another 
disappointing feature in the synthesis was the low yielding MOM elimination used to furnish 
the conjugated diene. Therefore in 2002 Lett published a second generation synthesis, which 
addressed this issue by exchanging the MOM protecting group with a methoxybenzyl 
group.78,79 This could be selectively removed and exchanged for a mesylate group allowing 
the elimination to proceed in excellent yields (83-91%). Additionally in the second synthesis, 
the Stille coupling was replaced with a Suzuki reaction to avoid tin contamination. 
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2.3.2 Danishefsky 
 
In 2001, Danishefsky and co workers reported the synthesis of radicicol (1) in 14 steps and 
an overall yield of 2.8%.80 Using three key intermediates, resorcylate 153, alcohol 154 and 
dithiane 155, a highly convergent synthesis of radicicol (1) was achieved (Scheme 35). A 
Mitsunobu esterification with optically pure alcohol 154 and arene 153 joined the first two 
components, while the lithium nucleophile 155 added the third fragment. Finally the 
macrocycle was formed through a ring-closing metathesis. 
 
Scheme 35: Retrosynthetic Analysis of Danishefsky’s Approach to Radicicol (1) 
Alcohol 154 was generated in eight steps from commercially available  (S)-3-hydroxybutyric 
acid methyl ester, with a Horner-Wadsworth-Emmons olefination and Sharpless epoxidation 
as key steps (Scheme 36). The esterification of alcohol 154 with acid 153 proved 
challenging, necessitating a wide range of conditions to be explored and the previous 
realisation by Lett that the unprotected ortho- phenol gave increased reactivity was used. 
Danishefsky ultimately found they were able to form resorcylate 158 through a Mitsunobu 
esterification using DIAD and tri(2-furyl)phosphine in 75% yield. Dithiane 155 was then 
joined in 43% yield, acting not only as an acyl anion equivalent but additionally it prohibited 
isocoumarin formation. Protection of the free phenol as the silyl ether and 
macrolactonisation through a ring-closing metathesis gave macrocycle 160. Conversion of 
the dithiane to the ketone necessitated an oxidation/Pummerer rearrangement and finally 
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chlorination gave radicicol (1). The expedient nature of this synthesis allowed the different 
stereoisomers of radicicol (1) to be produced. 
 
Scheme 36: Synthesis of Radicicol (1) by Danishefsky 
In 2005 Winssinger used a similar approach to radicicol (1) as Danishefsky.81 This involved 
a ring-closing metathesis, Mitsunobu esterification and utilised a preformed aromatic core. 
However, as in his synthesis of pochonin D (34) (see section 1.3.3), polymer-supported 
reagents were used to aid purification. 
 
2.3.3 Previous Work Towards Radicicol in the Barrett Group 
 
Prior to my contribution to this project, work towards a synthesis of radicicol (1) had already 
taken place and was accomplished by Jennifer Lachs and Christoph Pöverlein.82 The route 
utilised a ring-closing metathesis to form the macrocycle, as in the synthesis of Danishefsky 
(Scheme 37). For the key step, the ketene generated from diketo-dioxinone 163 was trapped 
with known alcohol 16280 to form the triketo-ester intermediate and in turn resorcylate 161. 
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Scheme 37: Previous Retrosynthetic Analysis of Radicicol (1) 
Diketo-dioxinone 163 was formed in four steps from sorbic acid (164) (Scheme 38). 
Transformation of acid (164) into the acid chloride and reaction with ethyl acetate gave the 
keto-ester, which was keto-protected as the ketal. Diketo-dioxinone 163 was formed through 
reaction of the Weinreb amide derivative of ester 165 with the lithium dianion of keto-
dioxinone 117 in 13% yield over the two steps. Reaction of known alcohol 16280 with 163, 
aromatisation of the resultant triketo-ester and acetylation of the phenol groups gave 
acetylated resorcylate 166 in 68% for the one-pot procedure.  
 
Scheme 38: Formation of Resorcylate 167 
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Ring-closing metathesis occurred with Hoveyda-Grubbs II catalyst (105) in 27% yield 
(unoptimised), with DMSO added following the reaction to remove ruthenium side-products. 
A brief investigation into acidic conditions to remove the ketal protecting group showed that 
preferential opening of the sensitive epoxide group occurred.  
In spite of this discovery, a suitable route towards radicicol (1) had been developed. This led 
to investigations into a silyl ether protecting group, which upon removal a subsequent 
oxidation would give the enone. Following the route previously outlined diketo-dioxinone 
170 was formed in three steps from the Weinreb amide 168 (Scheme 39). Interestingly, ring-
closing metathesis following aromatisation with alcohol 162 (Scheme 38) only afforded the 
macrocycle in yields of less than 5% despite many variations in conditions being 
investigated. Similar problems had been reported by Porco who postulated this was due to 
stable complexes of low reactivity from the diene terminus, such as 176 forming.  
 
Scheme 39: Formation of Resorcylate 175 
Porco employed a metathesis relay strategy to favour formation at the desired alkene, 
following elimination of cyclopentene, enabling metathesis to occur.83 Therefore, diene 173 
was formed from known aldehyde 17180 through a Wittig olefination and silyl deprotection. 
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Aromatisation occurred with modified conditions, whereby following trapping of the ketene, 
aromatisation was induced through heating in isopropanol and dichloromethane in a sealed 
tube. Acetylation of the phenols gave resorcylate 174 in 62% over the two steps and at this 
point the ring-closing metathesis was now possible in 75% yield. De-silylation again proved 
an insurmountable challenge due to the delicate epoxide and so the synthesis of radicicol (1) 
had not been reached. 
It was at this point that the project began in which we wanted to explore an intramolecular 
ketene-trapping route as an alternative approach. It was hoped that this would not only allow 
improvement on poorly yielding steps and prevent the need for phenol protecting groups but 
also achieve a total synthesis of radicicol (1). 
 
 Retrosynthetic Analysis of Radicicol 2.4
 
It was envisioned that all functionality would be in place prior to macrolactonisation and 
aromatisation, ensuring there would be no need for phenol protection. This would require the 
trapping and aromatisation to occur on diketo-dioxinone 177 (Scheme 40). Diketo-dioxinone 
177 could be generated from aldehyde 179 and chloro-keto-dioxinone 178 through an aldol, 
oxidation sequence. Should this be possible it would by-pass the chlorination of monocillin I 
(145), a known, moderately yielding step.80 An aldol addition and oxidation sequence was 
chosen to be investigated for the synthesis of the diketo-dioxinone portion as this route had 
not previously been explored within the group. It was therefore hoped a new route for the 
synthesis of diketo-dioxinones could be developed that would expand the scope of the 
methodology. It was considered that aldehyde 179 could be formed through a Suzuki 
coupling of boronic ester 181 and iodo-alkene 180. The ketal protecting group was chosen as 
few conditions for its removal had been investigated. Should it be necessary hydrogen 
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chloride could be used for this, which has been previously shown within the group to remove 
the ketal functionality while additionally opening the epoxide to give the chlorohydrin.84 It 
has been reported by Winssinger in the synthesis of radicicol (1) that the addition of 
potassium carbonate will regenerate the epoxide moiety from the chlorohydrin, so while this 
would add a further step to the synthesis, the protecting group could be removed and the 
synthesis of radicicol (1) achieved.81 
 
Scheme 40: Retrosynthetic Analysis of Radicicol (1) 
 
  Towards the Synthesis of Boronic Ester 181 2.5
2.5.1 Retrosynthesis of Boronic Ester 181 
 
It was proposed that formation of boronate ester 181 as one of the coupling partners in the 
Suzuki reaction could be achieved via ketal protection of the ketone in acetylene 183, 
followed by trimethylsilyl removal and a subsequent hydroboration to give 182 (Scheme 41). 
Ensuing deprotection and oxidation of the benzyl alcohol would yield the desired aldehyde 
181 as the first key fragment. Suzuki couplings on similar systems with a free aldehyde have 
been reported in the literature.85,86 
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Scheme 41: Proposed Route to Aldehyde 181 
 
2.5.2 First Route to Alkynone 183 
 
The first pathway to alkynone 183 began with the mono-protection of 1,3-propanediol 184 
followed by a Jones oxidation to give the carboxylic acid 186 in 23% yield over the two 
steps (Scheme 42). This was further derivatised to the Weinreb amide 187 in 87% yield. 
However, as a consequence of the low yielding initial steps, which additionally were not 
readily scalable, an alternative route was sought. 
 
Scheme 42: Formation of Weinreb amide 187 
 
2.5.3 Second Route to Alkynone 183 
 
A second pathway was devised that incorporated the ring opening of β-propiolactone 188. 
Direct conversion of 188 to alkyne 189 with ethynyltrimethylsilane was unsuccessful with 
multiple products formed and without any of alcohol 189 isolated (Scheme 43). 
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Scheme 43: An Attempt to Ring Open Lactone 188 
It was possible however to open the lactone as the Weinreb amide 190 (Scheme 44) and this 
transformation was optimised through the screening of conditions, enabling the formation of 
alcohol 190 in 73% yield (Table 1, Entry 6). 
 
Scheme 44: Synthesis of alkynone 183 
It was found that dimethylaluminium chloride acted as a superior additive over 
isopropylmagnesium chloride and diethylaluminium chloride (Entry 1-3).  Acetonitrile was 
established to be the most suitable solvent (Entry 3-5), while it was found four equivalents of 
dimethylaluminium chloride gave the highest yield of 73% (Entry 6). 
Entry Reagent (X) Equivalents of X Solvent Yield of 190 (%) 
1a i-PrMgCl 
 
4 THF 14 
2 AlEt2Cl 
 
2 CH2Cl2 37 
3 AlMe2Cl 
 
2 CH3CN 45 
4 AlMe2Cl 
 
2 Et2O 29 
5 AlMe2Cl 
 
2 CH2Cl2 33 
6 AlMe2Cl 
 
4 CH3CN 73 
7 AlEt2Cl 
 
4 CH3CN 33 
Table 1: Development of Conditions for the Synthesis of Weinreb Amide 190 
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Protection of the alcohol with methoxybenzyl trichloroacetimidate 191 occurred in a high 
yield (85%) and formation of Weinreb amide 187 was now achievable through a superior 
synthesis of two steps (Scheme 44). Generation of alkyne 183 was carried out in nearly 
quantitative yields using ethynyltrimethylsilane and n-butyllithium, while purification of the 
product through chromatography was not necessary. 
 
2.5.4 Formation of the Boronate Ester 
 
Continuing on to the target boronate ester, it was necessary to protect the ketone as the ketal. 
A methodical search of conditions made it possible to perform this challenging step (Table 
2). The difficulties presumably arose due to the high reactivity of the functionalities within 
alkynone 183 making it particularly susceptible to side reactions such as conjugate additions, 
eliminations and ultimately decomposition.  
 
Entry Conditions Yield of 192 (%) 
1 Ethylene glycol, pTSA (0.4 eq), Cy, 4 Å molecular sieves, 80 °C 
 
0 
2 Ethylene glycol, pTSA (0.4 eq), Cy, MgSO4, 80 °C 
 
0 
3 Ethylene glycol, pTSA (0.4 eq), (MeO)3CH, toluene, 80 °C 
 
0 
4 TMSOCH2CH2OTMS (1 eq), TMSOTf (0.01 eq), CH2Cl2, −78 °C 
 
0 
5 TMSOCH2CH2OTMS (2 eq), TMSOTf (0.01 eq), CH2Cl2, 
−78 °C to rt (warmed incrementally) 
 
18 
6 TMSOCH2CH2OTMS (3 eq), TMSOTf (0.01 eq), CH2Cl2, 
−78 °C to −30 °C 
 
47 
7 Ethylene glycol, pTSA (0.4 eq), (MeO)3CH, toluene, rt, 16 h 
 
61 
8 Ethylene glycol, pTSA (0.1 eq), (MeO)3CH, toluene, rt, 16 h 
 
75 
Table 2: Optimisation of Conditions for the Protection of Ketone 183 
192
PMBO
TMS
183
conditions
PMBO
TMS
OOO
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High temperatures were found to result in complete decomposition of the starting material 
(Entry 1-3), while Noyori conditions87 returned varying amounts of ketal product 192 
alongside multiple side products (Entry 4-6). It was then found that the conditions which 
employed ethylene glycol, trimethyl orthoformate and toluenesulfonic acid did not require 
heating and a yield of 61% could be achieved (Entry 7). This was improved to an optimal 
yield of 75% by reducing the amount of catalytic acid present (Entry 8). 
Removal of the trimethylsilyl group with potassium carbonate gave the alkyne precursor 193 
to the boronate ester 194 (Scheme 45). Acetylene 193 was treated with pinacolborane in 
dichloromethane or toluene at the respective refluxing temperatures in an attempt to generate 
the pinacol boronate ester, however no reaction was observed and starting materials were 
recovered. Catalytic bis(cyclopentadienyl)zirconium(IV) chloride hydride was added in an 
attempt to perform a hydrozirconation with subsequent transmetalation to the boron.88 This 
resulted in no change to the alkyne being observed despite the reaction being heated to 
100 °C. When alkyne 193 was heated in eight equivalents of pinacolborane, neat, to 60 °C 
for three days formation of the pinacol ester 194 was achieved. The yield of this 
transformation could be increased from 41% to 66% through ensuring minimal time was 
spent on the purification by chromatography. This was presumably due to the minimisation 
of transesterification possible during this procedure. Deprotection of the alcohol was 
achieved with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), however the highest yield 
obtained was a disappointing 53% to alcohol 195 and it was apparent that material was again 
being lost during purification of the crude material. As boronate ester 195 would in turn need 
to be brought through an additional step to the proposed coupling partner, aldehyde 181, 
where it was probable more material would be lost through purification, it was decided that 
the Suzuki coupling should be undertaken on the protected alcohol 194. The deprotection 
and oxidation could then be performed on the Suzuki coupled product with no foreseeable 
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problems. Therefore the first fragment for the Suzuki coupling was ready and attention was 
turned to the iodide coupling partner. 
 
Scheme 45: Synthesis of Alcohol 195 
 
  Synthesis of Known Aldehyde 171 2.6
 
The synthesis of aldehyde 171 was carried out in seven steps with an overall yield of 66% 
following the work of Danishefsky, which in turn closely followed the route reported by 
Waldmann (Scheme 46).80,89 The synthesis began with the protection of commercially 
available (R)-3-hydroxybutyric acid 196 as the analogous tertbutyldiphenylsilyl ether 
(TBDPS) 197. Reduction of the ester to aldehyde 198 with diisobutylaluminium hydride and 
a subsequent Horner-Wadsworth-Emmons homologation performed under Roush-
Masamune conditions90 gave the trans-alkene 199 in 86% yield over the two steps. 
Treatment of ester 199 with diisobutylaluminium hydride and warming of the reaction to 
room temperature gave the corresponding trans-allylic alcohol 200 (96% yield). A Sharpless 
asymmetric epoxidation yielded the required epoxy alcohol 201 with excellent selectivity 
(>20:1).91 It was found a mechanical stirrer was necessary to achieve high yields on scales 
over two grams as a result of the large quantities of molecular sieves required. Further 
derivatisation of the compound was executed through a Parikh-Doering oxidation92 to give 
aldehyde 171, the necessary precursor for the second coupling partner, iodo alkene 180.   
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Scheme 46: Synthesis of Aldehyde 171 
 
  Attempts Towards the Synthesis of Iodo-alkene 180 2.7
2.7.1 Via a Wittig Olefination 
 
The originally proposed route to alkene 180 was via a Stork-Zhao modified Wittig 
transformation to give the cis-stereochemistry of the iodo-alkene.93 With this in mind, 
phosphonium salt 202 was prepared according to the literature procedure from 
triphenylphosphine and diiodo-methane (Scheme 47). 
 
Scheme 47: Formation of 202 
Treatment of aldehyde 171 with phosphonium salt 202 and sodium hexamethyldisilazide, 
gave an inseparable mixture of the desired cis-alkene 180 and what was proposed to be the 
corresponding trans-alkene 203 and the diiodo-alkene 204 in a ratio of 10:1.2:0.7 
respectively (Scheme 48). Tentative assignment of these products was based on the presence 
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of peaks in the appropriate region of the 1H NMR spectra for vinylic proton shifts and their 
corresponding J values (JHaHb = 7.8 Hz; JHcHd = 14.8 Hz; JHeHf = 7.0 Hz). These reaction 
conditions also returned an inseparable impurity which despite careful analysis of the crude 
material was not identified or isolated. 
 
Scheme 48: Formation of Olefins 180, 203 and 204 
The detection of the diiodo-alkene side product had also been reported by Bestmann and co-
workers. They proposed it was the result of the formation of the diiodo phosphonium ion 
208 during the reaction, which could then partake in a Wittig transformation (Scheme 49).94 
 
Scheme 49: Proposed Route to Formation of the Diiodo-product 
The conditions for the Stork-Zhao reaction were varied in an attempt to form the cis-iodo-
alkene 180 as the predominant product in a reasonable yield (Table 3). It was found that 
increasing the temperature of the reaction after the addition of aldehyde 171 gave 
substantially less of the undesired diiodo-product 204 but significantly more of the impurity 
was observed (Entry 1-3). The conditions developed by Bestmann (Entry 4) to by-pass the 
diiodo-product were carried out, which returned a lower ratio of the diiodo-alkene 204 and 
additionally considerably less of the impurity relative to other attempts. Although the 
addition of hexamethylphosphoramide (Entry 5) gave mono-iodinated products 180 and 203 
exclusively, it also produced significantly more of the impurity compared to all other 
reaction conditions. The most substantial amounts of diiodo-product 204 was formed when 
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the ylide was generated at −78 °C and then warmed to 0 °C prior to addition of aldehyde 171 
(Entry 6). 
 
Conditions: a) ICH2PPh3I 202, NaN(TMS)2, THF, rt to −78 °C; b) 171, then warmed to X °C. 
Entry  Temperature (X °C) Variation Products
a 
180:203:204 + impurity 
1 
 
rt - 10:1.2:0.7 + impurity  
2 
 
−10 - 10:1.5:3.3 + impurity 
3 
 
−78 -  10:1.5:3.0 + impurity 
4 
 
rt Solvent: THF/DMF (1:1) 10:0.8:0.8 + impurity 
5 
 
−78 HMPA additive 10:2.1:0.0 + impurity 
6b 
 
rt b 10:2.7:19 + impurity 
Table 3: Attempted Optimisation of the Conditions Reported by Stork.  
a) Ratios were determined from the 1H NMR of the crude material, having been purified once by 
chromatography; b) ICH2PPh3I 202, NaN(TMS)2, THF, −78 °C to 0 °C; then 171 added. 
 
2.7.1.1     Suzuki Coupling with Crude Alkene 180 
 
Since the desired alkenyl iodide 180 was not able to be isolated cleanly the Suzuki coupling 
was attempted using the crude material from the Stork-Zhao olefination.  
 
Scheme 50: Suzuki Coupling Between Epoxide 180 and Boronate Ester 194 
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A number of reaction conditions were screened and when boronate ester 194 was employed 
as the limiting reagent an optimal yield of 38% was reached for the coupling (Scheme 50, 
Table 4). As shown in Table 4, under the various conditions screened this reaction gave a 
range of yields between 14-24% (over the two steps from aldehyde 171, Entry 1-3). The best 
conditions found utilised one equivalent of boronic ester 194 and an excess of alkene 180. 
This gave diene 205 in a yield of 38% for the single step (Entry 4).  
 
Entry Conditions Approximate eq. of 180a 
Eq. of 
194 
Yield of 205(%) over two 
steps from aldehyde 171 
1 
 
 
Pd(dppf)Cl2CH2Cl2, 
Ba(OH)2(OH2)8, DMF, rt, 16 h 
1.0 1.2 14 
2 
 
 
Pd(dppf)Cl2CH2Cl2, aq. NaOH, 
THF, rt, 16 h 
1.0 1.5 23 
3 
 
 
Pd(PPh3)4, aq. Cs2CO3, THF,  
55 °C, 16 h 
1.0 1.1 24 
4 Pd(PPh3)4, aq. Cs2CO3, THF, 
55 °C, 16 h 
 
2.0 1.0 38b 
Table 4: Optimisation of the Suzuki Coupling 
a) Approximating that 180 is the sole compound within the mixture of products; b) yield for the Suzuki 
coupling with boronate ester 194 as the limiting reagent. 
 
While it was pleasing to see that the coupling was indeed possible, due to the low overall 
yield and inefficiency of this transformation alternative approaches to alkene 180 were 
investigated. 
 
2.7.2 Via Horner-Wadsworth-Emmons and Hunsdiecker Reactions 
 
As an alternative to our previous approach it was envisioned that alkene 180 could be 
synthesised in a much improved fashion via the ester variant of the cis-alkene 206. 
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Hydrolysis of ester 206 to give acid 207 could then allow introduction of the vinyl iodide 
through a Hunsdiecker reaction (Scheme 51). 
 
Scheme 51: Proposed Route to Alkene 180 
Enoate 206 was readily available via a Still modification of the Horner-Wadsworth-Emmons 
reaction (Scheme 52).95 This gave both the cis and trans-alkenes in a 9:1 ratio respectively, 
which were easily separated by chromatography. Unfortunately hydrolysis of the ester was 
not possible with lithium or sodium hydroxide and starting materials were returned along 
with substantial decomposition. Thus the investigation to alkene 180 focused on alternative 
approaches. 
 
Scheme 52: Attempt Towards Formation of Acid 207 
 
2.7.3 Via the Alkyne 
2.7.3.1 Modified Corey-Fuchs Reaction 
 
Should generation of iodo-alkyne 208 be possible, then the cis-alkene could be accessible 
through a cis-reduction by hydrogenation. Direct generation of iodo-alkyne 208 was 
attempted through a modified Corey-Fuchs reaction, but this resulted in decomposition of 
the starting material (Scheme 53).96  
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Scheme 53: Modified Corey-Fuchs Reaction 
 
2.7.3.2   Corey-Fuchs Reaction 
 
Standard conditions for the Corey-Fuchs reaction were applied to aldehyde 171 and due to 
additional opening of the epoxide this gave bromohydrin 209 in 77% yield (Scheme 54).97 
Treatment of alcohol 209 with tetrabutylammonium fluoride at 0 °C regenerated the epoxide 
and gave the dibromo-alkene 210 without any removal of the silyl ether observed.  
 
Scheme 54: Synthesis of Dibromide 210 
Dibromide 210 was treated with either n-butyllithium or methyllithium and quenched with 
either iodine or a proton source in an attempt to convert the alkene to alkyne 211. It was 
revealed that two equivalents of n-butyllithium gave incomplete reaction with a mixture of 
returned starting material and mono-brominated alkenes recovered. When over two 
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equivalents of either lithium reagent were used, decomposition of dibromide 210 was 
observed. 
 
2.7.3.3       The Ohira-Bestmann Reagent and Synthesis of Iodo-alkene 180 
 
Terminal alkynes are accessible from aldehydes through the use of the Ohira-Bestmann 
reagent 215 in a transformation that only requires the mild conditions of potassium carbonate 
and methanol at 0 °C.98 Gratifyingly, when aldehyde 171 was treated with these reagents 
alkyne 212 was formed in 66% yield. This was readily converted to the iodo-alkyne in 98% 
yield with N-iodosuccinimide and silver nitrate. Finally a cis-reduction with diimide derived 
from o-nitrobenzenesulfonyl hydrazine 217 and triethylamine gave the iodo-alkene 180 
(80% yield).99 
 
Scheme 55: Synthesis of Iodo-alkene 180 
 
  Coupling of Fragments 180 and 194 2.8
 
With the two key fragments in hand, conditions were varied to find those that gave the 
highest yield for the coupling of the two compounds. This was found to be with the 
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[1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane 
and sodium hydroxide to give the cis, trans-diene 205 in 62% yield (Scheme 56).100 The 
ensuing step was intended to be removal of the methoxybenzyl protecting group to give 
alcohol 218, however unfortunately conditions were not found that left the rest of this 
sensitive molecule untouched. 
 
Scheme 56: Suzuki Coupling of 180 and 194 
 
  Attempts Towards the Formation of Alcohol 218 2.9
 
When DDQ was used to remove the para-methoxybenzyl group from diene 205, 1H NMR 
and IR analysis showed that in addition to its removal the resulting alcohol underwent an 
intramolecular Michael addition with oxidation of the epoxide functionality. This 
transformation gave the spiroketal 219 in 22% yield. The remaining crude reaction mixture 
contained none of the desired alcohol 218 but rather a mixture of non-isolable side-products 
(Scheme 57). Although this was a disappointment, it was not a complete surprise. The 
oxidation of allylic alcohols to the corresponding enone by DDQ is well documented in the 
literature.101,102 The replacement of DDQ with cerium ammonium nitrate (CAN) also proved 
ineffective. 1H NMR and IR data showed that both the ketal protecting group and the benzyl 
group had been removed. In addition, oxidation of the primary alcohol to give the 
unsaturated aldehyde 220 was also observed due to the presence of an aldehyde peak in the 
1H NMR. Upon this discovery it was found that the removal of ketal groups with CAN is a 
transformation that has been reported in the literature.103,104 Markó and others demonstrated 
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that stoichiometric amounts of CAN will remove ketal groups in high yields, which they 
proposed was via a single electron transfer mechanism.  They also showed that catalytic 
amounts of CAN, in the absence of a co-oxidant, could remove ketal groups by acting as a 
Lewis acid. By monitoring the reaction of catalytic amounts of CAN by cyclic voltammetry 
they revealed Ce(IV) to be the only cerium species present throughout the reaction process, 
which could therefore not behave as a redox catalyst. They found that Ce(NO3)3, Ce(OTf)4 
and other lanthanide salts were inert under the same reaction conditions. Nonetheless, the 
use of CAN was considered to be a mild option for the ketal deprotection at a later stage, i.e 
after the synthesis of the resorcylate.  
 
Scheme 57: Attempts Towards the Synthesis of Alcohol 218 
Since alcohol 195 had been synthesised previously, it was ultimately used in a Suzuki 
coupling with epoxide 180 (Scheme 57). This reaction gave the desired diene 218 in an 
unsatisfactory 26% yield. In looking to address these difficulties, it was thought to be 
appropriate not to utilise the benzyl protecting group and instead protect the primary alcohol 
as the triethylsilyl (TES) ether. 
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 Synthesis of Aldehyde 179 2.10
 
In a similar manner to that of the benzyl analogue 194, silyl ether 225 was synthesised in 
seven steps and 29% overall yield from β-propiolactone (Scheme 58). Alcohol 190 was 
treated with triethylsilyl ether to give the protected amide 221 in 99% yield. Alkylation gave 
alkynone 222 in 94% yield which was used directly in the next step without purification by 
chromatography. At this stage it was found that the unstable alkynone 222 had to be 
protected immediately as the ketal to avoid decomposition. This transformation, along with 
the simultaneous deprotection of the silyl ether, was performed according to the previously 
optimised procedure. This gave alcohol 223 in 68% yield. Removal of the trimethylsilyl 
group, silyl reprotection and hydroboration gave boronic ester 225 in 63% over three steps. 
It was found that leaving alkyne 224 and pinacol borane to react until complete consumption 
of starting material (as monitored by 1H NMR of the crude material) was in fact detrimental 
to the yield as slight decomposition of the product began to occur. Termination of the 
reaction at approximately 85-90% consumption of the starting material gave the best yield 
for this transformation (76%). 
 
Scheme 58: Synthesis of Boronic Ester 225 
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With boronic ester 225 in hand, the subsequent coupling with alkene 180 gave the 
cis, trans-diene 226 in 71% yield.105 Although it would have been preferred, direct 
conversion of 226 to aldehyde 179 under Swern conditions106 was not possible resulting in 
decomposition of diene 226.  On the other hand, a two-step procedure proved satisfactory. 
Tetrabutylammonium fluoride promoted removal of the silyl ether gave 218 in 91% yield. 
Oxidation with Dess-Martin periodinane gave aldehyde 179 in 83% yield. At this stage the 
key intermediate was ready for addition of the third and final fragment.  
 
Scheme 59: Synthesis of Aldehyde 179 
 
 Addition of the Dioxinone Fragment 2.11
 
The third fragment, chloro-keto-dioxinone 178, contained the remaining functionalities 
required for the synthesis radicicol (1). Through the modification of conditions, the synthesis 
of the known literature compound 178 was improved to 54% yield through the acylation of 
the lithium enolate derived from dioxinone 55 with chloroacetyl chloride (Scheme 60).107 
With the final component 178 in hand, attention turned to the aldol addition with aldehyde 
179. Although the dianion of keto-dioxinone 178 was successfully formed, no reaction was 
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observed upon addition of aldehyde 179. Increasing the reaction temperature also proved to 
be ineffective and starting materials were recovered (Scheme 60).  
 
Scheme 60: Synthesis of Keto-dioxinone 178 and Attempts Towards its Reaction with Aldehyde 
179 
The addition of diethylzinc has been shown previously within the group to aid C-acylations 
of keto-dioxinones.61 It has been proposed that transmetallation to the zinc enolate forms a 
less basic alkylzincate species which suppresses undesired α-proton exchange. This effect 
ultimately decreases the amount of side reactions and improves the overall efficiency of the 
enolate. Noyori first used dimethylzinc to aid C-acylations in 1989 and reported the 
improvement of the acylation of cyclohexanone with octanoyl chloride and a dimethylzinc 
additive from 65% (the highest previously reported yield with lithium enolates) to 88% yield 
(Scheme 61).108 It was suggested that upon transmetallation a lithium alkoxydialkyzincate 
species such as 232 could be formed and NMR experiments, which showed a chemical shift 
of the Li7 signal, supported this theory (Scheme 61). Unfortunately in this system the 
addition of diethylzinc did not offer any improvement and again no reaction was observed 
(Scheme 60). 
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Scheme 61: Noyori’s Work on Zinc Enolates 
To further investigate the reactivity of chloro-keto-dioxinone 178, its addition to 
butyraldehyde was examined (Scheme 62). In comparison to 179 this reaction proceeded 
sluggishly; product formation was not observed at temperatures below 0 °C. Contrary to 
what was expected this reaction gave the trans-epoxide 234 exclusively in 19% yield. The 
addition of diethylzinc did not improve the yield. At this point it became evident that the 
introduction of the required chlorine into the radicicol framework was not feasible via this 
protocol. Given the low reactivity of chloro-keto-dioxinone 178 to electrophiles and our 
interest in exploring aldol additions of this type, it was decided not to investigate a 
C-acylation with chloro-keto-dioxinone 178. 
 
Scheme 62: Reaction of Keto-dioxinone 178 with Butryaldehyde 233 
As a consequence an alternative approach was considered, which involved an aldol addition 
of the equivalent keto-dioxinone lacking the chlorine atom (117). This would ultimately give 
the natural product monocillin I (145), the chlorination of which to radicicol (1) is a known 
literature procedure.80 
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  Aldol Addition of Keto-dioxinone 117 2.12
 
Keto-dioxinone 117 is a known compound that was synthesised according to a procedure 
developed within the group (Scheme 63). For the first attempt of the aldol addition, the 
dianion of keto-dioxinone 117 was formed with freshly prepared lithium diisopropylamide 
and stirred for one hour at −78 °C prior to addition of aldehyde 179 at the same temperature. 
The reaction was warmed to −10 °C over three hours as TLC analysis showed aldehyde 179 
appeared to remain present. The mixture was quenched at −10 °C with a saturated aqueous 
solution of ammonium chloride when it was allowed to warm to room temperature and 
acidified to a pH of 3-4 prior to extraction with ethyl acetate. Purification by 
chromatography gave the desired hydroxy-keto-dioxinone 235 in a promising conversion of 
approximately 28%, with the remaining mass recovered as aldehyde 179 (Table 5, Entry 1). 
 
Scheme 63: Synthesis of Hydroxy-keto-dioxinone 235 
Following this result, the aldol transformation was extensively studied and conditions were 
optimised to reach those that gave a reliable procedure for this transformation (Table 5). 
When the reaction temperature was maintained at −78 °C for three hours following addition 
of aldehyde 179, this led to an improvement of the yield to 40%, however 30% starting 
material was recovered (Entry 2). As a result, further equivalents of the dianion were used 
(three equivalents, Entry 3) but this resulted in a side-product being formed, whereby the 1H 
NMR showed the protons in the diene-epoxide region to be significantly shifted relative to 
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that of aldehyde 179. Diethylzinc was utilised as an additive, although this in fact decreased 
the yield to 20%, with 30% returned aldehyde 179 (Entry 4). On formation of the dianion 
with lithium diisopropylamide, it was seen to precipitate out of solution and it was proposed 
that it was possible this was not being entirely formed when left stirring at −78 °C. Therefore 
the dianion was warmed to −40 °C over an hour prior to addition of aldehyde 179 at −78 °C. 
This slightly improved the yield to 52% (Entry 5) and when aldehyde 179 was added at 
−40 °C this made no difference to the yield (55%, Entry 6). On all occasions aldehyde 179 
persisted in being recovered following the reaction, despite the fact that when the reaction 
was monitored by TLC it appeared to be completely consumed after three hours. It was 
proposed that upon quenching and warming of the reaction to room temperature a retro-aldol 
transformation could be occurring which would return starting material when it had 
originally seemed to have been reacted. With this in mind, the quenching of the reaction was 
examined and a first attempt through the addition of aqueous 10% acetic acid solution at 
−40 °C resulted in the decomposition of material (Entry 7). When the reaction was quenched 
with 4.5 equivalents of formic acid, which was added in THF at −40 °C (Entry 8) and 
subsequently washed with water following warming to room temperature, only 40% of 235 
was isolated, however no starting material was returned. This was an encouraging result and 
it was hoped that material was being lost in the aqueous wash. As a result, in another 
attempt, the solution was washed with an acidic aqueous solution (pH 3-4) following 
quenching with formic acid and to our delight a yield of 73% was achieved with no aldehyde 
179 recovered (Entry 9). Finally it was confirmed that it did indeed take three hours for full 
consumption of the aldehyde 179 to occur (Entry 10) and that diethylzinc did not improve 
yields for this reaction (Entry 11). The aldol addition has since been repeated on numerous 
occasions, giving consistently high yields for the transformation. 
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Entry Conditionsa,b,c Yield of 235
d 
(%) 
1 a) LDA, 117, THF, −78 °C, 1 h; b) 179, −78 °C to −10 °C, 3 h 
 
~28e 
2 a) LDA, 117, THF, −78 °C, 1 h; b) 179, −78 °C, 3 h 
 
40 [30% 179] 
3 a) LDA, 117 (3 eq.), THF, −78 °C, 1 h; b) 179, −78 °C, 3 h 
 
0 [side product]f 
4 a) LDA, 117, THF, −78 °C, 1 h; b) Et2Zn; c) 179, −78 °C to −10 °C, 3 h 
 
20 [30% 179] 
5 a) LDA, 117, THF, −78 °C to −40 °C over 1 h; b) 179, −78 °C, 3 h 
 
52 
6 a) LDA, 117, THF, −78 °C to −40 °C over 1 h; b) 179, −40 °C, 3 h 
 
55 [27% 179] 
7 a) LDA, 117, THF, −78 °C to −40 °C over 1 h; b) 179, −40 °C, 3 h; c) 
10% aq. AcOH (excess), −40 °C to rtg 
 
decomposition 
8 a) LDA, 117, THF, −78 °C to −40 °C over 1 h; b) 179, −40 °C, 3 h; c) 
formic acidh, THF, −40 °C to rt; dilute H2Og 
 
40 [0% 179] 
9 a) LDA, 117, THF, −78 °C to −40 °C over 1 h; b) 179, −40 °C, 3 h; c) 
formic acidh, THF, −40 °C to rt; aq. wash, acidified to pH 3-4 with 
10% aq. AcOHg 
 
73 
10 a) LDA, 117, THF, −78 °C to −40 °C over 1 h; b) 179, −40 °C, 1.5 h; c) 
formic acidh, THF, −40 °C to rt; aq. wash, acidified to pH 3-4 with 10% 
aq. AcOHg 
 
4:3 ratio of 
235/179 
11 a) LDA, 117, THF, −78 °C to −40 °C over 1 h; b) Et2Zn −78 °C to −40 
°C, c) 179, −40 °C, 3 h; c) formic acidh; aq. wash, acidified to pH 3-4g 
58 
Table 5: Optimisation of Conditions for Aldol Addition 
a) all reactions used freshly prepared LDA to which 117 was added; b) work-up unless otherwise stated: 
quenching with sat. aq. NH4Cl, warming to rt, acidifying solution to pH 3-4 with aq. 10% AcOH and extracting 
with EtOAc; c) 2 equivalents of 117 used unless otherwise stated; d) yield of 235 unless otherwise stated; e) 
approximate conversion as 235 was contaminated with an impurity; f) side product was returned that had 
significantly shifted peaks in the 1H NMR for the diene-epoxide moiety; g) extracted EtOAc; h) 4.5 equivalents 
of formic acid. 
 
  Towards the Synthesis of Diketo-Dioxinone 237 2.13
 
The subsequent step was formation of the diketone portion so that the ketene could be 
generated, trapped to give a triketo-lactone and consequently aromatised. This was 
achievable through oxidation of alcohol 235 with Dess-Martin periodinane with an 
approximate yield of 65% (Scheme 64). Due to the instability of the diketo-dioxinone, 
purification by chromatography resulted in loss of the product. The 1H NMR of the product 
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showed the desired diketo-dioxinone 236, existing as the enol tautomer, and a HRMS 
supported this. However it was not possible to fully characterise 236 as it was inseparable 
from small amounts of either an impurity or the keto-tautomer that is depicted in Scheme 64. 
Different procedures were applied for the purification of 236 and it was found that filtration 
through Celite®, followed immediately by chromatography gave the best conversion. As a 
result, a new route to diketo-dioxinones has been developed, whereby aldol addition of keto-
dioxinone to an aldehyde and ensuing Dess-Martin periodinane oxidation forms the diketo-
dioxinone. 
 
Scheme 64: Oxidation to Diketo-dioxinone 236 and Attempted Formation of Alcohol 237 
Diketo-dioxinone 236 was then treated with several different fluoride reagents in an attempt 
to remove the silyl ether group, the results of which are outlined below (Table 6). Stirring 
silyl ether 236 with two equivalents of TBAF for 24 hours did not result in the full reaction 
of 236. Separation of the compounds from this reaction by chromatography was not possible 
and this additionally led to the majority of material decomposing during this procedure 
(Entry 1). When the reaction was repeated with five equivalents of TBAF, this led to 
complete decomposition of diketo-dioxinone 236 (Entry 2). Stirring 236 with two 
equivalents of TBAF for four days (Entry 3) or one equivalent for five days (Entry 4) 
resulted in consumption of diketo-dioxinone 236. However, multiple products were formed 
OH
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and any form of work-up or chromatography led to the decomposition of material and the 
separation of products from residual TBAF or ammonium salts was not possible.  
 
Entry Conditions Result 
1 TBAF (2 eq.), THF, rt, 24 h; 
chromatography 
 
partial reaction of 236. Chromatography could not 
separate products from 236 and led to decomposition 
2 TBAF (5 eq.), THF, rt, 24 h 
 
decomposition 
3 TBAF (2 eq.), THF, rt, 4 d consumption of 236, ultimately decomposition 
 
4 TBAF (1 eq.), THF, rt, 5 d consumption of 236, ultimately decomposition 
 
5 i) TBAF, rt, 4 d; ii) SO3H resin 
and (SO3)2Ca resin 
 
decomposition  
6 i) TBAF, rt; ii) (SO3)2Ca resin 
 
decomposition 
7 CsF, MeCN, rt 
 
decomposition 
8 HFpy, CH2Cl2, rt 
 
products were formed with significantly shifted hydrogen 
peaks in the 1H NMR of the crude material 
 
9 KF, 18-crown-6, THF, rt decomposition 
   
10 HFpy, py, CH2Cl2, rt; Ca(OH)2, 
azeotrope toluene 
products were formed with significantly shifted hydrogen 
peaks in the 1H NMR of the crude material 
 
Table 6: Attempts Towards the Removal of the TBDPS Protecting Group 
 
Parlow et al., described the use of Amberlyst® resins to sequester ammonium salt by-
products and excess TBAF from reactions (Scheme 65).109,110 When both the calcium (239) 
and sulfonic acidic (238) resins are added to the reaction upon its completion, excess TBAF 
is removed to give insoluble CaF2 and the tetrabutylammonium sulfonate 244. The 
ammonium alkoxide is quenched by resin 238 to give 244 and the free alcohol 243. 
Filtration and evaporation leaves the alcohol 243 and the silyl fluoride 241, if this is not 
volatile. However, when both resins were used for this purpose complete decomposition 
occurred (Entry 5). It was possible that just the sulfonic acid resin was causing 
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decomposition and as a result the calcium resin was used alone (Entry 6), however 
unfortunately this also resulted in decomposition.  
 
Scheme 65: Amberlyst Resins For Removal of Tetrabutylammonium Salts 
Other fluoride sources were explored (Entry 7-10) however, 1H NMR analysis of the crude 
material showed either complete decomposition (Entry 6, 7 and 9) or multiple products, 
where the proton peaks in the alkene region had been significantly shifted, implying the 
diene functionality in the product had also reacted (Entry 8 and 10). Disappointingly, all 
attempts to remove the silyl group from diene 236 proved unsuccessful. It was postulated 
that due to the diketo-dioxinone moiety, the hydrogen alpha to the two ketones was 
sufficiently acidic to be deprotonated by the fluoride ion and go on to react inter or 
intramolecularly in a number of ways.  
 
 Synthesis of Diol 245 2.14
 
 In order to address the concern of the stability of diketo-dioxinone 236, it was decided not 
to pursue this further and instead remove the silyl ether from the hydroxy-keto-dioxinone 
235. Should this be possible, it was proposed that on generation of the ketene, the desired 
macrocycle 246 might be favourably formed over the 8-membered lactone 247 (Scheme 66). 
As was predicted, removal of the silyl ether was facile for the hydroxy-ketone 235 with 
SO3H + Ca(OH)2 (SO3-)2Ca2+
ROSiR'3 + NBu4F FSiR'3 + NBu4F + RO-+NBu4 ROH
CaF2
(SO3-)+NBu4 SO3H(SO3-)2Ca2+
+
243
241240
239
242
238
244239 238
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tetrabutylammonium fluoride in 79% to give diol 245 (Scheme 66). Presumably this was due 
to the fact that 235 did not contain the acidic proton. After an initial attempt at generating the 
ketene and following chromatography (Table 7, Entry 1), the 1H NMR seemed to show a 
mixture of the two products 246 and 247. Partial separation allowed the 1H NMR to be 
assigned to 246 in a tentative manner as all peaks appeared as would be predicted, along 
with H couplings in the COSY NMR. The 1H NMR showed a shift in the position of the two 
alcohol protons 1 and 2 (highlighted in Scheme 66) by approximately 1 ppm relative to the 
starting material 245. This indicated a significant change to both environments, such as 
hydrogen 1 now forming part of the macrocycle and hydrogen 2 forming the lactone. Should 
it have been the eight membered lactone 247, one would only expect hydrogen 3 to have 
shifted as hydrogen 4, by contrast, would have a very similar environment to that of the 
starting material and it was for this reason 246 was assigned as the major product. The 
second compound, which was assumed to be lactone 247 contained too many contaminants 
to make a reasonable judgement as to whether this was the product, however there did 
appear to be the correct number of hydrogens in the predicted regions of the 1H NMR. There 
was significantly more of proposed macrolactone 246 than the proposed macrolactone 247. 
The mixture of products was taken on to the next step, but an attempt to oxidise the lactones 
246 and 247 to triketo-lactone 248 and diketo-lactone 249 with Dess-Martin periodinane led 
to decomposition of material (Scheme 66). 
   79 
 
Scheme 66: Synthesis of Diol 245 
Upon repetition of the ketene trapping, following the same conditions to those used 
previously (Table 7, Entry 1), only small amounts of the two macrocycles was formed 
(~14% conversion, Entry 2) and repetition a third time led to no product being returned at all 
(Entry 3).  
 
Entry Conditions Result 
1 toluene, reflux 
 
high conversion, with proposed 246 as major product 
3 toluene, reflux 
 
~14% conversion 
3 toluene, reflux similar products to Entry 1 and 2 seen in crude NMR, nothing 
returned following chromatography 
 
4 toluene, 90 °C similar products to Entry 1 and 2 seen in crude NMR, nothing 
returned following chromatography 
 
5 toluene (redistilled), 
reflux 
similar products to Entry 1 and 2 seen in crude NMR, nothing 
returned following chromatography 
 
6 MgBr2OEt2, toluene, 
reflux 
 
decomposition 
Table 7: Attempts Towards Formation of Macrocycle 246 
 
Analysis by 1H NMR of the crude material of Entry 3 showed similar products (but not 
identical) to that of the compounds 246 and 247 from Entry 1, but following chromatography 
no material was recovered. It was proposed that the diketo-acid could be being formed 
through trapping of the ketene with water from the solvent however re-distillation of the 
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toluene did not change the result (Entry 5). The reaction was repeated at a lower temperature 
but again this gave the same unidentifiable products (Entry 4). Finally magnesium bromide 
etherate was added in an effort to coordinate this between the alcohol and the adjacent β-
ketone in the hope of blocking reactivity at this site and promoting reaction at the desired 
alcohol, but this led to decomposition (Entry 6).   
It was anticipated that a selective oxidation of diol 245 might be possible due to the 
sufficiently different environments of the two alcohols in 245. Manganese dioxide and Dess-
Martin periodinane were both utilised for this investigation but these gave returned starting 
material and multiple by-products respectively (Scheme 67).  
 
Scheme 67: Attempted Oxidation of Diol 245 
Disappointingly it was thought that this was not a sensible route to pursue further and that 
given the delicate nature of these intermediates, when the diketo-dioxinone portion is 
installed, it was not appropriate to try to react the compound in any way other than 
generating and trapping the ketene. 
 
  Conclusion 2.15
 
Significant progress was made towards the synthesis of radicicol (1) in an intramolecular 
ketene-trapping manner and the scaffold to radicicol was generated.82 Additionally, a new 
route to diketo-dioxinones was developed through an aldol-oxidation sequence in good and 
reliable yields.82 It was found that due to the reactive nature of the conjugated diene-epoxide 
and diketone functionality, it was not a suitable pathway to take for the synthesis of such 
HO O
OOHOOOO
O
HO O
OOOOOO
O
oxidation
237245
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complex resorcylate natural products and the intermolecular ketene trapping route was more 
appropriate. It is important to note however that the sensitive diene-epoxide functionality did 
not survive multiple deprotection conditions, not only in this intramolecular ketene trapping 
pathway, but also during the intermolecular ketene trapping route (see section 2.3.3). By 
contrast the diene-epoxide survived the generation of the diketo-dioxinone through aldol and 
oxidation reactions and the epoxide remained intact under the aromatisation conditions of 
the intermolecular route (section 2.3.3). This highlights the mild nature of the Barrett group 
chemistry developed for the synthesis of complex resorcylate natural products and shows 
how functional group-tolerant the methodology is. 
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CHAPTER 3 
PAECILOMYCIN B 
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3. PAECILOMYCIN B 
  Isolation, Structure and Biological Activity 3.1
 
In 2010 Wei and co workers isolated six new RALs, paecilomycins A-F (Figure 6), from the 
mycelia solid culture of Paecilomyces sp. SC0924 collected in south China.111 Their 
structures were determined through the use of single-crystal X-ray analysis, NMR studies 
and chemical correlations. The paecilomycins A-F (250)-(254) were assessed for their 
antiplasmodial activity. Although paecilomycins C (251) and D (252) were discovered to be 
inactive, it was found that compounds A, B, E and F showed activity against the 
Plasmodium falciparum line 3D7 which is a chloroquine-susceptible line. The IC50 values of 
the compounds in this particular cell line were found to be 0.78 µM, 3.8 µM, 20.0 nM and 
1.1 µM respectively. A cytotoxicity assay found congeners A, B, E and F to be relatively 
noncytotoxic (IC50 > 50 µM) to the mammalian Vero cell line.  
 
Figure 6: Paecilomycins A-F 
This promising biological profile has sparked interest in the possible use of the 
paecilomycins as models for the investigation of new antimalarial targets. Although at the 
outset of this project there were no reported syntheses of paecilomycin B (5), very recently 
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(May 2015) Ohba and Nakata reported the first total synthesis of paecilomycin B (5). This 
shall be discussed later in the chapter (see section 3.5).112 
 
  Previous work Towards Paecilomycin B Within the Barrett Group 3.2
3.2.1 Retrosynthetic Analysis 
 
Previous unpublished work of former laboratory member Hideki Miyatake-Ondozabal had 
focused on the group’s first synthetic study of paecilomycin B (5). The aim of his approach 
was to construct the resorcylate through two key steps, an intramolecular ketene trapping 
and a late stage transannular aromatisation from diketo-dioxinone 256. From methodology 
developed in the Barrett laboratories, diketo-dioxinone 256 could be obtained from Weinreb 
amide 257 and keto-dioxinone 117 through a C-acylation. The retrosynthetic analysis of the 
approach is outlined below (Scheme 68). 
 
Scheme 68: Intramolecular Ketene Trapping Approach to Paecilomycin B (5) 
The proposed route to the key Weinreb amide building block 257 envisioned a cross 
metathesis between tetrahydropyran 259 and alkene 258 to install the trans-olefin in 257 
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(Scheme 69). The tetrahydropyran unit itself would be furnished through a 6-exo-tet 
cyclisation of epoxide 260. This in turn, could be constructed from the extended enone 261 
via a diastereoselective reduction/epoxidation sequence. Ketone 261 could be synthesised 
through an aldol reaction between (S)-glyceraldehyde acetonide 263 and enone 262.  
 
Scheme 69: Retrosynthetic Analysis of Weinreb Amide 257 
 
3.2.2 Attempt Towards the Tetrahydropyran Fragment 
 
A Swern oxidation of commercially available alcohol 264 furnished aldehyde 263. A 
subsequent aldol reaction with the lithium enolate derived from enone 262 provided 
predominantly the desired diastereoisomer 265 as predicted by the Felkin-Anh model.113 
TBS protection and a subsequent diastereoselective CBS reduction gave the syn mono-
protected diol 268. This configuration was assigned by removal of the TBS silyl ether to 
give the unprotected diol, which was in turn masked as the acetonide (271). Analysis of the 
13C NMR of 271 showed characteristic shifts for the syn configuration.114 Moving forward, a 
vanadium catalysed diastereoselective epoxidation and silyl protection sequence gave 
epoxide 269. Although numerous conditions were screened in hopes of removing the 
acetonide group, these resulted in decomposition or the formation of unknown side-products. 
Ultimately tetrahydropyran 270 was never detected. Although tin chloride was found to 
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effect the desired deprotection it unfortunately promoted the formation of bicycle 272. 
Derivatisation of alcohol 272 to the 3,5-dinitrobenzoyl ester analogue allowed a crystal 
structure to be acquired and the absolute stereochemistry of this compound was confirmed. 
 
Scheme 70: Attempt Towards Tetrahydropyran 270 
A proposed mechanism for the synthesis of bicycle 272 is shown (Scheme 71). Following 
acetonide deprotection a Lewis acidic catalysed epoxide opening could give the carbocation 
274. If a 1,2-hydride shift were to occur then cyclisation could form tetrahydropyran 276. 
Finally formation of the oxonium ion intermediate could lead to a second cyclisation and 
silyl deprotection would give the product 272. Yamamoto has reported similar 
rearrangements of optically active epoxy silyl ethers with an anti-migration of the hydride 
shift occurring in a concerted fashion.115 Further mechanistic studies would be needed to 
validate this mechanism. However were this pathway to occur as outlined, it shows there is a 
need for the protection of the primary alcohol. Additionally, Lewis acidic conditions would 
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preferentially be avoided for the deprotection of the acetonide to by-pass the side-product 
272 forming.  
 
Scheme 71: Proposed Route to Tetrahydropyran 272 
It was thought that an alternative route to encompass these pre-requisites would result in a 
long, linear synthesis with the need for many protecting group manipulations. Additionally, 
it was found previously that an intermolecular trapping of ketenes derived from highly 
functionalised diketo-dioxinones was a more suitable route than an intramolecular trapping 
(see Chapter 2). Given the complexity of paecilomycin B (5) it was postulated that this could 
be the case for this natural product as well. As a result an entirely new retrosynthesis was 
proposed. This synthetic study is the topic of this chapter.  
 
  First Approach to Paecilomycin B 3.3
3.3.1 Retrosynthetic Analysis 
 
It was anticipated that paecilomycin A (250) could initially be formed and from this 
paecilomycin B (5) through ring opening of the epoxide (Scheme 72). It was postulated that 
it was likely this is how paecilomycin B (5) is biosynthesised and we therefore wanted to 
exploit this rationale and achieve the total synthesis of both natural products. A ring-closing 
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metathesis on resorcylate 278 could be used to form the macrocycle and 278 could be 
created through ketene generation of diketo-dioxinone 279 and trapping with commercially 
available alcohol 36, followed by aromatisation. Diketo-dioxinone 279 could be generated 
through the aldol/oxidation sequence previously developed between keto-dioxinone 117 and 
aldehyde 280. 
 
Scheme 72: Retrosynthetic Analysis of Paecilomycin A (250) and B (5) 
 
3.3.2 Retrosynthetic Analysis of Aldehyde 280 
 
It was proposed that aldehyde 280 could be formed through oxidation of alcohol 281 
(Scheme 73). Epoxidation of allylic alcohol 282 should occur in a diastereospecific fashion 
through a Sharpless asymmetric epoxidation to give epoxide 281. Allyl alcohol 282 could be 
formed from a reduction of enoate 283 which itself would be the product of a cross-
metathesis between alkene 284 and methyl acrylate. The terminal alkene of 283 could be 
installed through a Wittig reaction and a Brown allylation with aldehyde 285 should give the 
desired stereochemistry of alkene 284. Finally it was anticipated that aldehyde 285 would be 
generated from ring opening of commercially available lactone 286. 
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Scheme 73: Retrosynthetic Analysis of Aldehyde 280 
 
3.3.3 Synthesis of Weinreb Amide 288 
 
Weinreb amide 288 is a known literature compound. However, when the reported conditions 
for its synthesis using trimethylaluminium and N,O-dimethylhydroxylamine hydrochloride 
were applied to lactone 286 with subsequent hydroxy protection, silyl ether 288 was isolated 
in a yield of 24% over the two steps with 21% returned lactone 286 (Table 8, Entry 1). A 
yield of 66% had been reported for this two step transformation.116 
 
Scheme 74: Synthesis of Amide 288 
It was proposed that cleavage of the alkoxy bond could be slow and therefore on repetition, 
the crude alcohol 287 was stirred with Rochelle’s salt overnight (Entry 2). This however 
returned almost entirely lactone 286. In a third attempt dimethylaluminium chloride was 
substituted for trimethylaluminium and a pH 8 phosphate buffer was utilised for the work-up 
as these conditions were reported for the ring-opening of a range of lactones to give the 
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corresponding Weinreb amides.117 When this was applied to lactone 286 very little reaction 
was observed with almost entirely lactone 286 returned (Entry 3). Washing with aqueous 
sodium hydroxide returned no material, starting material or otherwise, following extraction 
(Entry 4). It was considered that the lactone was reforming after addition of the amine as a 
result of the significant amount of starting material being returned on all attempts relative to 
alcohol 287 when TLC analysis prior to a work-up suggested otherwise. The previously 
optimised conditions for opening of β-propiolactone (see section 2.5.3) were applied to 
lactone 286 and while this returned a low ratio of the starting material there was very low 
conversion to alcohol 287 (<15%, Entry 5). Given the acidic wash had returned small 
amounts of lactone 286 this was used following reaction with trimethylaluminium and N,O-
dimethylhydroxylamine hydrochloride. Pleasingly, following silyl protection this gave 
Weinreb amide 288 in a good yield (71%) over the two steps (Entry 6). Chromatography of 
alcohol 287 resulted in partial re-laconisation so this was avoided.  
 
Entry Conditions Result 
1 MeNH(OMe)HCl, AlMe3, THF, −15 °C to rt; 
Rochelle’s salt; then TBSCl, Im, CH2Cl2 
 
24% 288 over 2 steps with 21% 
lactone 286 
2 MeNH(OMe)HCl, AlMe3, THF, −15 °C to rt, 
Rochelles salt 16 h 
 
lactone 286 major product 
3 MeNH(OMe)HCl, AlMe2Cl, CH2Cl2, 0 °C to rt;  
pH 8 phosphate buffer 
 
3:1 ratio of 286/287  
4 MeNH(OMe)HCl, AlMe2Cl, CH2Cl2, 0 °C to rt;  
aq. NaOH (1.0 M) 
 
nothing returned following 
extraction of aqueous phase 
5 
 
MeNH(OMe)HCl, AlMe2Cl, CH3CN, 0 °C to rt;  
aq. HCl (0.5 M) 
 
mainly alcohol 287 returned, 
however very low conversion 
(<15%) 
 
6 MeNH(OMe)HCl, AlMe3, CH2Cl2, 0 °C, aq. HCl 
(0.5 M) quench; TBSCl, Im, CH2Cl2 
 
71% 288 over 2 steps 
Table 8: Optimisation of Conditions for the Synthesis of Weinreb Amide 288 
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3.3.4 Synthesis of Aldehyde 292 
 
Weinreb amide 288 was successfully reduced to aldehyde 285 with diisobutylaluminium 
hydride in excellent yield (97%). A diastereoselective Brown allylation with (−)-Ipc2Ballyl 
was used to install the terminal alkene and gave the alcohol as almost the single 
diastereoisomer (dr ≥ 20:1).118 This was confirmed by the generation of the opposite epimer 
290 using (+)-Ipc2Ballyl (Scheme 75). It was not possible to separate the product of the 
Brown allylation from an unknown by-product so the alcohol was protected as the silyl 
ether. Thus upon treatment of the crude reaction mixture with tertbutyldimethylsilyl 
trifluoromethanesulfonate and 2,6-lutidine this gave alkene 289 in 84% yield over the two 
steps. 
 
Scheme 75: Brown Allylation to Install the Terminal Alkene 
The stereoselectivity from the Brown allylation is derived from the chair like-transition state 
of the transformation and the minimisation of steric hindrance (Scheme 76).119 In the lower 
energy transition state, the R group from the aldehyde occupies an equatorial position and 
thus the steric interactions between the methyl group from the diisopinocamphenyl ligand 
and the allyl group are avoided.  
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Scheme 76: Enantioselectivity of the Brown Allylation 
With the terminal alkene installed, a cross metathesis was used to further functionalise the 
olefin. It is often difficult to ensure high selectivity for cross metathesis over 
homodimerisation. It is therefore important to use olefins of different “types” to encourage 
selectivity for cross metathesis.120 If two olefins of the same type are used a statistical 
distribution of the homodimerised and cross coupled products will be returned. To avoid 
this, approximately ten equivalents of one olefin is needed to deliver 90% of the cross 
metathesis product. In addition some olefins are altogether unreactive to metathesis and will 
act as spectators. Often the most successful pairing is a type I olefin with a type II olefin. A 
type I olefin, such as a terminal alkene, will undergo rapid homodimerisation and can then 
readily undergo a secondary cross metathesis. A type II olefin, such as methyl acrylate, 
undergoes slow homodimerisation, the product of which is only partially reactive to cross 
metathesis. As a result the type I olefin will initially form the homodimerised product and 
will then partake in a cross metathesis with the type II olefin. A slight excess of the type II 
olefin should ensure full conversion of the type I olefin to the cross coupled product. This 
method was employed to form the enone moiety and given the compatibility of the two 
alkenes in question, enone 290 was formed with the desired trans geometry using Grubbs 
second-generation catalyst (131) in 78% yield (Scheme 77). From this point, moving 
forward required manipulation of the primary protected alcohol into the corresponding 
aldehyde. Removal of the tertbutyldimethylsilyl group from this alcohol was not possible 
with tetrabutylammonium fluoride as the reagent showed no selectivity between the two silyl 
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groups even at low temperatures. On the other hand, stirring the disilyl ether 290 with 
camphorsulfonic acid at 0 °C selectively removed the primary silyl ether exclusively to give 
alcohol 291 in 77% yield. Although a number of reagents and conditions were screened, the 
oxidation of alcohol 291 to the corresponding aldehyde 292 was ultimately performed with 
Dess-Martin periodinane as it gave the highest yield (91%). The key building block 292 was 
now ready for methylenation. 
 
Scheme 77: Synthesis of Aldehyde 292 
 
3.3.5 Addition of the Terminal Alkene 
3.3.5.1 Via a Wittig Transformation 
 
It soon became apparent that the transformation of aldehyde 292 to alkene 293 would not be 
trivial. The first two attempts (Table 9; Entry 1 and 2) using well-known Wittig conditions 
gave alkene 293 in a surprisingly low yield (30%) and also effected decomposition. A search 
of the literature showed this to be a common problem when there is an additional enone 
moiety in the compound. It was postulated that this could be due to the electrophilic nature 
of the enone causing side-reactions at this position.121,122 When several equivalents of the 
non-basic Lombardo’s reagent was utilised, while some reaction did occur, substantial 
amounts of aldehyde 292 was returned (Entry 3).123 Work published by Kaliappan reported 
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conditions using solid potassium tertbutoxide to form the ylide at 105 °C in toluene prior to 
addition of the aldehyde at 0 °C. He reported acceptable yields for the reaction on an 
aldehyde that also contained an enone moeity.124 A first attempt with aldehyde 292 gave 
alkene 293 in 48% yield along with 24% returned starting material 292 (Entry 4). To drive 
the reaction to completion, further equivalents of the ylide were added (Entries 5-7). While 
this initially seemed to improve the outcome (Entry 6, 57%), when the transformation was 
repeated on a tenfold scale (Entry 7) this result was found to be irreproducible (24% yield). 
Finally changing the temperature at which aldehyde 292 was added to the ylide (−78 °C; 
Entry 8) gave a very poor yield of just 4%.  
 
Entry Conditions Result 
1 MePPh3Br, NaHMDS, THF, 0 °C to rt to −10 °C 
 
30% 293 
2 MePPh3Br, KOt-Bu (1.0 M in THF), THF, −78 °C to rt 
 
decomposition 
3 CH2I2, Zn, TiCl4, solvent, rt to 0 °C to rt, 2 days 
 
1.0:0.7 292/293 
 
4 MePPh3Br, KOt-Bu (1.2 eq.), PhMe, 105 °C to 0 °C 
 
48% 293; 24% 292 
5 MePPh3Br, KOt-Bu (2.0 eq.), PhMe, 105 °C to 0 °C 
 
42% 293; 10% 292 
6a MePPh3Br, KOt-Bu (3.0 eq.), PhMe, 105 °C to 0 °C 
 
54% 293 
7b MePPh3Br, KOt-Bu (3.0 eq.), PhMe, 105 °C to 0 °C 
 
24% 293 
8 MePPh3Br, KOt-Bu (3.0 eq.), PhMe, 105 °C to -78 °C 
 
4% 293 
9 LiCH2TMS, THF, 0 °C; KHMDS, 0 °C to rt 
 
decomposition 
10 
 
LiCH2TMS, THF, −78 °C; sat. aqueous NH4Cl, −78 °C to rt decomposition 
 
11 ClMgCH2SiMe3, THF, −78 °C to rt no reaction 
 
Table 9: Optimisation of Conditions for the Generation of Diene 293 
a) 81 µmol of 292; b) 1.0 mmol of 292 
 
It appeared that a Wittig olefination would not be suitable for this transformation and as an 
alternative the Peterson reaction was investigated.125 This unfortunately proved uniformly 
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unsatisfactory. Either substrate decomposition was observed (Entries 9 and 10) or starting 
material was recovered (Entry 11). 
 
3.3.5.2     Via the β-Lactone 
 
As it was not possible to obtain alkene 293 in sufficiently high yields directly from aldehyde 
292, should formation of β-lactone 294 be possible, it was hoped thermolysis would yield 
the alkene with extrusion of carbon dioxide, as was reported in the work of Adam et al..126 
This unfortunately proved unfruitful. The requisite β-lactone was not formed as no reaction 
was observed upon treatment of aldehyde 292 with acetyl chloride and Hunig’s base 
(Scheme 78).127 In an attempt to generate alkoxy-acid 295 with acetic acid, several products 
were formed. None of these products showed protons in the vinylic region of the 1H NMR 
spectrum of the crude material showing additional reaction was occurring at the enoate. 
 
Scheme 78: Attempts Towards the Synthesis of Lactone 294 
At this stage of the synthesis it became apparent that generation of the alkene from this 
intermediate would be detrimental to the overall yield of the synthesis. Since there were no 
foreseeable problems in performing this transformation at a later stage in the synthesis, it 
was decided to carry out this sequence later on, i.e. following epoxide formation and 
construction of the resorcylate. 
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3.3.6 Generation of Aldehyde 300 
 
In order to install the allylic alcohol a cross metathesis was attempted with alkene 289 and 
allyl alcohol, however this reaction was not effective and starting material 289 was 
recovered (Scheme 79). Nonetheless, reduction of enone 290 with diisobutylaluminium 
hydride gave the allylic alcohol 296 in an excellent yield (95%). It was found it was 
necessary to maintain the temperature of the reduction around −25 °C to ensure this high 
yield. 
 
Scheme 79: Synthesis of Allyl Alcohol 296 
To initially form the epoxide meta-chloroperoxybenzoic acid (m-CPBA) was used. This 
gave a 1.0:0.8 297/298 ratio of an inseparable mixture of the two epoxides (Table 10, Entry 
1). Interestingly when the Sharpless asymmetric epoxidation conditions were applied to 
alcohol 296 to install the epoxide diastereospecifically, only small quantities of product 297 
were observed. This reaction gave predominantly starting material 296 back along with a 
small amount of unidentifiable side-products that could not be isolated. In addition, 1H NMR 
analysis of the crude material showed that these side-products no longer contained the 
acetonide (Entry 2). The same result was observed when temperatures were varied (Entry 3 
and 4) and when stoichiometric amounts of (−)-diethyl tartrate and titanium isopropoxide 
were used (Entry 5). Substitution of the peroxide for cumene hydroperoxide (Entry 6) or the 
O
O
OTBSOTBS
O
O
OTBSOTBS
MeO2C
O
O
OTBSOTBS
HO
O
O
OTBSOTBS
HO
OH
290
289
296
296
DIBALH, −25 °C
95%
Ru
PCy3
Cl
Cl
NMesMesN
Ph
(131)
Grubbs II 
catalyst
Grubbs II catalyst
(131)
CH2Cl2, 40 °C
   97 
tartrate for (−)-diisopropyl tartrate (Entry 6) also proved ineffective and gave only trace 
amounts of epoxide 297. Repetition of the conditions in Entry 2 with the allyl alcohol 
utilised for the synthesis of radicicol (1) (200, see section 2.6) gave the expected result with 
full conversion to the epoxide, showing the results with alcohol 296 could not be attributed 
to the quality of the reagents used.  
 
Entry Conditionsa Result 
1 m-CPBA, 0 °C to rt 83% 1.0:0.8 297/298 
 
2  (−)-DET cat., Ti(Oi-PrO)4 cat., TBHP,  
−30 °C 
 
1.0:0.7 296/297; 50% by weight of 
side-products  
3  (−)-DET cat., Ti(Oi-PrO)4 cat., TBHP,  
−10 °C 
 
trace 297; 296 and side-products 
4 (−)-DET cat., Ti(Oi-PrO)4 cat., TBHP,  
−40 °C 
 
trace 297; 296 and side-products b 
5  (−)-DET (1 eq.), Ti(Oi-PrO)4 (1 eq.), TBHP, 
−30 °C 
 
trace 297; 296 and side-products b 
6 (−)-DET cat., Ti(Oi-PrO)4 cat., cumene  
hydroperoxide, −30 °C 
 
trace 297; 296 and side-products b 
7  (−)-DIPT cat., Ti(Oi-PrO)4 cat., TBHP,  
−30 °C 
trace 297 and side-products; majority 296 
   
Table 10: Attempted Epoxidation Using Sharpless Conditions 
a) all reactions were performed in CH2Cl2; b) determined by TLC analysis 
 
Attention then turned to a vanadium catalyst with the use of a chiral ligand developed by 
Yamamoto to promote diastereoselectivity (Table 11, Entry 1).128 This employs 
vanadium(V) oxytriisopropoxide with a hydroxamic acid ligand 299 and tertbutyl 
hydroperoxide as the oxidant. 
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Entry Conditions Result 
1 299, VO(Oi-Pr)3, TBHP, CH2Cl2, 0 °C 1:1.3 297/298 
 
2 VO(acac)2, TBHP, CH2Cl2, −10 °C, 3 days 
 
44% 297; 0% 298 
3 VO(acac)2, TBHP, CH2Cl2, −30 °C, 5 days 
 
35% 297; 0% 298 
4 VO(acac)2, TBHP, CH2Cl2, −10 °C, 24 h 
 
48% 297; 0% 298 
Table 11: Epoxidation Using Vanadium Catalysts 
  
The proposed chiral transition state to explain the obtained diastereoselectivity for the 
reaction is shown in Figure 7. As can been seen from the ligand in i) when this is divided 
into four quadrants, b and d (as depicted in the circle) are significantly more sterically 
congested. Upon addition of the vanadium centre (VO(i-PrO)3) the hydroxy groups of the 
ligand will displace two of the isopropoxide ligands while tertbutyl hydroperoxide displaces 
the third isopropoxide group and occupies the less crowded third quadrant. The allyl alcohol 
will then coordinate to vanadium from above leaving attack of the tertbutyl hydroperoxide to 
the alkene from below. 
 
Figure 7: Proposed Intermediate for the Stereoselective Epoxidation 
When the conditions were applied to allyl alcohol 296 both epoxides were obtained in a ratio 
of 1:1.3 297/298, favouring the wrong diastereoisomer. Surprisingly, when VO(acac)2 was 
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used without a chiral ligand, the desired epoxide 297 was obtained without any of 
diastereoisomer 298 observed (Entry 2). Repetition of the reaction at a lower temperature 
(Entry 3) did not improve the yield. It was also found that when the reaction time was 
decreased to 24 hours the yields did not decrease, despite the fact the reaction did not go to 
completion (48%, Entry 4). 
Given the surprising diastereoselectivity of the epoxidation without the use of a chiral 
ligand, it was hoped a crystal structure could be obtained. Following oxidation of alcohol 
297 with Dess-Martin periodinane the aldehyde 300 was obtained in 88% yield as a white 
solid. Gratifyingly this material could be recrystallised from dichloromethane (Scheme 80) 
from which a crystal structure could be attained and the absolute stereochemistry confirmed 
(see appendix). 
 
Scheme 80: Synthesis and Crystal Structure of Aldehyde 300 
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3.3.7 Towards the Addition of the Diketo-dioxinone Functionality 
3.3.7.1     Via an Aldol Addition 
 
With the key fragment prepared, it was now possible to examine the addition of the 
dioxinone fragment. When the previously optimised conditions for the aldol addition of 
keto-dioxinone 117 (see section 2.12 and 2.13) were applied to aldehyde 300, decomposition 
was observed (Table 12, Entry 1).  
 
Entry Conditions Result 
1 
 
a) LDA, 117 (2 eq.), THF, −78 °C to −40 °C over 1 
h; b) 300, −40 °C, 10 min; c) formic acid, THF 
 
decomposition 
 
 
2 
 
a) LDA, 117 (2 eq.), THF, −78 °C to −40 °C over 1 
h; b) 300, −78 °C, 30 min; c) formic acid, THF 
 
two inseparable products with 117 
(max. conversion < 51%)a 
3 
 
a) LDA, 117 (1 eq.), THF, −78 °C to −40 °C over 1 
h; b) 300, −78 °C, 30 min; c) formic acid, THF 
 
two inseparable products with 117 
(max. conversion < 32%)a 
 
Table 12: Attempts Towards an Aldol Addition of 117 to 300 
a) maximum conversion if the product was clean, however there were impurities and 117 present  
 
 
The conditions were repeated with the addition of aldehyde 300 at a lower temperature 
(−78 °C) and the reaction was maintained at this temperature until it was quenched with 
formic acid (Entry 2). Chromatography gave an inseparable mixture of keto-dioxinone 117 
and two unidentifiable products. It was speculated that these may have been the two epimers 
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of alcohol 301 as there were protons in the necessary regions of the 1H NMR spectrum. 
Regardless, the data was inconclusive. Addition of one equivalent of the dianion of keto-
dioxinone 117 resulted in an increased number of side-products and lower conversion to 
what was tentatively assigned as the mixture of epimeric alcohols 301. 
Treatment of the products from the aldol addition with Dess-Martin periodinane gave a 
mixture of products, which did not contain the desired diketo-dioxinone 301. After this 
disappointing result, attention turned to other methods of installing the keto-dioxinone. In 
this regard, the direct C-acylation of keto-dioxinone 117 with varying electrophiles was 
investigated.  
 
3.3.7.2    Via a C-Acylation 
 
Acid 303 was obtained in quantitative yields through a Pinnick oxidation of aldehyde 300 
(Scheme 81). An initial attempt at generation of acyl imidazole 304 with carbonyl 
diimidazole gave what appeared to be the product in a 1H NMR of the crude material. 
However, 1H NMR analysis of the crude reaction mixture after further concentration 
revealed the absence of the desired product and the presence of a new major, unidentified 
product. This no longer resembled imidazole 304. Repetition of the reaction with careful 
drying following work-up gave the second unidentified product exclusively. It was 
anticipated that the acyl imidazole 304 could be transferred directly to the dianion of 
keto-dioxinone 117 without work-up or concentration. When this was undertaken many 
unidentifiable side-products were returned, without any of diketo-dioxinone 302 observed 
(Scheme 81). 
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Scheme 81: Utilising Acyl Imidazole 304 for the Attempted C-Acylation of 117 
It was hoped that the milder conditions for the acylation of β-keto, δ-ester dioxinones with 
magnesium chloride, pyridine and acid chlorides (see section 1.7.3) would be more suitable 
for this sensitive system. Should the acylation of acid chloride 305 with keto-ester 306 be 
possible, the benzyl ester functionality could be removed through a hydrogenation and 
decarboxylation (Scheme 82).  
 
Scheme 82: Utilising Acid Chloride 305 for the C-Acylation of 306 
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Acid chloride 305 was suspected to have formed using Ghosez’s reagent as oxalyl chloride 
resulted in decomposition of acid 303. However when this was added directly to the enolate 
of 306 decomposition of material occurred. 
Since an acylation with acid chloride 305 proved ineffective, the alkylation of Weinreb 
amide 308 was examined. In a standard manner, amide 308 was prepared via reaction of acid 
303 with carbonyl diimidazole and N,O-dimethylhydroxylamine hydrochloride in 89% yield 
(Scheme 83). Although the reaction of the lithium enolate of 117 with amide 308 gave 
several products, it was not possible to tell by 1H NMR analysis if diketo-dioxinone 302 was 
present. It was found that when amide 308 was added to the enolate at higher temperatures 
(i.e. from −60 °C to −20 °C) the reaction appeared to produce fewer by-products.  
 
Scheme 83: Utilising Weinreb Amide 308 for the C-Acylation of 117 and Subsequent Attempt 
at Ketene Generation and Aromatisation 
Since it was not possible to make any formal structural confirmation at this stage, the crude 
material from this transformation was treated with alcohol 36 in refluxing toluene in an 
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attempt to prepare triketo-ester 309. Subsequent to this, the proposed triketo-ester 309 
intermediate was subjected to several conditions known to effect aromatisation of triketo-
esters (see section 1.6) in hopes of forming resorcylate 310.  Although a number of reaction 
conditions were screened, they were uniformly unsuccessful. All attempts to prepare 
resorcylate 310 by this route led to substrate decomposition.  
Due to the instability of the diketo-dioxinone and triketo-ester compounds it is not possible 
to isolate or purify any intermediates along this portion of the synthetic route. In addition 
there are a large number of protons overlapping in the same region of the 1H NMRs in the 
system at hand, which rendered the monitoring of reactions and identification of 
intermediates nearly impossible. There was in fact no useful indicator for any step in the 
sequence from Weinreb amide 308 to resorcylate 310 that could reliably enable one to tell if 
the reaction was proceeding as desired. As a result it seemed appropriate to apply these 
conditions to a model system to see if this could shed light on whether these transformations 
were worth pursuing and whether conditions could be optimised. 
 
3.3.8 Model System 
3.3.8.1     Aldol Addition and Oxidation 
 
The epoxy-aldehyde substrate 171 previously prepared for radicicol (1) study provided a 
suitable model system to examine these challenging transformations. It contained the correct 
functionality and stereochemistry at the reactive site, whilst lacking the silyl ether moieties 
that made 1H NMRs particularly hard to decipher.  
The first effort at effecting an aldol addition of keto-dioxinone 117 to aldehyde 171 gave 
product 311 in low isolated yield. This was due in part to the presence of numerous side-
products as well as the inherent difficulty in removing excess keto-dioxinone 117 from the 
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product via silica gel chromatography (Scheme 84). In any case, a small sample of the pure 
epimers could be isolated from this experiment, which allowed the products to be 
characterised as hydroxy-keto-dioxinone 311. A second attempt with one and a half 
equivalents of keto-dioxinone 117 gave a better result and 311 was obtained in 
approximately 40% yield. Should the oxidation to diketo-dioxinone 312 be successful, it was 
hoped this low conversion could be improved at a later stage. 
 
Scheme 84: Aldol Addition and Oxidation on Model Substrate 171 
Much to our disappointment, the oxidation of hydroxy-ketone 311 to diketone 312 proved to 
be an insurmountable challenge. With Dess-Martin periodinane as the oxidising agent, a 
product was formed that did not seem to contain the epoxide (Table 13, Entry 1). Although 
buffering the reaction medium with sodium hydrogen carbonate appeared to offer some 
improvement, there was only approximately 50% conversion to the diketo-dioxinone (Entry 
2). The addition of pyridinium chlorochromate (PCC) led to decomposition of the starting 
material (Entry 3). Although the best results were obtained with 2-iodoxybenzoic acid (IBX) 
as the oxidising agent, it was still not synthetically useful. With either acetone (55 °C, Entry 
4) or ethyl acetate (80 °C, Entry 5) as the solvent these reactions gave the assumed diketo-
dioxinone 312 along with a significant amount of an unidentified by-product. Finally a 
Parikh-Doering oxidation gave multiple products with none of the proposed diketo-
dioxinone 312 observed in the 1H NMR of the crude material (Entry 6). It was decided that 
the yield of diketo-dioxinone 312 obtained in this model system was too low to be useful. 
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The observed substrate decomposition that occurred under these reaction conditions made 
transferal to the real system unrealistic.  
 
Entry Conditions Result 
1 DMP, CH2Cl2 
 
product formed lacking the epoxide 
2 DMP, NaHCO3, CH2Cl2 
 
1:1 311/312 
3 PCC, CH2Cl2 
 
decomposition 
4 IBX, acetone, 55°C 312 + majority silyl ether by-product 
 
5 IBX, EtOAc, 80 °C 
 
312 + majority silyl ether by-product 
6 SO3py, NEt3, DMSO, CH2Cl2 Multiple by-products, no 312 observed 
 
Table 13: Conditions for the Oxidation of Alcohol 311 
 
It was hoped that diketo-dioxinone 312 could be alternatively accessible through a C-
acylation on a substrate with a higher carbonyl oxidation state and this was subsequently 
explored. 
 
3.3.8.2    Via a C-acylation 
 
An oxidation of aldehyde 171 under Pinnick conditions to acid 313 was quantitative and 
conversion to the corresponding Weinreb amide 314 was achieved in 78% yield (Scheme 
85). 
 
Scheme 85: Synthesis of Weinreb Amide 314 
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When Weinreb amide 314 was submitted to the acylation conditions with keto-dioxinone 
117 this gave the same product that was seen in the oxidation with IBX. This was not a clean 
reaction however and multiple side-products were formed alongside diketo-dioxinone 312 
(Scheme 86). In any case, the crude material was subjected to the conditions for the 
generation of the ketene and trapping with isopropanol. 1H NMR analysis of the crude 
material obtained after this reaction sequence showed multiple products had formed and it 
did not appear that the desired product 315 was present in any significant amount. 
 
Scheme 86: Attempt Towards Triketo-ester 315 from Amide 314 
As a consequence of the results from the model system, it did not seem appropriate to 
continue investigating this route and an alternative approach was pursued. This new 
synthetic study was to proceed by way of an intermediate that had the tetrahydropyran 
system installed prior to addition of the diketo-dioxinone functionality. 
 
  Second Approach to Paecilomycin B 3.4
3.4.1 Retrosynthetic Analysis 
 
In order to incorporate the tetrahydropyran ring prior to the addition of keto-dioxinone 117 it 
was envisioned that the aldol addition of keto-dioxinone 117 could occur with aldehyde 316 
(Scheme 87). As with the previous synthetic approach, alcohol 36 could be used to trap the 
ketene and again a ring-closing metathesis would be employed to furnish the macrocycle. 
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Scheme 87: Second Retrosynthetic Approach to Paecilomycin B (5) 
The retrosynthetic analysis of aldehyde 316 is shown in scheme 88. It was seen that the 
stereochemistry of the tetrahydropyran moiety closely resembled that of the cheap and 
widely available D-glucose (322). Should this be employed as a starting material it would 
lend itself to an inexpensive and readily scalable route. The use of glucose as a chiral 
building block required for tetrahydropyran 316 necessitated the deoxygenation of D-glucose 
(322) at the 3 position. This could be achieved by proceeding via the known intermediate 
1,6-anhydro-β,D-glucose 321. With the addition of the second ring in the anhydro-glucose 
321 the hydroxy groups in the 2 and 4 positions are arranged in an axial position (pointing 
upwards) while the hydroxy group in the 3 position points downwards, in the same direction 
as the acetal cycle (Scheme 88). This conformation impedes attack from the sterically 
congested bottom face allowing for the chemoselective functionalisation of the 2 and 4 
positions. Indeed it has already been shown that the 2 and 4 positions can be selectively 
protected as the benzyl ether, while the hydroxy group in the 3 position is left untouched.129  
 
Scheme 88: Retrosynthetic Analysis of Aldehyde 316 
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After a selective deoxygenation of the 3 position to give bicycle 320, followed by acetal 
opening to give diacetate 319, a series of simple synthetic manipulations of 319 would give 
nitrile 318. This substrate could be parlayed from both ends to incorporate the necessary 
vinyl group for ring-closing metathesis and the aldehyde required for the aldol addition. 
 
3.4.2 Synthesis of Bicycle 320 
 
Fraser-Reid published the synthesis of triacetyl-1,6-anhydro sugar 323 via anhydro-sugar 
321 (Scheme 89).130 The triacetate 323 can be purified by chromatography and recrystallised 
from diethyl ether or tertbutyl methyl ether, to give a yield of 21% over the two steps.  
Ensuing treatment of 323 with sodium methoxide reforms the trihydroxy sugar 321. This 
compound is insoluble in ethanol and can simply be filtered and washed with this solvent to 
give triol 321. Although it would have been preferable, it was not possible to perform the 
benzyl protection on the crude material obtained upon tosylation of D-glucose as an 
intractable amount of side-products was obtained; hence why the longer route to 321 was 
employed.  It is worth nothing that 1,6 anhydro-β-D-glucose 321 can be bought from 
Fluorochem at £277 for 100 g. 
 
Scheme 89: Synthesis of 1,6-Anhydro Sugar 321 
Initially it was hoped that the trihydroxy sugar 321 could be protected as the para-
methoxybenzyl ethers. However when either PMBCl (Table 14, Entry 1) or PMBBr (Entry 
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2) were used for the transformation, trihydroxy 321 was returned. It was thought that the 
methoxybenzyl bromide was decomposing at 60 °C and on another attempt the reaction was 
heated at 40-50 °C however no reaction occurred below 60 °C, presumably due to the 
insufficient solubility of the barium oxide below this temperature (Entry 3). As a 
consequence the para-chlorobenzyl (PCB) protecting group was used and upon treatment of 
321 with PCBBr and barium oxide at 60 °C the desired product 324 (Ar = PCB) was formed 
in 68% yield (Entry 5). When pyridine was used as the base no reaction was observed (Entry 
6). Buchwald and Seeberger first established this novel para-halobenzyl group as a 
protecting group in 2000. It can be removed through a sequential Buchwald-Hartwig cross 
coupling of the halogen functionality to an aniline and this can subsequently be removed 
through the addition of a Lewis acid.131 
 
Entry Conditions Ar Result 
1 
 
PMBCl, BaO, DMF, 100 °C PMB returned 321 
2 
 
PMBBr, BaO, DMF, 60 °C PMB 321; decomposition of PMBBr 
3 
 
PMBBr, BaO, DMF, 40-50 °C PMB returned 321  
5 
 
PCBBr, BaO, DMF, 60 °C PCB 68% yield of 324 
6 
 
PCBBr, pyridine PCB returned 321  
Table 14: Optimisation of Conditions for the Di-protection of 1,6-Anydro-glucose 321 
 
Following on from this, it was postulated that the deoxygenation could occur via a hydride 
displacement of a tosyl group. Anhydro-sugar 325 was stirred with tosyl chloride and 
pyridine to give tosylate 326 in 82% yield (Scheme 90). It was found that an excess of tosyl 
chloride and high concentrations were necessary for the reaction to occur at this hindered 
site. Hydride sources were then screened to find one suitable for the nucleophilic 
O
OHHO
O
OH
O
OArArO
O
OH
Table 14
Entry 5; 68%
conditions
321 324
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substitution. It was discovered that lithium aluminium hydride returned alcohol 325, while 
diisobutylaluminium gave no reaction. Reaction of 326 with lithium triethyborohydride gave 
several products with alcohol 325 being the major compound isolated. Tosylate 326 was also 
treated with sodium iodide in acetone in an attempt to displace the tosyl group so that that 
the ensuing iodide 328 could be reduced to tetrahydropyran 327, yet no reaction occurred 
(Scheme 90).  
 
Scheme 90: Attempted Deoxygenation via Tosylate 326 
It was proposed that the significant steric congestion at the desired reaction site was 
hindering these transformations and it was therefore anticipated that a Barton-McCombie 
deoxygenation would be better suited to this substrate.  With this in mind, derivatisation of 
alcohol 325 to thiocarbonylimidazole 329 was executed through heating of alcohol 325 with 
thiocarbonyldiimidazole in 96% yield. Treatment of 329 with catalytic azobisisobutyronitrile 
and stoichiometric tributyltin hydride gave back starting materials (Table 15, Entry 1). 
 
Scheme 91: Barton McCombie Deoxygenation 
On the other hand, increasing the amount of azobisisobutyronitrile (one equivalent) and 
tributyltin hydride (ten equivalents) used for the transformation smoothly affected 
deoxygenation. Under these conditions compound 327 was obtained in 61% yield (Entry 2). 
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By varying the number of equivalents of the reagents an optimal yield of 87% could be 
reached (Entry 3-5).  
 
Entry Conditions Yield 327 (%)  
1 
 
AIBN (0.1 eq.), Bu3SnH (1.0 eq.), toluene, reflux 0  
2 
 
AIBN (1 eq.), Bu3SnH (10 eq.), toluene, reflux 61  
3 
 
AIBN (0.5 eq.), Bu3SnH (1.2 eq.), toluene, reflux 52  
4 
 
AIBN (0.5 eq.), Bu3SnH (3 eq.), toluene, reflux 71  
5 
 
AIBN (1 eq.), Bu3SnH (5 eq.), toluene, reflux 87  
6 AIBN (1 eq.), HSiEt3 (5 eq.), toluene, reflux 
 
<68%a  
Table15: Optimisation of Conditions for the Barton McCombie Deoxygenation 
a) as an inseparable mixture with side-products. 
 
With the hope of avoiding the use of tributyltin hydride, which is both highly toxic and 
difficult to remove following the reaction, triethylsilyl hydride was investigated as a greener 
alternative. Reaction with this compound gave bicycle 327 as an inseparable mixture with an 
unknown side-product (Entry 6). This side-product showed very similar chemical shifts in 
the 1H NMR to that of 327 and could not be removed after subsequent reactions. Although 
the use of tributyltin hydride was suitable on a smaller scale, for large scale reactions (ca 100 
mmol of tributyltin hydride) the removal of excess tin impurities became impractical with 
standard silica gel chromatography. To facilitate the removal of by-products, a protocol was 
employed which utilises silica gel impregnated with potassium fluoride.132  
 
3.4.3 Addition of the Nitrile Group 
 
Continuing to the cyano target, the addition of the nitrile group was attempted directly from 
acetal 327 with trimethylsilyl cyanide and boron trifluoride diethyl etherate. Unfortunately 
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this was not successful and starting material was recovered (Scheme 92). To work around 
this, a two-step protocol was employed. Thus diacetate 331 was generated in 97% yield 
(3.3:1.0 α/β anomer) through treatment of 327 with acetic anhydride and boron trifluoride 
diethyl etherate. The diacetate 331 was subsequently converted to nitriles 332 and 333, 
which were separable through chromatography. Trimethylsilyl trifluoromethanesulfonate 
was found to be a superior Lewis acid to boron trifluoride diethyl etherate. In addition, sub-
stoichiometric amounts of Lewis acid resulted in the highest yields giving a 1:1 ratio of 
epimers 332 to 333 in 84% overall yield. 
 
Scheme 92: Synthesis of Nitriles 332 and 333 
 
3.4.3.1      Characterisation of Nitriles 332 and 333 
 
When nitriles 332 and 333 were characterised it was discovered that the stretching frequency 
for the carbon nitrogen triple bond did not appear in the IR spectrum (~2260-2220 cm-1). 
Moreover, it did not appear in any subsequent reactions of the nitriles 332 and 333. A search 
of the literature found a similar compound 339 where the nitrile stretching frequency in the 
IR spectrum was also absent.133 Intrigued by this discovery and with a desire to eliminate 
OO
PCBO OPCB
O
PCBO OPCB
NC OHTMSCN, BF3·OEt2
O
PCBO OPCB
AcO OAcAc2O, BF3·OEt TMSCN, TMSOTf
O
PCBO OPCB
NC OAc
84% 1:1 332(β)/333(α)
CH2Cl2, 0 °C to rt
OO
PCBO OPCB
0 °C
97%; dr: 3.3:1.0 α/β
CH3CN, 0 °C
O
PCBO OPCB
NC OAc+
327 330
327 331
332 333
   114 
any ambiguities present, the characterisation of these compounds was pursued further. Both 
nitriles 332 and 333 were submitted for elemental analysis and while it was found that 
compound 333 showed the found and required values agreed with one another (Elem. Anal.: 
found C, 59.47; H, 5.15; N, 3.13; C23H23Cl2NO5 requires C, 59.49; H, 4.99; N, 3.02%) the 
elemental analysis for 332 came back high for the percentage of nitrogen and carbon and low 
with respect to hydrogen (Elem. Anal.: found C, 62.28; H, 3.02; N, 3.94; C23H23Cl2NO5 
requires C, 59.49; H, 4.99; N, 3.02%). It was reasoned that this could be a result of 
contamination with cyanide salts. To alleviate this issue, it was hoped that a crystal structure 
could be obtained through appropriate derivatisation.  
 
Scheme 93: Synthesis of Nitriles 336 and 338 and the Crystal Structure of 336 
Thus nitriles 332 and 333 were converted to alcohols 334 and 337 through saponification 
(Scheme 93). Treatment of the two alcohols with 3,5-dinitrobenzoyl chloride 335 gave the 
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corresponding esters 336 and 338. Although ester 338 was found to be an oil its epimer 
compound 336 existed as a solid. Recrystallisation through air diffusion of a 
dichloromethane/pentane solvent mix allowed crystals to be formed that were suitable for 
analysis. A crystal structure was acquired and not only did this confirm the nitrile was 
present but it served to unambiguously determine the absolute structure of nitrile 336.  
To probe the absence of the nitrile peak further, Dr Simperler from the chemistry department 
at Imperial College London ran IR calculations with compound 340 (Figure 8). All 
calculations were performed using Gaussian09 rev D.01.134 Nitrile 340 was optimised with 
the B3LYP hybrid functional135–138 and a 6-31G (d,p) basis set139,140 and a frequency 
calculation was used to confirm that the local minimum had been found. IR data was then 
obtained with this structure. 
 
Figure 8: Structure Used for Computational Calculations 
The IR data showed the carbon nitrogen triple bond stretch could be found at 2356 cm-1, 
however this was with very low intensity (Figure 9). 
340
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Figure 9: IR Stretch for Nitrile 340 
 
Figure 10: Magnified Image of Nitrile Stretch 
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This is highlighted in the magnified image shown in Figure 10 of the region surrounding the 
nitrile stretch. The predicted intensity is too weak to be differentiated from the baseline. 
It was assumed this low intensity resulted from the oxygen atom in the tetrahydropyran ring 
and to test this hypothesis, IR calculations for tetrahydropyran 341 and cyclohexane 342 
(Figure 11) were run and the results are shown in Figure 12 and Figure 13 respectively.  
 
Figure 11: Structures 341 and 342 Used to Test Hypothesis 
Indeed, it could be seen that when the oxygen is present alpha to the nitrile, the intensity of 
the nitrile shift at 2375 cm-1 was notably low at 0.98 km/mol (Figure 12). 
 
Figure 12: IR Spectrum for Tetrahydropyran 341 
By contrast as predicted, the IR spectrum of cyclohexane 342 appeared at 2360 cm-1 with an 
intensity of 12.8 km/mol, a value which one would usually associate with nitrile shifts. 
341 342
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Figure 13: IR Spectra of Cyclohexane 342 
Reference to this significantly reduced stretching frequency in nitriles alpha to 
electronegative groups has been reported in the literature and this could explain why the 
carbon nitrogen stretch in the compounds at hand (332 and 333) were not visible in the IR 
spectra.141,142 
 
3.4.4 Towards the Addition of the Vinyl Group 
 
Prior to continuing on with the synthesis, a few conditions were investigated to determine 
whether it would be possible to epimerise the hydrogen at the anomeric position of nitrile 
333 in order not to waste material (Table 16). When the nitrile was submitted to the original 
conditions for its formation no reaction was observed (Entry 1 and 2). Stirring nitrile 333 in 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) did not achieve this transformation nor was it 
possible upon treatment with lithium hexamethyldisilazide (Entry 3 and 4). At this point, due 
to time constraints, it was decided not to further examine the possibility of epimerising 
compound 333. 
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Entry Conditions Result 
1 
 
TMSCN, BF3OEt2, CH3CN, 0 °C to rt no reaction 
2 
 
TMSCN, TMSOTf, CH3CN, 0 °C to rt no reaction 
3 
 
DBU, CH2Cl2 no reaction 
4 
 
LiHMDS, THF product began to form which was not 343 
Table 16: Attempted Epimerisation of Nitrile 333 
 
Continuing with the synthesis to paecilomycin B (5), alcohol 334 was prepared and this was 
further derivatised to the corresponding aldehyde 344 with the use of Dess-Martin 
periodinane (Scheme 92). It was not possible to isolate the aldehyde as it was thought the 
hydrate was partially being formed alongside the aldehyde in an approximate ratio of 1:1. A 
variety of oxidising agents were applied to alcohol 334 and Dess-Martin periodinane was 
found to give the best conversion to the proposed product 344. 
 
Scheme 94: Synthesis of Proposed Aldehyde 344 
An initial attempt to install the vinyl group through addition of vinyl magnesium bromide to 
the mixture of aldehyde 344 and the hydrate by-product was made however this gave a low 
yield for a mixture of two products (46%). 1H NMR analysis of the reaction mixture 
revealed a 4:1 dr of the epimers of alcohol 345. At this point in our study no attempt was 
made to assign the major or minor diastereoisomers (Table 17, Entry 1). It has been reported 
in the literature that through the use of vinyl zinc chloride and TiCl4, coordination occurs to 
a β-hydroxy benzyl ether, directing addition of the vinyl group to give the desired 
diastereoisomer. The authors propose this is the result of a transition state such as 347.143 
O
PCBO OPCB
NC OAc O
PCBO OPCB
NC OAcconditions
Table 16
333 343
O
PCBO OPCB
NC OHO
PCBO OPCB
NC OAc
K2CO3
MeOH
332
O
PCBO OPCB
NC
ODMP, CH2Cl2
~45% conversion
334 344
86%
   120 
However when these conditions were substituted for this transformation, no reaction was 
seen (Entry 2).  
 
Entry Conditions Result 
1 vinyl magnesiumbromide, toluene, −78 °C to rt 46%a 345 
(dr 4:1) 
 
2 i) vinyl magnesiumbromide, ZnCl2, THF, rt; ii) 344, TiCl4, THF, −78 °C 
to rt 
 
no reaction 
Table 17: Attempts Towards a Vinyl Addition to Aldehyde 344 
a) assuming 50% of the starting material used was the hydrate by-product of aldehyde 344 
 
It was thought that a Carreira alkyne addition could also impart a diastereoselective addition 
to the chiral aldehyde 344.144,145 The terminal alkene should be easily accessible through 
reduction of the resulting alkyne. The selectivity that arises from these transformations is in 
agreement with a model suggested by Noyori for the alkyl addition of dialkylzinc reagents to 
aldehydes in the presence of N-methyl ephedrine.146 A transition state was proposed that 
incorporates two zinc atoms, one of which is coordinated through the oxygen alone and the 
other through the nitrogen and oxygen of methyl ephedrine and also to the reacting aldehyde. 
The enantioselectivity is governed by the avoidance of a steric interaction between the R 
group of the aldehyde and the alkyl group on the zinc atom the aldehyde is coordinated to 
(Scheme 95). When the conditions were applied to aldehyde 344 no reaction was observed 
until the reaction was heated to 80 °C at which point decomposition occurred.  
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Scheme 95: Attempted Carreira Addition to Aldehyde 344 
Given the low yields observed for the oxidation and the vinylation sequence and the 
possibility that the cyano group could be interfering with these transformations, it was 
decided to protect the primary alcohol in 334 and form the resorcylate prior to addition of 
the vinyl group. The para-bromobenzyl protecting group was chosen for this transformation 
as it has been shown that it can be selectively cleaved over the para-chlorobenzyl protecting 
group. It should also withstand harsh conditions that might be necessary to interconvert the 
nitrile into other functional groups. Finally it would be interesting to see the use of the 
selective removal of these new protecting groups in the synthesis of a complex natural 
product. To the best of our knowledge this feat has yet to be demonstrated in the literature. 
 
3.4.5 Synthesis of the Resorcylate Core 
3.4.5.1     Via an Aldol addition 
 
In order to join the keto-dioxinone portion to the tetrahydropyran fragment an aldol addition 
of keto-dioxinone was chosen. It was therefore necessary to synthesise the aldehyde 
precursor. Protection of alcohol 334 as the para-bromobenzyl ether 350 proceeded in 93% 
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yield. This compound was subsequently converted to methyl ester 351 in 99% yield by 
heating in acetyl chloride and methanol (Scheme 96). The direct conversion of nitrile 350 to 
the aldehyde by reaction with diisobutylaluminium hydride was not possible. One equivalent 
of the hydride source resulted in no reaction being observed by TLC analysis, while further 
equivalents gave multiple products. 
 
Scheme 96: Synthesis of Ester 351 
The reduction of methyl ester 351 was also attempted with diisobutylaluminium hydride. 
When one equivalent was used at −78 °C, ester 351 was returned along with what appeared 
to be an inseparable mixture of aldehyde 352 and the hydrate analogue 353 (Scheme 97, 
Table 18, Entry 1).  
 
Scheme 97: Attempts Towards the Synthesis of Aldehyde 352 
When additional equivalents of the hydride source were added, ester 351 was completely 
converted to a 3:2 mixture of aldehyde 352 and hydrate 353 (Entry 2). These ratios were 
determined by integration of the resonances for the aldehyde proton a to methylene proton b 
(Scheme 97). Proton b gives very similar chemical shifts in the 1H NMR for all compounds 
synthesised in this series and is useful for NMR analysis. Conveniently it is also in a region 
that is well resolved from other proton resonances within the molecule. A key assumption 
O
PCBO OPCB
NC OH O
PCBO OPCB
NC OPBB
DMF
93%
AcCl, MeOH O
PCBO OPCB
OPBBMeO
O
99%
NaH, PBBBr
0 °C to 65 °C
334 350 351
O
PCBO OPCB
OPBBMeO
O
351
O
PCBO OPCB
OPBBH
O
352
+ O
PCBO OPCB
OPBH2BH2
353
HO
OH
conditions
Table 18
DIBALH (2 eq.)
CH2Cl2, −20 °C to rt
354
O
PCBO OPCB
OPBBHO DMP or
Parikh-Doering
conditions
352
a
HH b HH b
   123 
made during this work was that proton b would also give the same shift for the hydrate 353 
as aldehyde 352.  
In an effort to convert the hydrate 353 to the aldehyde 352 the mixture was stirred with 
magnesium sulfate for two days. However 1H NMR analysis of the crude reaction mixture 
revealed that the ratio of the hydrate to the aldehyde had not changed. Changing the work up 
of the reaction from Rochelle’s salt to the sequential addition of methanol and a saturated 
aqueous solution of ammonium chloride followed by diethyl ether and magnesium sulfate 
returned almost entirely hydrate 353 (Entry 3).  
 
Entry Conditions Result 
1 DIBALH (1.2 eq.), CH2Cl2, 
 −78 °C; Rochelle’s salt 
 
~50% conversion to 352 and 353 (~3:1 
respectively)a; 40% 351   
2 DIBALH (2.0 eq.), CH2Cl2, 
 −78 °C; Rochelle’s salt 
 
~90% conversion to 352 and 353 (~3:2 
respectively)a 
3 DIBALH (2.0 eq.), CH2Cl2, 
 −78 °C; MeOH, aq. NH4Cl; Et2O; MgSO4 
 
Almost entirely hydrate 353 
Table 18: Attempted Optimisation of Reduction of Ester 351 
a) ratio of hydrogen a to hydrogen b in the 1H NMR of the crude material 
 
 
The complete reduction of ester 351 to alcohol 354 with diisobutylaluminium hydride was 
attempted by the warming of the reaction to room temperature. This gave an inseparable 
mixture of products (Scheme 97). Nonetheless, this mixture was treated with either Dess-
Martin periodinane or subjected to Parikh-Doering oxidation conditions in an attempt to 
form aldehyde 352. In either case however, only negligible amounts of the aldehyde were 
seen in the 1H NMR spectra of the crude material (Scheme 97). 
Concurrent to the synthesis of aldehyde 352, investigations were being made into the C-
acylation of keto-dioxinone 117 with a Weinreb amide electrophile 356 (this will be 
discussed in section 3.4.5.2). As a consequence Weinreb amide 356 was available and 
attempts towards the reduction of this to the aldehyde were also made. Amide 356 could be 
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synthesised via acid 355, which itself was formed directly from nitrile 350 through heating 
in hydrochloric acid and dioxane (Route A, Scheme 98). Through this procedure acid 355 
was formed with additional side products and could not be isolated. On the other hand amide 
356 could be generated in two steps and 54% yield from nitrile 350. Alternatively, 
hydrolysis of ester 351 with lithium hydroxide gave the pure acid 355 in excellent yields and 
this was converted to Weinreb amide 356 in 78% yield (Route B, Scheme 98).   
 
Scheme 98: Two Routes to the Synthesis of Amide 356 
Amide 356 was treated with diisobutylaluminium hydride in an attempt to convert this to 
aldehyde 352 yet no reaction was observed until the solution was warmed and further 
equivalents of the hydride were added. At this point, only substrate decomposition was 
observed (Scheme 98). Schwartz’s reagent was then employed as this has been shown to 
reduce tertiary amides to the corresponding aldehyde via the hydrolysis of proposed 
intermediates such as the zirconium complex 357. However in this system, treatment of 
amide 356 with Schwartz’s reagent only led to recovery of starting material.147 
Given the reduction of ester 351 with diisobutylaluminium hydride gave the best conversion 
to the aldehyde, the products from this transformation were used in the aldol addition. When 
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this was performed on a 0.09 mmol scale, hydroxy-ketone 358 appeared to have formed as 
the characteristic chemical shifts were present in the 1H NMR of the crude material (Scheme 
99). 358 could not be isolated as it was inseparable from side-products and excess keto-
dioxinone 117. After silica gel chromatography the cleanest fractions were combined and 
treated with Dess-Martin periodinane. 1H NMR analysis of the crude material showed 
diketo-dioxinone 359 to be present with very little side-product. This result seemed 
promising and the sequence was repeated on a 0.3 mmol scale, where aldehyde 352 was 
formed in a 3:2 ratio with hydrate 353. Following aldol addition of keto-dioxinone 117 a 
maximum yield of 40% was achieved. Following silica gel chromatography the fractions 
containing the hydroxy-ketone 358 were combined and treated with Dess-Martin 
periodinane, yet on this occasion no diketo-dioxinone 359 was observed in the 1H NMR of 
the crude material. It therefore became apparent that this route was neither scalable, nor 
practical and as a consequence C-acylations of keto-dioxinone 117 were investigated. 
 
Scheme 99: Aldol Addition with Aldehyde 352 
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3.4.5.2     Via a C-Acylation 
 
The initial investigation into the use of a C-acylation began with the condensation of 
Weinreb amide derivative 356 onto the dianion of keto-dioxinone 117. Although a series of 
different reaction temperatures was screened (X = 60, 40, 20 °C). In all these attempts no 
reaction was observed. The addition of diethyl zinc showed no beneficial effect (Scheme 
100). 
 
Scheme 100: Attempted Reaction of Amide 356 
Although the acyl imidazole derivative 360 could be formed from acid 355, this could not be 
purified; attempts at chromatography led to decomposition of the product (Scheme 101). 
Upon treatment of the dianion of keto-dioxinone 117 with the crude material of the reaction 
product from acid 355, decomposition occurred. Keto-dioxinone 117 was the only 
compound that appeared in the 1H NMR of the crude material following this reaction. 
 
Scheme 101: Attempted Reaction of Acyl Imidazole 360 
 
3.4.5.3     Via a C-Acylation of the Keto-Ester  
 
β-Keto-δ-ester-dioxinones such as 363 have been used previously in our group as precursors 
to diketo-dioxinones because the corresponding C-acylated products may be prepared under 
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extremely mild conditions. If acylation with allyl ester 363 could be effected, a deallylation 
and decarboxylation should be possible with a palladium catalyst to give diketo-dioxinone 
359 (see section 1.6.3; Scheme 102). Such diketo-ester-dioxinone and diketo-dioxinone 
compounds are particularly unstable and as a consequence purification by chromatography 
and characterisation is not possible. As a result the only means to follow the progress of 
these transformations was via 1H NMR analysis of the crude material. Fortunately there were 
characteristic chemical shifts present in the intermediates that permitted the analysis. Acid 
355 was recognisable due the doublet from hydrogen 1 at 3.89 ppm (Scheme 102). 
Intermediate 365 did not contain any identifiable hydrogens that were sufficiently resolved 
in the 1H NMR, therefore the relative amount of this product in the reaction mixture was 
crudely estimated from the intensity of the multiplet of proton 2. The shift of this proton at 
approximately 2.6 ppm does not vary significantly between similar compounds in this 
synthesis and is well resolved in the 1H NMR. As a result it was assumed that the peak in 
this region was from exclusively acid 355 and diketo-ester-dioxinone 365. For diketo-
dioxinone 359 the resonance used for the analysis was the singlet of proton 3 at 5.75 ppm.  
 
Scheme 102: Synthesis of 363 and Attempts Towards the Synthesis of Diketo-dioxinone 359 
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Reactions that seemed to contain significant amounts of 365 following addition of dioxinone 
363 to acid chloride 364 were taken on to the deallylation and decarboxylation step. 
Reactions that appeared to give a poor result were terminated after the addition of dioxinone 
363. Following our group’s established procedure, allyl ester 363 was formed in two steps 
and 45% yield from allyl alcohol, Meldrum’s acid (361) and dioxinone 55 (Scheme 102).  
Formation of the potassium salt of acid 355 was necessary to achieve a reaction with oxalyl 
chloride and DMF to give the acid chloride 364. Although it was not possible to isolate or 
characterise the acid chloride intermediate, its formation was confirmed by derivatisation to 
the methyl ester 351 upon treatment with methanol. To form dioxinone 365, allyl ester 363 
was treated with magnesium chloride and pyridine at 0 °C and allowed to stir for 30 minutes. 
After acid chloride 364 was added, the reaction was stirred at room temperature for an 
additional hour. Following an acidic work up, acid 355 and allyl ester 363 were returned as 
the only products (Table 19, Entry 1). For all the reactions that will be described a small 
amount of acid chloride 364 was retained following its addition to allyl ester 363. This was 
then treated with methanol to form the methyl ester 351 to ensure the acid chloride was the 
only reactant being added to the reaction.  
On a second attempt following the same conditions there appeared to be reaction of the acid 
chloride to product 365 and the crude material from this transformation was treated with 
Pd(PPh3)4 and morpholine. From 1H NMR analysis of the crude material of the deallylation 
and decarboxylation there showed a 2:1 ratio of acid 355 to diketo-dioxinone 359 (Entry 2). 
Repetition of these conditions returned varying amounts of acid 355 and diketo-dioxinone 
359 however the ratio of the two was always in favour of acid 355. Repetition of the 
conditions with two equivalents of allyl ester 363, magnesium chloride and pyridine gave 
acid 355 exclusively (Entry 3). 
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Entry Conditions 
1  
Conditions  
2 
Work-up Ratio 
355:(365 or 359)a,b 
1 c MgCl2, py, 363, CH2Cl2, 
 0 °C to rt 
d 1:0 (365) 
2 c MgCl2, py, 363, CH2Cl2, 
 0 °C to rt 
 
d 2:1 (359) 
3 c  MgCl2, py, 363 (2 eq.), CH2Cl2,  
0 °C to rt 
 
d 1:0 (365) 
4 c MgCl2, py, 363, CH2Cl2, 
 0 °C to rt 
 
 MeOH 
then d 
 
9:1 (365) 
5 e MgCl2, py, 363, CH2Cl2, 
 0 °C to rt 
 
d 1:0 (365) 
6 e MgCl2, py, 363, CH2Cl2, 
 0 °C to rt 
 
MeOH then 
d 
 
1:0.4:0.4 
(355/365/351) 
7 e anhydrous MgCl2 beads, py, 363, 
CH2Cl2, 0 °C to rt 
 
MeOH then 
d 
2:1 (365) 
Table 19: Attempted Optimisation of Conditions for the Synthesis of Diketo-dioxionone 359 
a) ratio of 355:either 365 or 359 as stated. b) ratios were determined by the 1H NMR of the crude 
material as previously discussed in the text. c) potassium salt of 355 formed through reaction of acid 355 
with KOH and EtOH; then (COCl)2, DMF, CH2Cl2, rt. d) aq. HCl (1.0 M)/brine/Et2O 1:2:5, separate 
phases and dry (MgSO4). e) SOCl2, CH2Cl2, rt.  
 
Given we were certain it was just acid chloride 364 being added to the reaction, the reaction 
was quenched with methanol to ensure that acid 355 was not being returned as a result of 
incomplete reaction of the acid chloride and indeed no methyl ester 351 was observed (Entry 
4). It was thought it was possible that water could be in the reaction mixture and quenching 
acid chloride 364 prior to reaction with allyl ester 363. One source of this could be through 
the ineffective removal of water from the formation of the potassium salt of acid 355.  To 
probe this question, a new method to form the acid chloride 364 was examined and the acid 
chloride was generated from acid 355 through its reaction with thionyl chloride. This did not 
change the result for the C-acylation however and the original conditions with an acidic 
work up returned entirely acid 355 (Entry 5). In a separate experiment methanol was added 
following the reaction to determine whether the acid chloride had fully reacted. In this 
instance methyl ester 351 was returned (Entry 6). However longer reaction times and the use 
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of anhydrous magnesium chloride beads that had been stored in a glove box still returned 
predominantly acid 355 (Entry 7). It was postulated that the reason acid 355 was seen after 
the reaction could be a result of an O-acylation occurring. This product could then hydrolyse 
to regenerate acid 355 or methyl ester 351 during an acidic work up or following the 
addition of methanol. If this was indeed the case this would not be an appropriate route to 
diketo-dioxinone 359 and alternative methods were explored. 
 
3.4.5.4     Via the Benzotriazole Derivative 
 
In work published by Coltart, a range of 1,3-diketones were synthesised through the reaction 
of the enol derived from a methyl ketone with magnesium bromide and 
diisopropylethylamine with an acyl benzotriazole electrophile.148 The acyl benzotriazole was 
formed on the system in question through treatment of acid 355 with thionyl chloride and 
benzotriazole (Scheme 103). Since the product could not be purified by chromatography, the 
crude product was added directly to the enol of allyl ester 363. Although TLC analysis 
suggested that a reaction with 366 had occurred, treatment of the crude reaction mixture with 
Pd(PPh3)4 and morpholine did not lead to the formation of diketo-dioxinone 359. 
 
Scheme 103: Attempt Towards Diketo-dioxinone 359 via Acyl benzotriazole 366 
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3.4.5.5     Reversing the Reactivity 
 
As an alternative strategy to the diketo-dioxinone moiety, the nature of the reactivity of the 
two fragments was switched. We were curious to see if transformation of the keto-dioxinone 
to an electrophile and the tetrahydropyran ring fragment to the nucleophile would offer an 
improvement. To test this strategy a model system was used that employed acid 368. Thus, 
acid 368 was formed through oxidation of the known alcohol 367 in 94% yield. Acylation of 
Meldrum’s acid (361) with acid 368 mediated by N,N’-dicyclohexylcarbodiimide gave 
intermediate 369 which was heated with allyl alcohol to form keto-ester 370. This compound 
would serve as the nucleophilic partner. The key electrophilic partner was acid-dioxinone 
372. The preparation of this compound was established within the group and was originally 
made by Peter Blencowe. Following his synthesis it was generated in two steps and 32% 
yield through reaction of the anion of dioxinone with benzyl chloroformate to give benzyl 
ester 371. Hydrogenation with palladium on carbon exposed the free acid. 
 
Scheme 104: Synthesis of Allyl Ester 370 and Acid 372 
With the two fragments 370 and 372 in hand, a number of reaction conditions were screened 
with the goal of coupling the two components (Table 20). The use of just 
N,N’-dicyclohexylcarbodiimide, triethylamine and 4-dimethylaminopyridine left allyl ester 
370 unreacted (Entry 1). It was therefore considered that pre-stirring ester 370 with a 
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stronger base could induce a reaction. However when either sodium hydride or magnesium 
chloride in conjunction with pyridine were added, the allyl ester was still returned 
unchanged (Entry 2 and 3).  
 
Entry Conditions Result 
1 
 
DCC, DMAP, NEt3, CH2Cl2, rt 372 reacted, 370 returned 
2 
 
DCC, DMAP, NaH, 0 °C to rt 372 reacted, 370 returned 
3 
 
DCC, DMAP, MgCl2, pyridine, 0 °C to rt 372 reacted, 370 returned 
Table 20: Attempt Towards Coupling of Fragments 370 and 372 
 
As a result, other electrophiles were investigated to couple with allyl ester 370. During this 
study we found that it was not possible to form acid chloride 374 as all conditions applied 
for this transformation led to decomposition of the starting material. It was proposed that due 
to the particularly acidic nature of proton a upon formation of the acid chloride, it could be 
deprotonated to form the ketene which could then decompose via a number of possible 
pathways. Attempted generation of acyl imidazole 375 suffered the same fate, presumably 
for the same reasons. 
 
Scheme 105: Attempts Towards the Synthesis of Different Electrophiles 
It was possible however to form the Weinreb amide, which was synthesised from acid 372 
through its successive reaction with carbonyldiimidazole and N,O-dimethylhydroxylamine 
hydrochloride in 68% yield. Methyl ketone 377 could be formed through treatment of 
Weinreb amide 356 with methylmagnesium bromide at 0 °C in 91% yield. Disappointingly, 
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Table 20 O O
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O
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when ketone 377 was sequentially treated with lithium diispropylamide and Weinreb amide 
376 no reaction was observed and starting materials were again returned.  
 
Scheme 106: Synthesis of Amide 376 and Methyl Ketone 377 
 
3.4.5.6     A Second Look at Allyl Ester 363 
 
With no route to the diketo-dioxinone established, attention returned to the reaction of allyl 
ester 363 with acid chloride 355. It was thought that by changing the base, formation of the 
presumed O-acylated intermediate (which upon hydrolysis returned the acid 355) could be 
avoided. The addition of acid chloride 364 to the enolate generated through the addition of 
isopropylmagnesium bromide to allyl ester 363 gave a promising result. Following the 
removal of the allyl ester, the addition of methanol and an acidic work up, the ratio of the 
products observed now favoured the diketo-dioxinone (1:0.5:0.4 diketo-dioxinone 359/acid 
355/ester 351). However approximately 50% of the returned material was the acid 355, ester 
351 and side-products that included what appeared to be a prematurely aromatised 
resorcylate (Table 21, Entry 1). In a second experiment, methanol was not added following 
the transformation and the reaction was left stirring in the acidic work up for several 
minutes. This reaction gave acid 355 as the predominant product (Entry 2). It was then 
observed that following the acylation, upon addition of methanol and concentration of the 
reaction in vacuo the methyl ester 351 was the only derivative of acid 355 seen in the 1H 
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NMR (Entry 3). It seemed plausible that the allyl ester product from the acylation (365) was 
particularly susceptible to nucleophilic attack and was undergoing a retro-Claisen reaction to 
give back acid 355. This phenomenon had not yet been reported in the Barrett group for 
work performed on similar systems. It was therefore likely that the oxygen alpha to the point 
of nucleophilic attack was increasing the electrophilicity of this position enough for the retro 
reaction to occur. On further repetitions of steps 1 and 2 of the transformations it was found 
that the form of the work up and duration was paramount to the ratios of acid 355 or ester 
351 returned. There was found to be no method that reliably gave reasonable conversion to 
dioxinone 365 and so an alternative was sought. 
 
Entry Conditions 
Step 2 
Work-up Step 
3a 
Result 
 
1 i-PrMgBr, 363, 
THF, 0 °C 
MeOH then HCl (1.0 
M)/brine/Et2O 1:2:5  
 
Yes 1.0:0.5:0.4:0.5 
359:355:351:other 
tetrahydropyran productsb 
 
2 i-PrMgBr, 363, 
THF, 0 °C  
 
stirred HCl (1.0 M)/brine/Et2O 
1:2:5 10 min then phases 
separated 
 
No predominantly 355 
3 i-PrMgBr, 363, 
THF, 0 °C 
 
MeOH then concentrated in 
vacuo 
No predominantly 351 
4 i-PrMgBr, 363, 
THF, 0 °C 
solution was degassed with Ar; 
Pd(PPh3)4 and morpholine were 
added directly 
 
Yes 1.0:0.5:2.0 355:359:other 
tetrahydropyran productsb 
 
Table 21: Attempted Optimisation of Conditions for the synthesis of Diketo-dioxionone 359 
a) whether or not step 3 was performed. b) ratios were determined through the 1H NMR of the crude 
material 
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It was considered that it might not be necessary to have a work-up as the by-product from 
this reaction, MgBrCl, should in fact be innocuous. Therefore following the C-acylation, 
Pd(PPh3)4  and morpholine were added directly to the reaction. After a further three hours of 
stirring at room temperature TLC analysis appeared to show very little deallylation and 
decarboxylation had occurred (Entry 4). From the 1H NMR of the crude material it was 
confirmed that only minor amounts of deallylation and decarboxylation had ensued. It was 
then decided that given the deallylation had previously occurred in dichloromethane as the 
solvent, this should be used as the solvent for the reaction. Therefore following the reaction 
of acid chloride 364 with dioxinone 363 in THF, the solvent was removed in vacuo and the 
reaction was redissolved in dichloromethane. Pd(PPh3)4 and morpholine were then added to 
the crude residue (Scheme 107). Much to our satisfaction it was found that not only was 
there high conversion to diketo-dioxinone 359 with little side-products but the ratio of 
diketo-dioxinone 359 to other tetrahydropyran derivatives was 1:0.6 respectively, with none 
of acid 355 observed. 
 
Scheme 107: Synthesis of Diketo-dioxinone 359 
With the route to diketo-dioxinone 359 established it was necessary to form the ketene, trap 
this with alcohol 36 and subsequently aromatise the ensuing triketo-ester 378. Therefore the 
crude material containing diketo-dioxinone 359 was heated with alcohol 36 in toluene 
(Scheme 108). Conditions were then varied to find those most suitable to aromatise triketo-
ester 378 (Table 22). 
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Scheme 108: Synthesis of Resorcylate 380 
Following the standard conditions used to effect such aromatisations within the Barrett 
group, triketo-ester 378 was sequentially treated with cesium carbonate and acetic acid. A 1H 
NMR of the crude material showed no resorcylate was present. Nonetheless the material was 
chromatographed and following this resorcylate 379 was obtained as an inseparable mixture 
with a side-product (Entry 1). It was clear that acetic acid was not effective for aromatisation 
and as a result other reagents were screened. Triketo-ester 378 was stirred for two hours with 
cesium carbonate and then immediately purified by chromatography (Entry 2). However on 
this occasion no resorcylate was isolated. When triketo-ester 378 was stirred with silica for 
five days resorcylate 379 was returned with an inseparable product and with poor conversion 
to the resorcylate 379 (Entry 3). It was thought a stronger acid was necessary to promote 
dehydration and as a result triketo-ester 378 was stirred with either cesium carbonate (Entry 
4) or cesium acetate (Entry 5) for two hours and subsequently treated with methanolic 
hydrochloric acid. The reaction with cesium carbonate returned multiple products with little 
resorcylate observed, however the reaction with cesium acetate returned resorcylate 379 in 
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   137 
good yield. During the reaction methyl ester 351 was additionally formed alongside 
resorcylate 379 and the two products co-eluted during chromatography.  
 
Entry Conditions Result 
1 Cs2CO3, MeOH; AcOH; chromatography 
 
poor conversion to resorcylate 379 
2 Cs2CO3, MeOH; chromatography 
 
no conversion to resorcylate 379 
3 silica gel, 5 days 
 
poor conversion to resorcylate 379 
4 Cs2CO3, MeOH; HClMeOH 
 
multiple side-products 
5 CsOAc, CH2Cl2/i-PrOH (1:1); HClMeOH 
 
Good conversion to resorcylate 379 
Table 22: Optimisation of Conditions for the Aromatisation of Triketo-ester 378 
 
 
 
This was not a problem however as treatment of the two compounds with methyl iodide and 
potassium carbonate gave the methylated resorcylate 380 as the clean, isolable product in 
32% yield from acid 355. The para-phenol is presumably selectively methylated as a result 
of the hydrogen bond that forms between the ortho-phenol and the adjacent ester, reducing 
reactivity at the ortho position. Over methylation to resorcylate 381 (~7% from acid 355) 
was also observed and since this product also co-runs with the starting resorcylate 379, 
monitoring of this reaction was difficult. Due to time constraints this methylation step was 
not optimised but it is hoped this will be possible in the future to ensure material is not lost 
as resorcylate 381. Alternatively, resorcylate 379 could be dimethylated in its entirety to give 
381, which could then be taken through to the end of the synthesis. The ortho methyl could 
ultimately be selectively removed with boron trichloride, as was seen in the synthesis of 
cruentaren A.56 
The addition of the diketo-dioxinone functionality to acid 355 is now possible in a revised 
acylation, one-pot procedure. The product can be derivatised to the triketo-ester and through 
the sequential addition of base and acid, resorcylate 379 is generated with these three steps 
also occurring in a one-pot sequence. Methylation of 379 yields resorcylate 380 in 32% yield 
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from acid 355. This has proved to be an extremely reliable and reproducible procedure in the 
system at hand. It is suitable for highly functionalised and delicate substrates, particularly 
those that are susceptible to retro-Claisen reactions prior to removal of the ally ester. It also 
eliminates the need to purify the allyl ester intermediate, allowing the diketo-dioxinone to be 
formed from the acid chloride in one pot. It is hoped that this method will find its use in 
subsequent syntheses of similar compounds.  
For the purpose of the characterisation of resorcylate 379 the mixture of resorcylate 379 and 
ester 351 was treated with lithium hydroxide to hydrolyse the methyl ester (Scheme 109). 
Removal of acid 355 from the resorcylate was straightforward, which permitted isolation and 
complete characterisation of resorcylate 379. 
 
Scheme 109: Characterisation of Resorcylate 379 
 
  Previous Synthesis of Paecilomycin B 3.5
 
As was previously mentioned, during the course of this work Ohba and co workers published 
the first total synthesis of paecilomycin B (5).112 Key steps in their synthesis were a 
Mitsunobu reaction to form the ester functionality and a ring-closing metathesis to form the 
macrocycle. This is shown in the retrosynthetic analysis below (Scheme 110).149  
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Scheme 110: Retrosynthetic Analysis of Paecilomycin B (5) 
 Acid 382 was accessed from lactone 383, which was formed through the addition of arene 
384 to lactone 385 under Barbier-type conditions. 
The first fragment, lactone 385, came from the known intermediate tetrahydropyran 388, 
which was generated in five steps from sugar 386 (Scheme 111). As in our synthesis the 
route begins from a β-glucose precursor, which could be selectively deoxygenated in the 3 
position as a result of the stereochemistry of the substrate and the selective protection of 
alcohols. Protection of glucose 386 at the 4 and 6 position gave the benzylidene acetal that 
was converted to the bis-chlorosulfate ester through reaction of the diol with sulfuryl 
chloride.  
 
Scheme 111: Ohba’s Synthesis of Fragments 385 and 384 
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Treatment of the bis-chlorosulfate with tetrabutylammonium bromide achieved the 
bromination selectively at the 3 position presumably as a result of substrate control. 
Hydrolysis of the chlorosulfate in the 2 position gave bromide 387. Protection of the alcohol 
and a subsequent reduction with hydrogen and palladium on carbon gave 3-deoxyglucose 
388. Further protecting group manipulations and oxidation gave lactone 385 in four 
additional steps and 51% overall yield. The aromatic portion 384 was synthesised via the 
known intermediate 391, which itself was formed in three steps from bromoarene 390.150 A 
selective demethylation and addition of the dimethylcarbamoyl group gave arene 384. The 
carbamoyl group was chosen as it is stable under acidic conditions and relatively unreactive 
towards nucleophiles.  
At this point addition of the lithium reagent derived from triisopropylphenyllithium 392 and 
arene 384 to lactone 385 gave the β-product exclusively. The authors proposed that this was 
a result of slow spontaneous lactonisation due to low reactivity of the methyl ester as a result 
of the highly electron rich aromatic ring. They proposed that as a result of this, isomerisation 
could occur to the more stable β-product prior to the lactonisation. Basic quenching 
conditions were necessary as an acidic quench resulted in only partial generation of lactone 
383 with the coupled product stopping at the lactol. Attempted deoxygenation at the 
anomeric position of spiroketal 383 instead gave desilylation (393) using triethylsilane and 
BF3OEt2. Therefore sprioketal 383 was transformed into methyl glycoside 394 with 
methanesulfonic acid and in turn the stereoselective deoxygenation gave the β-glycoside 395 
exclusively. This was again presumed to be a result of the known stereoelectronic preference 
of the β conformation of glucosides.151 A selective removal of the primary benzyl ether 
followed by an oxidation gave the aldehyde. This allowed installation of the vinyl group 
through a Nozaki−Hiyama−Kishi coupling to give 397 in 44% along with its epimer 398. 
The authors found that a Grignard addition with vinyl magnesium bromide was poorly 
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yielding. Although a catalytic asymmetric Nozaki−Hiyama−Kishi approach did not invoke 
stereoselectivity the authors were able to recycle material through an oxidation/reduction 
sequence of diastereoisomer 398 back to 397 with Dess-Martin periodinane and 
zincborohydride. A Luche reduction gave back the undesired epimer 398 while a Corey-
Bakshi-Shibata reduction did not produce epimer 397. Subsequent protecting group 
manipulations and opening of the lactone gave acid 382 which was transformed to the ring-
closing metathesis precursor through a Mitsunobu esterification. Finally ring-closing 
metathesis with Grubbs II catalyst (131) and global deprotection afforded paecilomycin B 
(5). 
 
Scheme 112: Ohba’s Synthesis of Paecilomycin B (5) 
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  Towards the Addition of the Vinyl Group 3.6
 
Returning to our synthesis, for the addition of the vinyl fragment it was necessary to remove 
the para-bromobenzyl group and oxidise the resulting primary alcohol to the aldehyde. If a 
stereoselective addition of the vinyl group was unsuccessful this could be added in a similar 
fashion to that of the Ohba group. It was hoped that this sequence could be realised with the 
ortho phenol unprotected. To this end a selective Buchwald-Hartwig coupling with 
tris(dibenzylideneacetone)dipalladium and (2-biphenyl)di-tert-butylphosphine was achieved, 
giving aniline 401 in 77% yield (Scheme 113).131 Treatment of 401 with tin chloride at room 
temperature removed the aniline to unveil the primary alcohol in 73% yield.  
 
Scheme 113: Synthesis of Alcohol 402 
Conditions were then screened for the oxidation of alcohol 402 to aldehyde 403. 
Unfortunately none were found that could achieve this transformation (Table 23). When one 
equivalent of Dess-Martin periodinane was used no reaction was observed (Entry 1). It was 
thought that the phenol could be interfering with the reagent and a second equivalent of 
Dess-Martin periodinane might induce reaction at the alcohol. However further equivalents 
and longer reaction times saw no change to the alcohol (Entry 2). Pyridinium 
chlorochromate (Entry 3), tetrapropylammonium perruthenate and N-methylmorpholine-N-
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oxide (Entry 4) and Parikh-Doering conditions (Entry 5) were tried but each reaction 
returned starting material.  A Swern oxidation (Entry 6) or oxidation with  
(diacetoxyiodo)benzene and 2,2,6,6-tetramethylpiperidinyloxy (Entry 7) resulted in 
decomposition of the material. 
 
Entry Conditions Result 
1 
 
DMP (1 eq.), CH2Cl2 no reaction 
2 
 
DMP (3 eq.), CH2Cl2 no reaction 
3 
 
PCC, CH2Cl2 no reaction 
4 
 
TPAP, NMO, CH2Cl2, 3 days majority returned 402  
5 
 
SO3pyridine, NEt3, DMSO, CH2Cl2, 0 °C to rt no reaction 
6 
 
(COCl)2, NEt3, DMSO, CH2Cl2 decomposition 
7 (diacetoxyiodo)benzene, TEMPO, CH2Cl2 
 
decomposition 
Table 23: Screening of Conditions for the Oxidation of 402 
 
It was probable that the unprotected phenol was inhibiting these reactions and with this in 
mind the ortho phenol of aniline 401 was protected as the corresponding acetate in 93% 
yield (Scheme 114). Subsequent removal of the aniline from 404 with tin chloride now had 
to be performed at −78 °C to avoid additional removal of the acetate group. This enabled 
alcohol 405 to be synthesised in 90% yield. Pleasingly, treatment of alcohol 405 with Dess-
Martin periodinane showed from a 1H NMR of the crude material that aldehyde 406 had 
formed in approximately 50% conversion. Unfortunately the side-products generated from 
this reaction could not be separated from aldehyde 406 and a screen of conditions will be 
necessary to optimise this oxidation. 
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Scheme 114: Synthesis of Alcohol 405 
 
  Conclusions and Future Work 3.7
 
In the time that was available the total synthesis of paecilomycin B (5) was not achieved. 
Despite this, significant progress has been made to this target and the remaining steps closely 
mimic that of the Ohba group so it is predicted that they will proceed without difficulty. 
Completing the synthesis of paecilomycin B (5) will entail optimisation of the oxidation and 
addition of the vinyl group to give alcohol 407. A subsequent ring-closing metathesis and 
ultimately global deprotections will achieve the total synthesis of paecilomycin B (5) 
(Scheme 115). Where the Ohba group did not add the vinyl group stereoselectively, we 
would like to investigate a stereoselective transformation to improve the synthesis, possibly 
through a Carreira asymmetric alkyne addition.  
O
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OH O
O
N Me
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O
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O
O
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Scheme 115: Future Work for the Completion of the Total Synthesis of Paecilomycin B (5) 
The synthesis of the tetrahydropyran ring was carried out from the cheap and commercially 
available D-glucose (322) and incorporated a selective deoxygenation. An improved route 
for the synthesis of delicate diketo-dioxinones was developed through the careful screening 
of conditions. This allowed the simplification of the route to diketo-dioxinones with a robust 
procedure giving consistently high yields. We hope this method will be used in future 
syntheses of related compounds. Additionally, the selective removal of a para-bromobenzyl 
group in the presence of the chloro-equivalent has been utilised for the first time in natural 
product synthesis. Upon removal of the para-chlorobenzyl groups we will have effectively 
applied these novel protecting groups and showcased their utility in the synthesis of a 
complex natural product. The completion of the total synthesis of paecilomycin B (5) will be 
investigated by the group in the near future.  
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CHAPTER 4 
EXPERIMENTAL 
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4. EXPERIMENTAL 
4.1 General Methods 
 
All reactions were carried out under nitrogen or argon and in oven-dried glassware, unless 
otherwise stated. The following reaction solvents were distilled under nitrogen: Et2O, THF 
and toluene were dried over Na/Ph2CO; MeOH, CH2Cl2, NEt3 and pyridine were dried over 
CaH2. H2O refers to redistilled H2O. Other solvents and all reagents were obtained from 
commercial suppliers and, if purity was >98%, used as obtained. References in the 
experimental to “hexanes” indicate use of petroleum spirit (b.p. 40-60 °C). Room 
temperature was taken as 23 °C, where no external heating or cooling was applied. 
Prolonged periods of reaction cooling were accomplished through the use of CryoCool 
apparatus.  
1H NMR spectra were recorded at 400 or 500 MHz. The solvent used in each case is 
specified and spectra are referenced to residual solvent peaks. Chemical shifts (δ) are quoted 
to two decimal places in parts per million (ppm) with signal splittings recorded as singlet (s), 
doublet (d), triplet (t), quartet (q), quintet (qu) and multiplet (m). Coupling constants, J, are 
quoted to one decimal place in Hertz (Hz). 13C NMR spectra were recorded at 101 or 126 
MHz. Chemical shifts are quoted to one decimal place in ppm. The solvent used in each case 
is specified and spectra are referenced to residual solvent peaks. For CDCl3: δ H =7.26, δ C 
= 77.00 ppm.  
Infrared (IR) spectra were recorded on a PerkinElmer FT-IR spectrometer and were recorded 
neat. Indicative features of spectrum are given with adsorptions reported in wavenumbers 
(cm-1). 
   148 
High resolution mass spectra (HRMS) (EI, CI, ESI) were recorded by the Imperial College 
Mass Spectrometry Service. 
Melting points were obtained using a Reichert-Thermovar melting point apparatus and are 
uncorrected. 
Microanalysis data was determined at the London Metropolitan University Analytical 
Service. 
Optical rotations were recorded on a Perkin-Elmer 241 Polarimeter with a path length of 0.5 
dm. Concentrations (c) are quoted in g/100 mL. 
X-ray diffraction data was recorded by the Imperial College Department of Chemistry  X-ray 
diffraction service or by the University of Bath X-ray diffraction service. 
Flash column chromatography was performed using Merck silica gel 60 (particle size 40 -63 
µm) unless otherwise stated. Thin layer chromatography (TLC) was performed on Merck 
Kiesegel 60 F254 0.25 mm precoated aluminium backed plates. Product spots were 
visualised under UV light (λmax = 254 nm) and/or by staining with aqueous potassium 
permanganate solution or vanillin.  
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  Procedures and Compound Characterisation 4.2
 
3-((4-methoxybenzyl)oxy)propan-1-ol 185 
 
Sodium hydride (60 wt % in mineral oil, 0.58 g, 14.5 mmol) was added to a solution of 1,3-
propanediol (1.0 g, 13.1 mmol) in DMF (40 mL) at 0 °C. The reaction mixture was stirred at 
rt for 30 min after which time it was cooled back down to 0 °C. 4-Methoxybenzyl chloride 
(2.0 mL, 14.5 mmol) was added slowly, followed by tertabutylammonium iodide (0.49 g, 
1.31 mmol), and the resulting mixture was stirred at 0 °C for 6 h. The reaction was quenched 
with ice cold water (50 mL) at 0 °C. The phases were then separated and the aqueous layer 
was extracted with EtOAc (2 x 50 mL). The organic layers were combined, washed with 
brine (50 mL), dried (MgSO4) and concentrated in vacuo. Chromatography (6:4 
hexanes/EtOAc) gave alcohol 185 (1.2 g, 5.92 mmol, 45%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.27-7.24 (2H, m, CArH), 6.90-6.86 (2H, m, CArH), 4.45 
(2H, s, CArCH2OCH2), 3.81 (3H, s, OCH3), 3.78 (2H, app. q, J = 5.3 Hz, CH2OH), 3.64 (2H, 
t, J = 5.8 Hz, CArCH2OCH2), 2.30 (1H, t, br, J = 5.3 Hz, OH), 1.85 (2H, qu, J = 5.7 Hz, 
CH2CH2CH2). 13C NMR (101 MHz, CDCl3) δ: 159.2, 130.1, 129.2 (2C), 113.8 (2C), 72.9, 
69.2, 62.1, 55.3, 32.0. HRMS: (ES+) Calculated for C11H20NO3 [M+NH4]+: 214.1443; 
Found: 214.1445. IR νmax/cm-1 (neat): 3395 br, 1612, 1512, 1244, 1174, 1082, 1032, 818. 
 
  
PMBO OH
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3-((4-methoxybenzyl)oxy)propanoic acid 186 
 
Freshly prepared Jones reagent (2.78 M, 3.4 mL), was added to a solution of alcohol 185 
(0.52 g, 2.66 mmol) in acetone (35 mL) at −10 °C. The resultant mixture was stirred at rt for 
5 h, after which time it was quenched with isopropanol (5 mL). The solution was extracted 
with EtOAc (3 x 50 mL) and the organic layers were combined, dried (MgSO4) and 
concentrated in vacuo. Chromatography (1:1 hexanes/EtOAc then 100% EtOAc) yielded 
acid 186 (0.33 g, 1.58 mmol, 59%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 8.91 (1H, s, br, CO2H), 7.28-7.26 (2H, m, CArH), 6.91-6.87 
(2H, m, CArH), 4.50 (2H, s, CArCH2OCH2), 3.81 (3H, s, OCH3), 3.74 (2H, t, J = 6.3 Hz, 
CArCH2OCH2), 2.66 (2H, t, J = 6.3 Hz, CH2CO2H). 13C NMR (101 MHz, CDCl3) δ: 177.2, 
159.2, 129.8, 129.4 (2C), 113.8 (2C), 72.8, 64.8, 55.2, 34.9. HRMS: (ES+) Calculated for 
C11H18NO4 [M+NH4]+: 228.1236; Found: 228.1238. IR νmax/cm-1 (neat):  2987 br, 1685, 
1187, 1175, 1087, 1069, 813. 
 
  
PMBO OH
O
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N-methoxy-3-((4-methoxybenzyl)oxy)-N-methylpropanamide 187 
 
To a solution of acid 186 (0.42 g, 2.01 mmol) in CH2Cl2 (5.5 mL) was added 
carbonyldiimidazole (0.39 g, 2.42 mmol) and N,O-dimethylhydroxylamine hydrochloride 
(0.24 mg, 2.42 mmol) at rt and the reaction was left stirring for 16 h. Following this, brine 
(30 mL) was added and the phases were separated. The aqueous phase was extracted with 
EtOAc (3 x 30 mL) and the combined organic layers were dried (MgSO4) and concentrated 
in vacuo. Chromatography (2:1 hexanes/EtOAc) gave Weinreb amide 187 (0.44 g, 1.73 
mmol, 84%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.26-7.24 (2H, m, CArH), 6.88-6.84 (2H, m, CArH), 4.47 
(2H, s, CArCH2OCH2), 3.79 (3H, s, CH3), 3.76 (2H, t, J = 6.5 Hz, CArCH2OCH2), 3.67 (3H, 
s, CH3), 3.18 (3H, s, CH3), 2.74 (2H, t, J = 6.5 Hz, CH2C(O)N). 13C NMR (101 MHz, 
CDCl3) δ: 159.1, 130.3, 129.2 (2C), 128.0, 113.7 (2C), 72.8, 65.5, 61.2, 55.2, 32.4, 32.0. 
HRMS: (ES+) Calculated for C13H19NNaO4 [M+Na]+: 276.1212; Found: 276.1204 
IR νmax/cm-1 (neat):  1658, 1513, 1245, 1173, 1112, 1092, 1032, 993, 819. 
 
  
PMBO N
O
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3-hydroxy-N-methoxy-N-methylpropanamide 190 
 
The reaction was carried out in triplicate in parallel. Me2AlCl (1.0 M in hexanes; 200 mL, 
200 mmol) was added with stirring to N,O-dimethylhydroxylamine hydrochloride (9.8 g, 
100 mmol) in CH3CN (160 mL) at 0 °C. Following this, the reaction mixture was warmed to 
rt and stirred for a further 1 h. After recooling to 0 °C, β-propiolactone 188 (3.6 g, 50.0 
mmol) was added and the solution allowed to warm to rt over 16 h. The reaction was 
quenched with aqueous HCl (0.5 M, 400 mL) at 0 °C, the phases were separated and each 
aqueous phase was extracted with CH2Cl2 (8 x 150 mL). All the organic layers were 
combined, dried (MgSO4) and concentrated in vacuo. Chromatography (99:1 EtOAc/MeOH) 
gave amide 190 (14 g, 109 mmol, 73%) as a colourless oil.  
1H NMR (400 MHz, CDCl3) δ: 3.86 (2H, app. qu, J = 5.0 Hz, CH2OH), 3.68 (3H, s, CH3), 
3.18 (3H, s, CH3), 3.07 (1H, t, J = 6.5 Hz, OH), 2.66 (2H, t, J = 4.9 Hz, C(O)CH2). 
13C NMR (101 MHz, CDCl3) δ: 173.8, 61.2, 58.2, 33.8, 31.9. HRMS: (ES+) Calculated for 
C5H12NO3 [M+H]+: 134.0817; Found: 134.0814. IR νmax/cm-1 (neat): 3421 br, 1638, 1463, 
1387,1179, 1055, 1036, 992. 
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4-methoxybenzyl 2,2,2-trichloroacetimidate 191 
 
Sodium hydride (60 wt % in mineral oil, 1.6 g, 40.3 mmol) was added to 4-methoxybenzyl 
alcohol (20 mL, 161 mmol) in Et2O (62 mL) over 15 min and left stirring for a further 30 
min at rt. The solution was then cooled to 0 °C and trichloroacetonitrile (17 mL, 177 mmol) 
was added dropwise over 20 min. After 1 h the reaction was warmed to rt and stirred for a 
further 45 min. The solution was then concentrated in vacuo, dissolved in pentane/MeOH 
275:1 (170 mL) and stirred for 30 min. Following this, the mixture was filtered through 
Celite® and the solution was concentrated in vacuo to give 191 (37 g, 130 mmol, 90%) as an 
orange oil. The crude material was used without further purification and spectroscopic data 
is consistent with that previously reported in the literature.152 
1H NMR (400 MHz, CDCl3) δ: 8.36 (1H, s, br, NH), 7.37 (2H, d, J = 8.6 Hz, CArH), 6.91 
(2H, d, J = 8.6 Hz, CArH), 5.27 (2H, s, CH2O), 3.82 (3H, s, OCH3). 13C NMR (101 MHz, 
CDCl3) δ: 162.5, 159.6, 129.6 (2C), 127.4, 113.8 (2C), 91.4, 70.6, 55.1. 
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N-methoxy-3-((4-methoxybenzyl)oxy)-N-methylpropanamide 187 
 
Camphorsulfonic acid (720 mg, 30.8 mmol) was added to a solution of alcohol 190 (4.1 g, 
30.8 mmol) and 191 (13 mL, 61.6 mmol) in CH2Cl2 (75 mL) at rt and left stirring for 16 hr. 
Following this, the reaction mixture was filtered through celite®, diluted with CH2Cl2 (250 
mL) and washed with NaHCO3 (250 mL). The aqueous phase was extracted with CH2Cl2 (3 
x 250 mL) and the organic phases were combined, washed with brine (250 mL), dried 
(MgSO4) and concentrated in vacuo. Chromatography (1.5:1 hexanes/EtOAc) gave Weinreb 
amide 187 (6.6 g, 26.1 mmol, 85%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.26-7.24 (2H, m, CArH), 6.88-6.84 (2H, m, CArH), 4.47 
(2H, s, CArCH2OCH2), 3.79 (3H, s, CH3), 3.76 (2H, t, J = 6.5 Hz, CArCH2OCH2), 3.67 (3H, 
s, CH3), 3.18 (3H, s, CH3), 2.74 (2H, t, J = 6.5 Hz, CH2C(O)N). 13C NMR (101 MHz, 
CDCl3) δ: 159.1, 130.3, 129.2 (2C), 128.0, 113.7 (2C), 72.8, 65.5, 61.2, 55.2, 32.4, 32.0. 
HRMS: (ES+) Calculated for C13H19NNaO4 [M+Na]+: 276.1212; Found: 276.1204. 
IR νmax/cm-1 (neat): 1658, 1513, 1245, 1173, 1112, 1092, 1032, 993, 819. 
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5-((4-methoxybenzyl)oxy)-1-(trimethylsilyl)pent-1-yn-3-one 183 
 
n-Butyllithium (2.5 M in hexanes, 35 mL, 87.3 mmol) was added to a solution of 
ethynyltrimethylsilane (12 mL, 87.3 mmol) in Et2O (120 mL) at −78 °C. The reaction 
mixture was left stirring at this temperature for 30 min, following which time, amide 187 
(7.4 g, 29.1 mmol) in Et2O (75 mL) was added. The solution was allowed to warm to −20 °C 
and stirred at this temperature for 30 min, when it was quenched with sat. aqueous NH4Cl 
(200 mL). The two phases were separated and the aqueous phase was extracted with Et2O 
(2 x 200 mL). The organic phases were combined, washed with brine (200 mL) and dried 
(MgSO4). Concentration in vacuo provided ynone 183 (7.9 mg, 27.1 mmol, 93%) as an 
orange oil which was used in subsequent reactions without further purification. 
1H NMR (400 MHz, CDCl3) δ: 7.27-7.23 (2H, m, CArH), 6.89-6.85 (2H, m, CArH), 4.45 
(2H, s, CArCH2OCH2), 3.80 (3H, s, OCH3), 3.79 (2H, t, J = 6.3 Hz, CArCH2OCH2), 2.83 (2H, 
t, J = 6.3 Hz, CH2C(O)), 0.24 (9H, s, SiCH3). 13C NMR (101 MHz, CDCl3) δ: 185.5, 159.2, 
130.0, 129.3 (2C), 113.8 (2C), 101.8, 98.3, 72.8, 64.4, 55.2, 45.4, −0.8 (3C). HRMS: (ES+) 
Calculated for C16H26NO3Si [M+NH4]+: 308.1682; Found: 308.1685. IR νmax/cm-1 (neat): 
1677, 1513, 1247, 1095, 1034, 844, 761, 732. 
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O
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((2-(2-((4-methoxybenzyl)oxy)ethyl)-1,3-dioxolan-2-yl)ethynyl)trimethylsilane 192 
 
p-Toluenesulfonic acid monohydrate (470 mg, 2.71 mmol) was added to a solution of ynone 
183 (7.9 g, 27.1 mmol), trimethyl orthoformate (30 mL, 271 mmol) and ethylene glycol 
(23 mL, 407 mmol) in toluene (75 mL) at rt and stirred for 16 h. NaHCO3 (2.0 g) was then 
added and the solution stirred for a further 30 min. The reaction mixture was filtered through 
Celite® and concentrated in vacuo. Chromatography (15:1 hexanes/EtOAc) generated 
acetylene 192 (6.8 g, 20.3 mmol, 75%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.28-7.26 (2H, m, CArH), 6.89-6.86 (2H, m, CArH), 4.68 
(2H, s, CArCH2OCH2), 4.09-4.05 (2H, m, OCHa2CHb2O), 3.97-3.94 (2H, m, OCHa2CHb2O), 
3.79 (3H, s, OCH3), 3.68 (2H, t, J = 7.4 Hz, CArCH2OCH2), 2.24 (2H, t, J = 7.4 Hz, 
CArCH2OCH2CH2), 0.17 (9H, s, SiCH3). 13C NMR (101 MHz, CDCl3) δ: 159.1, 130.5, 
129.3 (2C), 113.7 (2C), 102.0, 101.4, 89.0, 72.6, 65.5, 64.5 (2C), 55.2, 39.0, −0.3 (3C). 
HRMS: (ES+) Calculated for C18H26O4SiNa [M+Na]+: 357.1498; Found: 357.1498 
IR νmax/cm-1 (neat): 1613, 1513, 1302, 1247, 1173, 1093, 1034, 946, 861, 841. 
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2-ethynyl-2-(2-((4-methoxybenzyl)oxy)ethyl)-1,3-dioxolane 193 
 
K2CO3 (1.5 g, 11.2 mmol) was added to a solution of acetylene 192 (530 mg, 1.59 mmol) 
and water (0.20 mL) in MeOH (6.1 mL) and stirred at rt for 16 h. The mixture was then 
diluted with water (10 mL) and the aqueous phase extracted with CH2Cl2 (3 x 10 mL). The 
organic phases were combined, washed with brine (10 mL), dried (MgSO4) and concentrated 
in vacuo. Chromatography (15:1 hexanes/EtOAc) gave alkyne 193 (340 mg, 1.30 mmol, 
82%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ: 7.28-7.26 (2H, m, CArH), 6.88-6.86 (2H, m, CArH), 4.64 
(2H, s, CArCH2OCH2), 4.08-4.07 (2H, m, OCHa2CHb2O), 4.00-3.98 (2H, m, OCHa2CHb2O), 
3.80 (3H, s, OCH3), 3.70 (2H, t, J = 7.3 Hz, CArCH2OCH2), 2.51 (1H, s, CCH), 2.27 (2H, t, 
J = 7.3 Hz, CArCH2OCH2CH2). 13C NMR (101 MHz, CDCl3) δ: 159.1, 130.4, 129.3 (2C), 
113.7 (2C), 101.3, 81.0, 72.7, 72.2, 65.3, 64.6 (2C), 55.2, 38.9. HRMS: (ES+) Calculated for 
C15H18O4Na [M+Na]+: 285.1103; Found: 285.1094. IR νmax/cm-1 (neat): 3282, 1612, 1512, 
1302, 1245, 1174, 1091, 1032, 991, 912. 
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(E)-2-(2-(2-(2-((4-methoxybenzyl)oxy)ethyl)-1,3-dioxolan-2-yl)vinyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane 194 
 
Acetylene 193 (1.0 g, 4.02 mmol) and pinacol borane (4.1 mL, 28.1 mmol) were stirred, 
neat, for 72 h at 60 °C. Following this, the reaction mixture was cooled to rt and 
chromatography (6:1 hexanes/EtOAc) furnished borane 194 (1.0 g, 2.66 mmol, 66%) as a 
colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.25 (2H, d, J = 8.9 Hz, CArH), 6.86 (2H, d, J = 8.9 Hz, 
CArH), 6.41 (1H, d, J = 18.1 Hz, BCHCH), 5.74 (1H, d, J = 18.1 Hz, BCHCH), 4.41 (2H, s, 
CArCH2OCH2), 3.92-3.87 (2H, m, OCHa2CHb2O), 3.87-3.81 (2H, m, OCHa2CHb2O), 3.79 
(3H, s, OCH3), 3.56 (2H, t, J = 7.3 Hz, CArCH2OCH2), 2.08 (2H, t, J = 7.3 Hz, 
CArCH2OCH2CH2), 1.27 (12H, s, CCH3). 13C NMR (101 MHz, CDCl3) δ: 159.1, 150.5, 
130.6, 129.3 (2C), 118.4, 113.7 (2C), 108.0, 83.4 (2C), 72.6, 65.4, 64.6 (2C), 55.2, 37.5, 
24.8 (4C). HRMS: (ESI+) Calculated for C21H31BO6Na [M+Na]+: 413.2675; Found: 
413.2056. IR νmax/cm-1 (neat):  1513, 1351, 1340, 1325, 1246, 1168, 1142, 1093, 1034, 
1000, 964. 
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(E)-2-(2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)-1,3-dioxolan-2-
yl)ethanol 195 
 
2,3-Dichloro-5,6-dicyanobenzoquinone (350 mg, 0.890 mmol) was added to a solution of 
borane 194 in CH2Cl2/pH 7 buffer (10:1, 10 mL) at 0 °C. The resultant mixture was then 
stirred at rt for 30 min when the reaction was quenched with sat. aqueous NaHCO3 and 
filtered through Celite®. The filtrate was separated and the aqueous layer was extracted with 
Et2O (3 x 30 mL). The combined organic layers were washed with brine (30 mL), dried 
(MgSO4) and concentrated in vacuo. Chromatography (1:1 hexanes/EtOAc) afforded alcohol 
195 (280 mg, 1.04 mmol, 53%) as an orange oil. 
1H NMR (400 MHz, CDCl3) δ: 6.39 (1H, d, J = 18.0 Hz, BCHCH), 5.78 (1H, d, J = 18.0 
Hz, BCHCH), 4.02-3.96 (2H, m, OCHa2CHb2O), 3.93-3.87 (2H, m, OCHa2CHb2O), 3.75 (2H, 
app. q, J = 5.7 Hz, HOCH2), 2.70 (1H, t, J = 5.9 Hz, OH), 2.00 (2H, t, J = 5.4 Hz, 
HOCH2CH2), 1.29 (12H, s, CCH3). 13C NMR (101 MHz, CDCl3) δ: 149.8, 119.4, 109.4, 
83.4 (2C), 64.4 (2C), 58.2, 38.8, 24.7 (4C). HRMS: (CI+) Calculated for C13H24BO5 
[M+H]+: 271.1717; Found: 271.1736. IR νmax/cm-1 (neat):  3431 br, 1643, 1341, 1325, 
1141, 1038, 1002, 969, 947, 849. 
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(R)-methyl 3-((tert-butyldiphenylsilyl)oxy)butanoate 197 
 
Imidazole (9.8 g, 144 mmol) was added to a solution of methyl (R)-3-hydroxybutyrate (10 g, 
84.7 mmol) in CH2Cl2 at 0 °C. After 10 min t-butyldiphenylsilyl chloride (24 mL, 
93.1 mmol) was added. The resulting mixture was warmed to rt and stirred for 16 h. The 
reaction was then diluted with Et2O (200 mL) and washed with sat. aqueous NH4Cl (200 
mL)  and brine (200 mL). The organic layer was dried (MgSO4), concentrated in vacuo and 
chromatography (5:1 hexanes/EtOAc) furnished ester 197 (29 g, 81.5 mmol, 96%) as a 
colourless oil. The spectroscopic data is consistent with that previously reported in the 
literature.153 
1H NMR (400 MHz, CDCl3) δ: 7.70-7.66 (4H, m, CArH), 7.44-7.35 (6H, m, CArH), 4.34-
4.26 (1H, m, CHCH3), 3.59 (3H, s, OCH3), 2.56 (1H, dd, J = 14.6, 7.1 Hz, CHaHbCO2Me), 
2.39 (1H, dd, J = 14.6, 5.7 Hz, CHaHbCO2Me), 1.11 (3H, d, J = 6.1 Hz, CHCH3), 1.03 (9H, 
s, CCH3). 13C NMR (101 MHz, CDCl3) δ: 171.8, 135.8 (4C), 134.2, 133.8, 129.6, 129.5, 
127.5 (4C), 66.8, 51.4, 44.4, 26.8, 23.6 (3C), 19.1. [α]25D: −5.9 (c = 0.67, CH2Cl2), {lit.21 
[α25D] −5.1 (c = 0.67, CH2Cl2)}. 
 
  
OMe
O
TBDPSO
   161 
(R)-3-((tert-butyldiphenylsilyl)oxy)butanal 198 
 
A solution of ester 197 (17 g, 44.6 mmol) in toluene was treated with DIBALH (1.0 M in 
CH2Cl2, 49 mL, 49.1 mmol) at −78 °C. After 10 min, MeOH (10 mL) and sat. aqueous  
NH4Cl (32 mL) were added and the reaction mixture was stirred for a further 1 h at rt. Et2O 
(325 mL) was then added and the suspension stirred for 1 h when MgSO4 (16.8 g) was 
added. The resulting suspension was filtered through Celite® and concentrated in vacuo to 
give aldehyde 198 (14 g, 43.3 mmol, 97%) as a colourless oil, which was used in subsequent 
reactions without further purification. The spectroscopic data is consistent with that 
previously reported in the literature.153 
1H NMR (400 MHz, CDCl3) δ: 9.76 (1H, t, J = 2.1 Hz, C(O)H), 7.68-7.66 (4H, m, CArH), 
7.46-7.36 (6H, m, CArH), 4.38-4.31 (1H, m, CHCH3), 2.56-2.43 (2H, m, CH2C(O)H), 1.17 
(3H, d, J = 6.3 Hz, CHCH3), 1.04 (9H, s, CCH3). 13C NMR (101 MHz, CDCl3) δ: 202.0, 
135.8 (2C), 135.8 (2C), 134.0, 129.8, 129.7, 127.7 (2C), 127.6 (2C), 65.7, 52.7, 26.9 (3C), 
26.5, 23.8, 19.2. [α]25D: +6.7 (c = 0.70, CH2Cl2). 
 
  
O
TBDPSO H
   162 
(R,E)-ethyl 5-((tert-butyldiphenylsilyl)oxy)hex-2-enoate 199 
 
Aldehyde 198 (12 g, 38.0 mmol) in CH3CN (10 mL) was added to a solution of anhydrous 
LiCl (1.9 g, 45.6 mmol), triethylphosphonoacetate (9.0 mL, 45.6 mmol) and 
diisopropylethylamine (6.7 mL, 38.0 mmol) in CH3CN (100 mL) at rt and the reaction 
stirred for 16 h. Following this, the solution was diluted with Et2O (300 mL) and washed 
with water (300 mL). The aqueous phase was extracted with Et2O (2 x 300 mL) and the 
combined organic layers were washed with brine, dried (MgSO4) and concentrated in vacuo. 
Chromatography (98:2 hexanes/EtOAc) afforded unsaturated ester 199 (13.4 g, 33.7 mmol, 
89%) as a colourless oil. The spectroscopic data is consistent with that previously reported in 
the literature.153 
1H NMR (400 MHz, CDCl3) δ: 7.69-7.67 (4H, m, CArH), 7.45-7.36 (6H, m, CArH), 6.93 
(1H, dt, J = 15.7, 7.4 Hz, CH2CH=CH), 5.77 (1H, dt, J = 15.7, 1.8 Hz, CH=CHCO2Et), 
4.19-4.17 (2H, m, CH2CH=CH) 4.00-3.93 (1H, m, CHCH3), 2.38-2.26 (2H, m, OCH2CH3), 
1.29 (3H, t, J = 7.2 Hz, OCH2CH3), 1.10 (3H, d, J = 6.1 Hz, CHCH3), 1.06 (9H, s, CCH3). 
13C NMR (101 MHz, CDCl3) δ: 166.4, 145.5, 136.1 (2C), 135.8 (2H), 134.3, 134.0, 129.6, 
129.6, 127.7 (2C), 127.6 (2C), 123.4, 68.5, 60.1, 42.1, 26.9 (3C), 23.2, 19.2, 14.2. [α]25D: 
+23.6 (c = 0.71, CH2Cl2), {lit.21 [α25D] +31 (c = 0.17, CH2Cl2)}. 
 
  
TBDPSO OEt
O
   163 
(R,E)-5-((tert-butyldiphenylsilyl)oxy)hex-2-en-1-ol 200 
 
DIBALH (1.0 M in toluene, 86 mL, 86.1 mmol) was added to a solution of ester 199 (16 g, 
41.0 mmol) in CH2Cl2 (325 mL) at −20 °C and left to stir at this temperature for 1 h. After 
this, the reaction was allowed to warm to rt and stirred for a further 15 min. The solution was 
then treated with sat. aqueous NH4Cl (30 mL) and stirred for 1 h, following which time it 
was diluted with Et2O (600 mL) and stirred for a further 1 h. MgSO4 (10 g) was then added 
and the suspension filtered through a pad of Celite® and concentrated in vacuo. 
Chromatography (95:5 hexanes/EtOAc) furnished allylic alcohol 200 (14 g, 39.4 mmol, 
96%) as a colourless oil. The spectroscopic data is consistent with that previously reported in 
the literature.153 
1H NMR (400 MHz, CDCl3) δ: 7.70-7.65 (4H, m, CArH), 7.44-7.35 (6H, m, CArH), 5.63-
5.52 (2H, m, CHa=CHb and CHa=CHb), 4.02 (2H, dd, J = 5.8, 4.4 Hz, CH2OH), 3.98-3.86 
(1H, m, CHCH3), 2.24-2.09 (2H, m, CH2CH=CH), 1.09 (3H, d, J = 6.0 Hz, CHCH3), 1.05 
(9H, s, CCH3). 13C NMR (101 MHz, CDCl3) δ: 135.9 (2C), 135.9 (2H), 134.6, 134.4, 131.3, 
129.5, 129.5, 129.4, 127.5 (2C), 127.4 (2C), 69.2, 63.7, 42.3, 27.0 (3C), 23.1, 19.2. [α]25D: 
+19.7 (c = 0.71, CH2Cl2), {lit.21 [α25D] +20 (c = 0.71, CH2Cl2)}. 
 
  
TBDPSO OH
   164 
((2R,3R)-3-((R)-2-((tert-butyldiphenylsilyl)oxy)propyl)oxiran-2-yl)methanol 201 
 
 (D)-(−)-diethyl tartrate (0.40 mL, 2.33 mmol), Ti(Oi-Pr)4 (0.59 mL, 1.94 mmol) and t-
butylhydroperoxide (5.5 M in decane, 5.3 mL, 29.1 mmol) were added sequentially to a 
suspension of flame dried 4 Å molecular sieves (7.0 g) in CH2Cl2 (70 mL) at −30 °C and the 
reaction mixture was stirred with an electrical stirrer for 30 min. Following this, allylic 
alcohol 200 (6.9 g, 19.4 mmol) in CH2Cl2 (20 mL) was added to the mixture. The reaction 
was stirred for 16 h at −30 °C, then warmed to −20 °C and quenched by the addition of 10% 
aqueous NaOH solution (8.0 mL) saturated with NaCl (15 g). Upon further warming to 
−10 °C the reaction was diluted with Et2O (200 mL), treated with MgSO4 (8.0 g) and 
Celite® (4.0 g) and stirred for a further 15 min. The reaction mixture was allowed to settle 
before filtration through a pad of Celite® using Et2O to wash the residue. The solution was 
concentrated in vacuo and chromatography (7:1 to 2:1 hexanes/EtOAc) yielded epoxide 201 
(7.0 g, 18.8 mmol, 97%) as a single diastereoisomer and colourless oil. The spectroscopic 
data is consistent with that previously reported in the literature.153 
1H NMR (400 MHz, CDCl3) δ: 7.68-7.67 (4H, m, CArH), 7.45-7.35 (6H, m, CArH), 
4.10-4.02 (1H, m, CHCH3), 3.87-3.82 (1H, m, CHaHbOH), 3.59-3.53 (1H, m, CHaHbOH), 
3.07 (1H, td, J = 5.9, 2.4 Hz, CH2CH(O)C), 2.83 (1H, dt, J = 4.3, 2.4 Hz, CH(O)CH2OH), 
1.81-1.75 (1H, m, CHCHaHbCH(O)CH), 1.67-1.61 (1H, m, CHCHaHbCH(O)CH), 1.16 (3H, 
d, J = 6.1 Hz, CHCH3), 1.06 (9H, s, CCH3). 13C NMR (101 MHz, CDCl3) δ: 135.8 (2H), 
135.8 (2H), 134.3, 134.1, 129.7, 129.6, 127.6 (2H), 127.5 (2H), 67.5, 61.6, 58.1, 52.9, 41.1, 
27.0 (3H), 23.3, 19.2. [α]25D: +25.6 (c = 0.80, CH2Cl2), {lit.21 [α25D] +23 (c = 0.8, CH2Cl2)}. 
 
  
TBDPSO
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O
   165 
(2S,3R)-3-((R)-2-((tert-butyldiphenylsilyl)oxy)propyl)oxirane-2-carbaldehyde 171 
 
SO3.pyridine (7.2 g, 44.8 mmol) was added to a solution of alcohol 201 (4.8 g, 12.8 mmol) 
and NEt3 (8.9 mL, 64.0 mmol) in 4:1 CH2Cl2/DMSO (160 mL) at 0 °C, then stirred for 
30 min at rt. The reaction was diluted with EtOAc (150 mL) and washed sequentially with 
water (150 mL), aqueous HCl (0.5 M, 2 x 150 mL), sat. aqueous NaHCO3 (150 mL), and 
brine (150 mL). Following this the solution was dried (MgSO4) and concentrated in vacuo. 
Chromatography (15:1 hexanes/EtOAc) generated aldehyde 171 (4.0 g, 10.8 mmol, 85%) as 
a colourless oil. The spectroscopic data is consistent with that previously reported in the 
literature.153 
1H NMR (400 MHz, CDCl3) δ: 8.95 (1H, d, J = 6.3 Hz, C(=O)H), 7.67-7.64 (4H, m, CArH), 
7.46-7.36 (6H, m, CArH), 4.11-4.04 (1H, m, CHCH3), 3.37 (1H, dt, J = 6.4, 1.9 Hz, 
CH2CH(O)CH), 3.04 (1H, dd, J = 6.3, 2.0 Hz, CH(O)CHC(=O)H), 1.78-1.68 (2H, m, 
CHCH2CH(O)CH), 1.18 (3H, d, J = 6.2 Hz, CHCH3), 1.06 (9H, s, CCH3). 
13C NMR (101 MHz, CDCl3) δ: 198.3, 135.8 (2C), 135.8 (2C), 134.1, 133.8, 129.8, 129.7, 
127.7 (2C), 127.6 (2C), 67.3, 58.6, 53.9, 40.6, 27.0 (3C), 23.3, 19.2. [α]25D: −22.5 (c = 0.54, 
CH2Cl2), {lit.21 [α25D] −15 (c = 0.54, CH2Cl2)}. 
 
  
TBDPSO
O
O
   166 
(iodomethyl)triphenylphosphonium iodide 202 
 
Methylene iodide (6.0 mL 74.4 mmol) was added to a suspension of triphenylphosphine 
(15 g, 57.2 mmol) in toluene (15 mL) and heated to 50 °C for 16 h. Following this, the 
consequential crystals were collected, washed with toluene (3 x 50 mL) and dried in vacuo 
to give phosphonium salt 202 (20 g, 38.4 mmol, 67%) as a white solid. The spectroscopic 
data is consistent with that previously reported in the literature.154 
1H NMR (400 MHz, d6-DMSO) δ: 7.96-7.78 (15H, m, CArH). 5.10 (2H, d, JP-H = 8.7 Hz, 
CH2). 13C NMR (101 MHz, d6-DMSO) δ: 135.1 (3C, d, J = 2 Hz), 133.8 (6C, d, J = 10 Hz), 
130.1 (6C, d, J = 13 Hz), 118.2 (3C, d, J = 88 Hz), −16.2 (1C, d, J = 52 Hz). Mpt: 
227-229 °C {toluene} (lit.= 228-230 °C). 
 
  
I P+Ph3I-
   167 
(Z)-ethyl 3-((2R,3R)-3-((R)-2-((tert-butyldiphenylsilyl)oxy)propyl)oxiran-2-yl)acrylate 
206 
 
Potassium bis(trimethylsilyl)amide (0.5 M in toluene, 2.8 mL, 1.40 mmol) was added 
dropwise over 30 min to a solution of 18-crown-6 (830 mg, 3.16 mmol) and ethyl [bis(2,2,2-
trifluoroethoxy)phosphinyl]acetate (0.33 mL, 1.40 mmol) in THF (30 mL) at −78 °C. After a 
further 10 min of stirring, a solution of aldehyde 171 (430 mg, 1.17 mmol) in THF (1.3 mL) 
was added and the reaction mixture stirred for 1 h. The mixture was quenched with sat. 
aqueous NH4Cl  (15 mL) and the reaction mixture warmed to rt. The phases were separated 
and the aqueous layer was extracted with EtOAc (2 x 30 mL). The organic phases were 
combined, washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo. 
Chromatography (50:1 hexanes/EtOAc) gave conjugated ester 206 (360 mg, 0.830 mmol, 
71%), as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.69-7.65 (4H, m, CArH), 7.44-7.34 (6H, m, CArH), 5.97 
(1H, d, J = 11.8 Hz, CH=CHCO2Et), 5.59 (1H, dd, J = 11.8, 8.5 Hz, CH=CHCO2Et), 4.27 
(1H, dd, J = 8.5, 1.0 Hz, CHCH=CHCO2Et), 4.19 (2H, q, J = 7.2 Hz, CO2CH2CH3), 4.10 
(1H, app. sex, J = 5.9 Hz, CHCH3), 3.05 (1H, td, J = 5.6, 1.0 Hz, CH2CH(O)CH), 1.85-1.72 
(2H, m, CHCH2CH(O)CH), 1.30 (3H, t, J = 7.2 Hz, CO2CH2CH3) 1.14 (3H, d, J = 6.1 Hz, 
CHCH3), 1.05 (9H, s, CCH3). 13C NMR (101 MHz, CDCl3) δ: 165.8, 146.7, 135.8 (4C), 
134.4, 134.0, 129.6, 129.5, 127.6 (2C), 127.5 (2C), 123.6, 67.6, 60.4, 57.3, 53.8, 41.6, 26.9 
(3C), 23.4, 19.2 14.2. HRMS: (ES+) Calculated for C26H35O4Si [M+H]+: 439.2305; Found: 
439.2305. IR νmax/cm-1 (neat): 1718, 1473, 1428, 1192, 1111, 1029, 823. [α]25D : −31.4 (c = 
0.56, CH2Cl2). 
 
TBDPSO O
EtO2C
   168 
(3S,4R,6R)-1,1,3-tribromo-6-((tert-butyldiphenylsilyl)oxy)hept-1-en-4-ol 209 
 
Triphenyl phosphine (2.8 g, 10.6 mmol) was added to a solution of aldehyde 171 (710 mg, 
1.93 mmol) in CH2Cl2 (20 mL) at 0 °C and stirred for 10 min. Following this, 
tetrabromomethane (1.7 g, 5.21 mmol) was added and the solution was stirred for a further 
1 h. The solution was then diluted with water (20 mL), the layers were separated and the 
aqueous phase washed with Et2O (2 x 20 mL). The combined organic phases were washed 
with brine (20 mL), dried (MgSO4) and concentrated in vacuo. Chromatography (50:1 
hexanes/EtOAc) gave bromohydrin 209 (900 mg, 1.49 mmol, 77%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.73-7.69 (4H, m, CArH), 7.48-7.38 (6H, m, CArH), 6.73 
(1H, d, J = 10.2 Hz, CH=CBr2), 4.58 (1H, dd, J = 10.2, 3.1 Hz, CHBr), 4.11-4.04 (2H, m, 
CHCH3 and CHOH), 2.98 (1H, d, J = 3.0 Hz, OH), 1.76-1.68 (1H, m, CHaHbCHOH) 1.60-
1.54 (1H, m, CHaHbCHOH), 1.08 (3H, d, J = 6.5 Hz, CHCH3), 1.06 (9H, s, CCH3). 13C 
NMR (101 MHz, CDCl3) δ: 135.8 (4C), 134.2, 134.1, 133.4, 130.0, 129.7, 127.8 (2C), 127.5 
(2C), 95.4, 72.3, 68.7, 56.6, 42.8, 27.0 (3C), 23.8, 19.1. HRMS: (ES+) Calculated for 
C23H30Br3O4Si [M+H]+: 602.9565; Found: 602.9570. IR νmax/cm-1 (neat): 3460 br, 1427, 
1142, 1110, 1076, 1035, 1006. [α]25D: −59.6 (c = 0.76, CH2Cl2). 
 
  
TBDPSO OHBr
Br
Br
   169 
tert-butyl(((R)-1-((2R,3R)-3-(2,2-dibromovinyl)oxiran-2-yl)propan-2-yl)oxy)diphenyl 
silane 210 
 
TBAF (1.0 M in THF, 2.2 mL, 2.18 mmol) was added to a solution of bromohydrin 209 
(660 mg, 1.09 mmol) in THF (11 mL) at 0 °C. After 1 min the solution was diluted with 
water (10 mL) and the aqueous phase extracted with Et2O (3 x 20 mL). The combined 
organic phases were dried (MgSO4) and concentrated in vacuo. Chromatography (40:1 
hexanes/EtOAc) generated epoxide 210 (470 mg, 0.870 mmol, 80%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.70-7.67 (4H, m, CArH), 7.44-7.36 (6H, m, CArH), 6.05 
(1H, d, J = 7.9 Hz, CH=CBr2), 4.10-4.03 (1H, m, CHCH3), 3.27 (1H, dd, J = 7.9, 2.1 Hz, 
CHCH=CBr2), 3.06 (1H, td, J = 5.8, 2.1 Hz, CH2CH(O)CH), 1.81-1.75 (1H, m, 
CHCHaHbCH(O)CH), 1.69-1.62 (1H, m, CHCHaHbCH(O)CH) 1.15 (3H, d, J = 6.3 Hz, 
CHCH3), 1.06 (9H, s, CCH3). 13C NMR (101 MHz, CDCl3) δ: 135.8, 135.6 (4H), 134.4, 
134.4, 133.9, 129.7, 129.6, 127.7 (2H), 127.5 (2H), 67.4, 57.1, 56.5, 41.3, 26.9 (3H), 23.4, 
19.2. HRMS: (ES+) Calculated for C23H29Br2O2Si [M+H]+: 525.3687; Found: 525.0272. 
IR νmax/cm-1 (neat): 1427, 1379, 1126, 1104, 1068, 1026, 997. [α]25D: +26.6 (c = 0.96, 
CH2Cl2). 
 
  
TBDPSO O
Br
Br
   170 
dimethyl (1-diazo-2-oxopropyl)phosphonate 215 
 
Dimethyl (2-oxopropyl)phosphonate (3.3 mL, 24.1 mmol) in 5:1 PhMe/THF (130 mL) was 
cooled to 0 °C and sodium hydride (60% wt in mineral oil, 1.1g, 26.5 mmol) was added 
slowly. After 1 h 4-acetamidobenzenesulfonyl azide (6.4 g, 26.5 mmol) was added and the 
reaction was stirred for a further 12 h at rt. Following this, the reaction mixture was filtered 
through Celite® and the filtrate was concentrated in vacuo. Chromatography (2:1 
EtOAc/hexanes) yielded diazo compound 215 (2.7 g, 14.0 mmol, 58%) as a yellow oil. The 
spectroscopic data is consistent with that previously reported in the literature.155 
1H NMR (400 MHz, CDCl3) δ: 3.83 (6H, d, JH-P = 11.8 Hz, OCH3), 2.27 (3H, s, CCH3). 
13C NMR (101 MHz, CDCl3) δ: 189.9 (d, JC-P = 12.8 Hz), 62.1, 53.3 (2C, d, JC-P = 4.7 Hz), 
27.1. 
 
  
O
P OMe
O
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   171 
tert-butyl(((R)-1-((2R,3R)-3-ethynyloxiran-2-yl)propan-2-yl)oxy)diphenylsilane 212 
 
K2CO3 (2.3 g, 16.6 mmol) was added to a solution of aldehyde 171 (2.7 g, 7.21 mmol) in 
MeOH (90 mL) at 0 °C. Following this, phosphonate 215 (1.9 g, 10.1 mmol) in MeOH 
(25 mL) was added slowly to the mixture, which was stirred for a further 3 h at 0 °C. The 
reaction was then diluted with Et2O (100 mL) and washed with sat. aqueous NaHCO3 
(150  mL). The phases were separated and the aqueous phase was extracted with Et2O (3 x 
150 mL). The combined organic layers were washed with brine (150 mL), dried (MgSO4) 
and concentrated in vacuo. Chromatography (50:1 hexanes/EtOAc) yielded alkyne 212 
(1.7 g, 4.75 mmol, 66%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.69-7.66 (4H, m, CArH), 7.45-7.36 (6H, m, CArH), 4.06 
(1H, app. sex, J = 6.0 Hz, CHCH3), 3.27 (1H, td, J = 5.6, 2.3 Hz, CH2CH(O)CH), 3.03 (1H, 
dd, J =  2.3, 1.6 Hz, CH(O)CHCCH), 2.32 (1H, d, J = 1.6 Hz, CCH), 1.74-1.59 (2H, m, 
CHCH2CH(O)CH), 1.14 (3H, d, J = 6.2 Hz, CHCH3), 1.06 (9H, s, CCH3). 
13C NMR (101 MHz, CDCl3) δ: 135.8 (2C), 135.8 (2C), 134.3, 133.9, 129.7, 129.6, 127.7 
(2C), 127.5 (2C), 80.4, 71.8, 67.2, 57.4, 44.7, 41.1, 27.0 (3C), 23.2, 19.2. HRMS: (CI+) 
Calculated for C23H32NO2Si [M+NH4]+: 382.2202; Found: 382.2189. IR νmax/cm-1 (neat): 
3288, 1427, 1380, 1110, 1074, 997, 878, 821, 700. [α]25D: +30.5 (c = 0.97, CH2Cl2). 
 
  
TBDPSO O
   172 
tert-butyl(((R)-1-((2R,3R)-3-(iodoethynyl)oxiran-2-yl)propan-2-yl)oxy)diphenylsilane 
208 
 
Silver nitrate (160 mg, 0.914 mmol) was added to a solution of alkyne 212 (1.7 g, 
4.57 mmol) and N-iodosuccinimide (1.2 g, 5.48 mmol) in acetone (40 mL) in the dark at rt. 
The reaction was stirred for 1 h, after which time it was quenched with ice-cold water 
(40 mL). The aqueous layer was extracted with EtOAc (3 x 50 mL) and the combined 
organic layers were washed with brine (50 mL), dried (MgSO4) and concentrated in vacuo. 
Chromatography (50:1 hexanes/EtOAc) gave iodo-alkyne 208 (2.2 g, 4.53 mmol, 98%) as a 
yellow oil. 
1H NMR (500 MHz, CDCl3) δ: 7.69-7.66 (4H, m, CArH), 7.45-7.42 (2H, m, CArH), 
7.40-7.36 (4H, m, CArH), 4.05 (1H, app. sex, J = 6.0 Hz, CHCH3), 3.25 (1H, td, J = 5.8, 2.1 
Hz, CH2CH(O)C), 3.11 (1H, d, J =  2.1 Hz, CH(O)CHCCI), 1.73-1.68 (1H, m, 
CHCHaHbCH(O)CH), 1.61-1.56 (1H, m, CHCHaHbCH(O)CH), 1.14 (3H, d, J = 6.2 Hz, 
CHCH3), 1.06 (9H, s, CCH3). 13C NMR (125 MHz, CDCl3) δ: 135.8 (2C), 135.8 (2C), 
134.2, 133.8, 129.7, 129.6, 127.7 (2C), 127.5 (2C), 90.9, 67.2, 57.7, 46.1, 41.1, 27.0 (3C), 
23.2, 19.2, 1.5. HRMS: (ES+) Calculated for C23H28IO2Si [M+H]+: 491.0903; Found: 
491.0901. IR νmax/cm-1 (neat): 1428, 1112, 1025, 822, 740, 702. [α]25D: +48.3 (c = 0.77, 
CH2Cl2). 
 
  
TBDPSO O
I
   173 
2-nitrobenzenesulfonohydrazide 217 
 
Hydrazine monohydrate (0.61 mL, 12.5 mmol) was added to a solution of 
2-nitrobenzenesulfonyl chloride (1.2 g, 5.00 mmol) in THF (5.0 mL) at −30 °C. After 45 
min, TLC analysis showed there was still starting material left so further hydrazine 
monohydrate (0.4 mL, 8.27 mmol) was added and the reaction stirred for a further 30 min. 
EtOAc (10 mL) was then added to the cold reaction and the mixture was washed repeatedly 
with ice cold 10% aqueous NaCl solution (5 x 7.5 mL). The organic phase was dried 
(MgSO4) at 0 °C and then slowly added to a stirring solution of hexanes (60 mL) at rt over 5 
min. Within 10 min a white precipitate had formed which was collected by filtration. The 
filter cake was washed with hexanes (2 x 5 mL) and dried in vacuo for 16 h. This gave 
hydrazide 217 (850 mg, 3.89 mmol, 78%) as an off-white solid. The spectroscopic data is 
consistent with that previously reported in the literature.156 
1H NMR (400 MHz, CD3CN) δ: 8.08-8.06 (1H, m, CArH), 7.88-7.80 (3H, m, CArH), 6.91 
(1H, s, br, NH), 3.98 (2H, s, br, NH2). 13C NMR (101 MHz, CD3CN) δ: 149.4, 135.5, 133.5, 
133.3, 130.8, 125.9. Mpt: 100-101 °C {CD3CN} (lit: 100-101 °C). 
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tert-butyl(((R)-1-((2R,3R)-3-((Z)-2-iodovinyl)oxiran-2-yl)propan-2-yl)oxy)diphenyl 
silane 180 
 
Hydrazide 217 (790 g, 3.66 mmol) was added in the dark to a solution of alkyne 208 (1.6 g, 
3.32 mmol) in i-PrOH/THF (1:1, 40 mL). Subsequently NEt3 (0.69 mL, 4.98 mmol) was 
added and the solution stirred for 24 h. TLC analysis showed the reaction had not yet gone to 
completion and further hydrazide 217 (290 mg, 1.33 mmol) and NEt3 (0.25 mL, 1.65 mmol) 
were added and the reaction stirred for a further 16 h. The mixture was then diluted with 
Et2O (50 mL) and washed with 10% aqueous NaCl (5 x 50 mL). The organic phase was 
dried (MgSO4) and concentrated in vacuo. Chromatography (100:1 hexanes/EtOAc) gave 
iodo-alkene 180 (1.3 g, 2.66 mmol, 80%) as a yellow solid. 
1H NMR (500 MHz, CDCl3) δ: 7.69-7.66 (4H, m, CArH), 7.45-7.36 (6H, m, CArH), 6.49 
(1H, dd, J = 7.9, 1.0 Hz, CH=CHI), 5.94 (1H, t, J = 7.9 Hz, CH=CHI), 4.09 (1H, app. sex, 
J = 5.5 Hz, CHCH3), 3.32 (1H, ddd, J = 7.7, 2.1, 1.1 Hz, CH2CH(O)CHCH), 3.08 (1H, dt, 
J = 5.9, 2.2 Hz, CH2CH(O)CHCH), 1.83-1.78 (1H, m, CHCHaHbCH(O)CH), 1.75-1.69 (1H, 
m, CHCHaHbCH(O)CH), 1.16 (3H, d, J = 6.2 Hz, CHCH3), 1.06 (9H, s, CCH3). 
13C NMR (101 MHz, CDCl3) δ: 138.3, 135.8 (2C), 135.8 (2C), 134.4, 134.0 129.7, 129.6, 
127.7 (2C), 127.5 (2C), 84.8, 67.5, 60.1, 56.7, 41.4, 27.0 (3C), 23.4, 19.2. HRMS: (CI+) 
Calculated for C23H30IO2Si [M+H]+: 493.1060; Found: 493.1048. IR νmax/cm-1 (neat): 1428, 
1380, 1272, 1111, 1074, 1040, 1025. [α]25D: −27.4 (c = 2.19, CH2Cl2). Mpt: 50-52 °C 
{CHCl3}. 
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tert-butyl(((R)-1-((2R,3R)-3-((1Z,3E)-4-(2-(2-((4-methoxybenzyl)oxy)ethyl)-1,3-
dioxolan-2-yl)buta-1,3-dien-1-yl)oxiran-2-yl)propan-2-yl)oxy)diphenylsilane 205 
 
Pd(dppf)Cl2CH2Cl2 (7 mg, 7.9 µmol) was added to pinacol borane 194 (31 mg, 79.4 µmol) 
and alkene 180 (58 mg, 0.118 mmol) in a degassed solution of THF (3.5 mL). To this 
solution, aqueous NaOH (3M, 0.16 mL, 0.474 mmol) was also added. The reaction was then 
stirred at rt for 24 h. Sat. aqueous NH4Cl (20 mL) was added to the reaction and the phases 
were separated. The aqueous phase was extracted with EtOAc (3 x 10 mL). The combined 
organic phases were washed with brine (10 mL), dried (MgSO4) and concentrated in vacuo. 
Chromatography (7:1 hexanes/EtOAc) afforded diene 205 (31 mg, 49.4 µmol, 62%) as a 
yellow oil. 
1H NMR (400 MHz, CDCl3) δ: 7.69-7.65 (4H, m, CArH), 7.44-7.34 (6H, m, CArH), 7.25 
(2H, d, J = 8.6 Hz, CArH), 6.87 (2H, d, J = 8.6 Hz, CArH), 6.72 (1H, dd, J = 15.1, 12.4 Hz, 
H8), 6.24 (1H, dd, J = 12.4, 11.2, H7), 5.69 (1H, d, J = 15.1 Hz, H9), 5.07 (1H, dd, J = 11.1, 
9.3 Hz, H6), 4.42 (2H, s, H14), 4.08 (1H, app. sex, J = 6.1 Hz, H1), 3.95-3.83 (4H, m, H11), 
3.80 (3H, s, CH3), 3.57 (2H, t, J = 7.2 Hz, H13), 3.44 (1H, dd, J = 9.2, 1.9 Hz, H5), 3.02 (1H, 
td, J = 5.8, 1.9 Hz, H4), 2.11 (2H, t, J = 7.2 Hz, H12), 1.82-1.68 (2H, m, H3), 1.15 (3H, d, 
J = 6.1 Hz, H2), 1.06 (9H, s, CCH3). 13C NMR (101 MHz, CDCl3) δ: 159.1, 135.8 (2C), 
135.8 (2C), 135.4, 134.4, 134.0, 132.9, 130.5, 129.6, 129.5, 129.4, 129.3 (2C), 127.6 (2C), 
127.5 (2C), 124.7, 113.7 (2C), 107.8, 72.7, 67.5, 65.4, 64.7, 64.5, 57.6, 55.2, 54.0, 41.6, 
38.4, 27.0 (3C), 23.3, 19.2. HRMS: (ES+) Calculated for C38H48NaO6Si [M+Na]+: 
651.3118; Found: 651.3119. IR νmax/cm-1 (neat): 1613, 1513, 1428, 1247, 1110, 1034, 997, 
950, 821. [α]25D: +6.6 (c = 0.88, CH2Cl2). 
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N-methoxy-N-methyl-3-((triethylsilyl)oxy)propanamide 221 
 
Triethylsilyl chloride (13 mL, 78.2 mmol) was added to a solution of Weinreb amide 190 
(9.5 g, 71.1 mmol) and NEt3 (12 mL, 85.3 mmol) in CH2Cl2 (60 mL) at 0 °C. After 15 min, 
the ice bath was removed and the mixture was stirred at rt for 16 h. The reaction was filtered 
and the filtrate washed successively with sat. aqueous NaHCO3 (300 mL), water (300 mL) 
and brine (300 mL), dried (MgSO4) and concentrated in vacuo. Chromatography (8:1 
hexanes/EtOAc) gave amide 221 (18 g, 70.5 mmol, 99%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 3.94 (2H, t, J = 6.6 Hz, CH2OSi), 3.70 (3H, s, CH3), 3.18 
(3H, s, CH3), 2.69 (2H, t, J = 6.6 Hz, C(O)CH2), 0.95 (9H, t, J = 7.9 Hz, SiCH2CH3), 0.61 
(6H, q, J = 7.9 Hz, SiCH2CH3). 13C NMR (126 MHz, CDCl3) δ: 172.4, 61.3, 58.9, 35.2, 
31.9, 6.6 (3C), 4.3 (3C). HRMS: (ES+) Calculated for C11H26NO3Si [M+H]+: 248.1682; 
Found: 248.1691. IR νmax/cm-1 (neat): 1665, 1461, 1416, 1383, 1093, 1005. 
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5-((triethylsilyl)oxy)-1-(trimethylsilyl)pent-1-yn-3-one 222 
 
n-BuLi (2.5 M in hexanes, 34 mL, 84.9 mmol) was added dropwise to a solution of 
ethynyltrimethylsilane (12 mL, 84.9 mmol) in Et2O (120 mL) at −78 °C. The reaction 
mixture was left stirring at this temperature for 30 min, when Weinreb amide 221 (7.0 g, 
28.3 mmol) in Et2O (70 mL) was added dropwise. The reaction mixture was allowed to 
warm to −20 °C and stirred at this temperature for 30 min, when it was quenched with sat. 
aqueous NH4Cl (250 mL). The two phases were separated and the aqueous phase was 
extracted with Et2O (2 x 300 mL). The organic phases were combined, washed with brine 
(250 mL), dried (MgSO4) and concentrated in vacuo to give ynone 222 (7.5 g, 26.5 mmol, 
94%) as an orange oil which was used in subsequent reactions immediately following 
isolation and without further purification. 
1H NMR (400 MHz, CDCl3) δ: 3.98 (2H, t, J = 6.3 Hz, CH2OSi), 2.78 (2H, t, J = 6.3 Hz, 
CCH2CH2), 0.95 (9H, t, J = 8.0 Hz, SiCH2CH3), 0.60 (6H, q, J = 8.0 Hz, SiCH2CH3), 0.24 
(9H, s, SiCH3). 13C NMR (101 MHz, CDCl3) δ: 186.0, 101.9, 98.1, 58.0, 48.3, 6.7 (3C), 4.3 
(3C), −0.8 (3C). HRMS: (ES+) Calculated for C14H29O2Si2 [M+H]+: 285.1706; Found: 
285.1714. IR νmax/cm-1 (neat): 1681, 1252, 1092, 1007, 844. 
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2-(2-((trimethylsilyl)ethynyl)-1,3-dioxolan-2-yl)ethanol 223 
 
p-Toluenesulfonic acid monohydrate (61 mg, 0.356 mmol) was added to a solution of ynone 
222 (1.0 g, 3.56 mmol), trimethyl orthoformate (3.9 mL, 35.6 mmol) and ethylene glycol 
(3.0 mL, 53.4 mmol) in toluene (10 mL) at rt. After 16 h, the reaction was washed with sat. 
aqueous NaHCO3 (100 mL) and the aqueous phase was extracted with Et2O (3 x 100 mL). 
The organic layers were combined, washed with brine (100 mL), dried (MgSO4) and 
concentrated in vacuo. Chromatography (2:1 hexanes/Et2O) yielded acetylene 223 (520 mg, 
2.42 mmol, 68%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 4.13-4.07 (2H, m, OCH2aCH2bO), 4.06-4.00 (2H, m, 
OCH2aCH2bO), 3.86 (2H, dt, J = 6.1, 5.5 Hz, CH2OH), 2.46 (1H, t, J = 6.1 Hz, OH), 2.19 
(2H, t, J = 5.5 Hz, CCH2CH2OH), 0.18 (9H, s, SiCH3). 13C NMR (101 MHz, CDCl3) 
δ: 102.7, 101.7, 89.6, 64.5 (2C), 58.6, 41.0, −0.3 (3C). HRMS: (CI+) Calculated for 
[M+NH4]+: 232.1369; Found: 232.1367. IR νmax/cm-1 (neat): 3425 br, 1251, 1194, 1107, 
1031, 863, 843. 
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2-(2-ethynyl-1,3-dioxolan-2-yl)ethanol  
 
Potassium carbonate (1.6 g, 11.3 mmol) was added to a solution of alcohol 223 (2.0 g, 
9.38 mmol) in MeOH (40 mL) and stirred at rt. After 2 h water was added (100 mL) and the 
aqueous phase was extracted with CH2Cl2 (3 x 100 mL). The organic phases were combined, 
washed with brine (100 mL), dried (MgSO4) and concentrated in vacuo. Chromatography 
(1:1 hexanes/Et2O) gave alcohol 2-(2-ethynyl-1,3-dioxolan-2-yl)ethanol (1.1 g, 7.78 mmol, 
83%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ: 4.18-4.12 (2H, m, OCH2aCH2bO), 4.09-4.06 (2H, m, 
OCH2aCH2bO), 3.91 (2H, td, J = 5.7, 5.4 Hz, CH2OH), 2.59 (1H, s, CCH), 2.45 (1H, t, 
J = 5.7 Hz, OH), 2.24 (2H, t, J = 5.4 Hz, CCH2CH2OH). 13C NMR (101 MHz, CDCl3) 
δ: 102.6, 80.8, 72.6, 64.6 (2C), 58.3, 40.9. HRMS: (EI+) Calculated for C7H10O3 [M]: 
142.0630; Found: 142.0642.  IR νmax/cm-1 (neat): 3403 br, 3278, 1196, 1108, 1066, 1028, 
946. 
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triethyl(2-(2-ethynyl-1,3-dioxolan-2-yl)ethoxy)silane 224 
 
Triethylsilyl chloride (1.7 mL, 10.0 mmol) was added to a solution of 2-(2-ethynyl-1,3-
dioxolan-2-yl)ethanol (1.2 g, 8.36 mmol) and NEt3 (1.5 mL, 10.9 mmol) in CH2Cl2 (12 mL) 
at 0 °C. After 15 min, the ice bath was removed and the mixture was stirred at rt for 16 h. 
The reaction mixture was filtered through Celite® and the filtrate was washed with sat. 
aqueous NaHCO3 (100 mL), water (100 mL), brine (100 mL), dried (MgSO4) and 
concentrated in vacuo. Chromatography (99:1 hexanes/EtOAc) gave acetylene 224 (2.1 g, 
8.36, mmol, 100%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 4.09-4.03 (2H, m, OCH2aCH2bO), 4.02-3.96 (2H, m, 
OCH2aCH2bO), 3.86 (2H, t, J = 7.9 Hz, CH2OSi), 2.50 (1H, s, CCH), 2.21 (2H, t, J = 7.9 Hz, 
CCH2CH2OSi), 0.96 (9H, t, J = 7.8 Hz, OSiCH2CH3), 0.61 (6H, q, J = 7.8 Hz, OSiCH2CH3). 
13C NMR (101 MHz, CDCl3) δ: 101.1, 81.1, 72.1, 64.5 (2C), 58.4, 41.9, 6.7 (3C), 4.3 (3C). 
HRMS: (ES+) Calculated for C13H24O3Si [M+H]+: 257.1573; Found: 257.1582. 
IR νmax/cm-1 (neat): 3308, 2109, 1238, 1199, 1144, 1088, 1038, 1004, 976, 944.  
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(E)-triethyl(2-(2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)-1,3-dioxolan-2-
yl)ethoxy)silane 225 
 
Acetylene 224 (1.2 g, 4.76 mmol) and pinacol borane (6.9 mL, 47.6 mmol) were stirred, 
neat, for 3 days at 70 °C, after which time further pinacol borane (2.3 mL, 15.9 mmol) was 
added and the mixture stirred for an additional 3 days. The reaction mixture was allowed to 
cool to rt and was chromatographed (10:1 then 5:1 hexanes/EtOAc) to furnish borane 
derivative 225 (1.4 mg, 3.61 mmol, 76%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 6.41 (1H, d, J = 18.1 Hz, BCH=CH), 5.72 (1H, d, 
J = 18.1 Hz, BCH=CH), 3.92-3.87 (2H, m, OCH2aCH2bO), 3.86-3.81 (2H, m, 
OCH2aCH2bO), 3.72 (2H, t, J = 7.7 Hz, CH2OSi), 2.02 (2H, t, J = 7.7 Hz, CCH2CH2OSi), 
1.26 (12H, s, CCH3), 0.94 (9H, t, J = 8.0 Hz, OSiCH2CH3), 0.58 (6H, q, J = 8.0 Hz, 
OSiCH2CH3). 13C NMR (101 MHz, CDCl3) δ: 150.8, 118.4, 107.9, 83.4 (2C), 64.5 (2C), 
58.2, 40.7, 24.8 (4C), 6.8 (3C), 4.4 (3C). HRMS: (ES+) Calculated for C19H38BO5Si 
[M+H]+: 385.2582; Found: 385.2588. IR νmax/cm-1 (neat): 1643, 1459, 1352, 1326, 1207, 
1144, 1088, 1045, 1003, 971. 
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tert-butyldiphenyl(((R)-1-((2R,3R)-3-((1Z,3E)-4-(2-(2-((triethylsilyl)oxy)ethyl)-1,3-
dioxolan-2-yl)buta-1,3-dien-1-yl)oxiran-2-yl)propan-2-yl)oxy)silane 226 
 
A degassed solution of pinacol borane 225 (420 mg, 1.09 mmol) and aqueous Cs2CO3 
(3.0 M, 6.1 mL, 18.2 mmol) in THF (4.1 mL) was added to a degassed solution of iodide 
180 (390 mg, 0.792 mmol) and Pd(PPh3)4 (53 mg, 45.5 µmol) in THF (6.5 mL). The 
resulting mixture was then heated to 55 °C for 7 h, cooled to rt and the aqueous layer was 
extracted with EtOAc (3 x 25 mL). The combined organic layers were washed with brine (25 
mL), dried (MgSO4) and concentrated in vacuo. Chromatography (20:1 hexanes/EtOAc) 
afforded diene 226 (350 mg, 0.558 mmol, 71%) as an orange oil. 
1H NMR (400 MHz, CDCl3) δ: 7.69-7.66 (4H, m, CArH), 7.45-7.35 (6H, m, CArH), 6.71 
(1H, dd, J = 15.1, 11.4 Hz, H8), 6.24 (1H, t, J = 11.3 Hz, H7), 5.69 (1H, d, J = 15.1 Hz, H9), 
5.06 (1H, dd, J = 10.2, 10.0 Hz, H6), 4.08 (1H, app. sex, J = 6.0 Hz, H1), 3.96-3.81 (4H, m, 
H11), 3.76-3.72 (2H, m, H13), 3.44 (1H, dd, J = 9.2, 1.8 Hz, H5), 3.02 (1H, dt, J = 5.9, 2.0 Hz, 
H4), 2.07-2.03 (2H, m, H12), 1.82-1.68 (2H, m, H3), 1.16 (3H, d, J = 6.2 Hz, H2), 1.06 (9H, s, 
CCH3), 0.96 (9H, t, J = 7.8 Hz, OSiCH2CH3), 0.60 (6H, q, J = 7.8 Hz, OSiCH2CH3). 
13C NMR (101 MHz, CDCl3) δ: 135.8 (2C), 135.8 (2C), 135.6, 134.4, 134.0, 132.9, 129.6, 
129.5, 129.3, 127.6 (2C), 127.5 (2C), 124.5, 107.8, 67.5, 64.7, 64.4, 58.3, 57.6, 54.0, 41.6, 
41.5, 27.0 (3C), 23.3, 19.2, 6.7 (3C), 4.4 (3C). HRMS: (ES+) Calculated for C36H55O5Si2 
[M+H]+: 623.3588; Found: 623.3573. IR νmax/cm-1 (neat): 1428, 1105, 1085, 1044, 1006, 
950, 822. [α]25D: +4.2 (c = 1.40, CH2Cl2). 
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2-(2-((1E,3Z)-4-((2R,3R)-3-((R)-2-((tert-butyldiphenylsilyl)oxy)propyl)oxiran-2-yl)buta-
1,3-dien-1-yl)-1,3-dioxolan-2-yl)ethanol 218 
 
TBAF (1.0 M in THF, 0.92 mL, 0.918 mmol) was added to a solution of diene 226 (520 mg, 
0.835 mmol) in THF (20 mL) at 0 °C and left to stir for 30 min. Following this, the reaction 
was quenched with sat. aqueous NaHCO3 (25 mL), the layers were separated and the 
aqueous phase was extracted with EtOAc (3 x 25 mL). The combined organic layers were 
washed with water (25 mL), brine (25 mL), dried (MgSO4) and concentrated in vacuo. 
Chromatography (1:1 hexanes/EtOAc) yielded alcohol 218 (390 mg, 0.757 mmol, 91%) as a 
colourless, viscous syrup. 
1H NMR (400 MHz, CDCl3) δ: 7.69-7.65 (4H, m, CArH), 7.44-7.35 (6H, m, CArH), 6.74 
(1H, dd, J = 15.1, 12.1 Hz, H8), 6.24 (1H, t, J = 11.2 Hz, H7), 5.67 (1H, d, J = 15.1 Hz, H9), 
5.10 (1H, t, J = 10.1 Hz, H6), 4.08 (1H, app. sex, J = 6.0 Hz, H1), 4.04-3.85 (4H, m, H11), 
3.77 (2H, td, J = 10.9, 5.6 Hz, H13), 3.43 (1H, dd, J = 9.2, 1.9 Hz, H5), 3.03 (1H, dt, J = 5.9, 
2.1 Hz, H4), 2.67 (1H, t, J = 5.8 Hz, OH), 2.04-2.01 (2H, m, H12), 1.82-1.68 (2H, m, H3), 
1.15 (3H, d, J = 6.2 Hz, H2), 1.05 (9H, s, CCH3). 13C NMR (101 MHz, CDCl3) δ: 135.8 
(2C), 135.8 (2C), 134.8, 134.3, 134.0, 132.6, 129.9, 129.6, 129.6, 127.6 (2C), 127.5 (2C), 
125.4, 109.3, 67.5, 64.7, 64.4, 58.4, 57.6, 53.9, 41.5, 39.7, 27.0 (3C), 23.3, 19.2. 
HRMS: (ES+) Calculated for C30H40NaO5Si [M+Na]+: 531.2543; Found: 531.2531. 
IR νmax/cm-1 (neat): 3473 br, 1738, 1428, 1381, 1364, 1111, 1037. [α]25D: −2.0 (c = 1.3, 
CH2Cl2). 
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2-(2-((1E,3Z)-4-((2R,3R)-3-((R)-2-((tert-butyldiphenylsilyl)oxy)propyl)oxiran-2-yl)buta-
1,3-dien-1-yl)-1,3-dioxolan-2-yl)acetaldehyde 179 
 
Dess-Martin periodinane (230 mg, 0.538 mmol) was added to a solution of alcohol 218 
(230 mg, 0.448 mmol) in CH2Cl2 (3.0 mL) and stirred for 2 h. The reaction mixture was then 
washed with sat. aqueous NaHCO3 (10 mL) and the two phases were separated. The aqueous 
layer was extracted with Et2O (3 x 10 mL) and the combined organic phases were washed 
with water (10 mL), brine (10 mL), dried (MgSO4) and concentrated in vacuo. 
Chromatography (3:1 hexanes/EtOAc) furnished aldehyde 179 (190 mg, 0.371 mmol, 83%) 
as a colourless viscous syrup. 
1H NMR (400 MHz, CDCl3) δ: 9.73 (1H, t, J = 2.8 Hz, H13), 7.68-7.66 (4H, m, CArH), 
7.44-7.35 (6H, m, CArH), 6.79 (1H, dd, J = 15.1, 11.8 Hz, H8), 6.24 (1H, t, J = 11.2 Hz, H7), 
5.71 (1H, d, J = 15.1 Hz, H9), 5.13 (1H, t, J = 10.0 Hz, H6), 4.08 (1H, app. sex, J = 5.7 Hz, 
H1), 4.04-3.90 (4H, m, H11), 3.43 (1H, dd, J = 9.1, 1.7 Hz, H5), 3.03 (1H, dt, J = 5.8, 2.0 Hz, 
H4), 2.78 (2H, d, J = 2.8 Hz, H12), 1.83-1.69 (2H, m, H3), 1.16 (3H, d, J = 6.2 Hz, H2), 1.06 
(9H, s, CCH3). 13C NMR (101 MHz, CDCl3) δ: 199.6, 135.8 (2C), 135.7 (2C), 134.3, 134.0, 
133.9, 132.2, 130.6, 129.6, 129.6, 127.6 (2C), 127.5 (2C), 125.8, 106.5, 67.5, 65.0, 64.7, 
57.6, 53.8, 51.0, 41.5, 27.0 (3C), 23.3, 19.2. HRMS: (ES+) Calculated for C30H38NaO5Si 
[M+Na]+: 529.2386; Found: 529.2389. IR νmax/cm-1 (neat): 1725, 1473, 1428, 1379, 1199, 
1110, 1069, 1038, 997, 950. [α]25D: +1.6 (c = 1.25, CH2Cl2). 
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6-(3-chloro-2-oxopropyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 178 
 
2,2,6-Trimethyl-4H-1,3-dioxin-4-one 55 (0.80 mL, 6.00 mmol) in THF (0.80 mL) was added 
dropwise to LiHMDS (1.0 M in THF, 6.3 mL, 6.30 mmol) in THF (10 mL) at −78 °C. After 
stirring for 1 h, chloroacetyl chloride (0.24 mL, 3.00 mmol) was added and the mixture was 
left stirring at this temperature for a further h. The reaction was quenched with sat. aqueous 
NH4Cl (35 mL), diluted with Et2O (35 mL) and the pH was adjusted to pH 1-2 with conc. 
HCl and warmed to rt. The phases were separated and the aqueous layer was extracted with 
Et2O (3 x 35 mL). The organic layers were combined, washed with brine (50 mL), dried 
(MgSO4) and concentrated in vacuo. Chromatography (3:1 to 2:1 to 1:1 to 1:2 
hexanes/EtOAc) gave keto-dioxinone 178 (357 mg, 1.63 mmol, 54%) as a yellow solid. The 
data for which is consistent with that reported in the literature.107 
1H NMR (400 MHz, acetone-d6) δ: 5.42 (1H, s, CH=C), 4.53 (2H, s, CH2Cl), 3.74 (2H, s, 
CH2C=C), 1.68 (6H, s, C(CH3)2). 13C NMR (101 MHz, acetone-d6) δ: 196.4, 165.2, 160.4, 
107.6, 97.6, 49.4, 44.6, 25.1 (2C). HRMS: (ES-) Calculated for C9H10O4Cl [M-H]−: 
217.0268; Found: 217.0271. IR νmax/cm-1 (neat): 1728, 1709, 1642, 1388, 1374, 1271, 1254, 
1051, 1013, 904. 
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2,2-dimethyl-6-(2-oxo-2-(3-propyloxiran-2-yl)ethyl)-4H-1,3-dioxin-4-one 234 
 
n-BuLi (2.5 M in hexanes, 0.92 mL, 2.31 mmol) was added to i-Pr2NH (0.32 mL, 2.31 
mmol) in THF (10 mL) at −78 °C and stirred for 20 min. Keto-dioxinone 178 (250 mg, 1.16 
mmol) in THF (1.8 mL) was added to the solution and left to stir for 1 h when butyraldehyde  
(50 µL, 0.550 mmol) in THF (1 mL) was added and stirred for  a further hour. It was then 
warmed incrementally to rt over 3 h. The reaction was quenched with sat. aqueous NH4Cl 
(15 mL) and the pH was adjusted to 3-4 with 10 % aqueous AcOH. The reaction was diluted 
with Et2O (10 mL), the phases were separated and the aqueous layer was extracted with Et2O 
(3 x 15 mL). The organic layers were then combined, washed with brine (15 mL), dried 
(MgSO4) and concentrated in vacuo. Chromatography (5:1 to 2:1 hexanes/EtOAc) gave 
epoxide 234 (30 mg, 0.107 mmol, 19%) as a yellow oil and as the pure trans-isomer.  
1H NMR (400 MHz, CDCl3) δ: 5.33 (1H, s, H4), 3.32 (1H, d, J = 17.0 Hz, H6a), 3.25 (1H, d, 
J = 1.9 Hz, H8), 3.21 (1H, d, J = 17.0 Hz, H6b), 3.12 (1H, ddd, J = 6.3, 4.9, 1.9, H9), 1.69 
(6H, s, H1 and H2) 1.69-1.45 (4H, m, H10 and H11), 0.97 (3H, t, J = 7.3 Hz, H12). 13C NMR 
(101 MHz, CDCl3) δ: 200.8, 163.8, 160.5, 107.3, 97.1, 59.5, 58.0, 41.1, 33.5, 25.1, 24.8, 
19.0, 13.7. HRMS: (CI+) Calculated for C13H22NO5 [M+NH4]+: 272.1498; Found: 272.1476. 
IR νmax/cm-1 (neat): 1719, 1638, 1390, 1374, 1272, 1253, 1201, 1014, 902. 
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2,2-dimethyl-6-(2-oxopropyl)-4H-1,3-dioxin-4-one 117 
 
2,2,6-Trimethyl-4H-1,3-dioxin-4-one 55 (3.1 mL, 23.3 mmol) was added dropwise to 
LiHMDS in THF (1.0 M, 33 mL, 32.6 mmol) at −78 °C and left stirring for 40 min. 
Following this, Et2Zn (1.0 M in hexanes, 33 mL, 32.6 mmol) was added over 20 min and the 
mixture stirred for a further 40 min. N-acetylimidazole (3.6 g, 32.6 mmol) was then added 
portion-wise and the reaction was warmed to −10 °C where it was left stirring at this 
temperature for 3 h. The reaction was quenched with aqueous HCl (1.0 M, 33 mL), followed 
by the addition of EtOAc (33 mL), then conc. HCl (17 mL) and warmed to rt. The phases 
were separated and the aqueous layer was extracted with EtOAc (3 x 33 mL). The organic 
layers were then combined, washed with brine (50 mL), dried (MgSO4) and concentrated in 
vacuo. Chromatography (3:1 to 1:2 hexanes/EtOAc) gave keto-dioxinone 117 (2.1 g, 
11.6 mmol, 50%) as a pale yellow solid. The data for which is consistent with that reported 
in the literature.157 
1H NMR (400 MHz, CDCl3) δ: 5.35 (1H, s, CH=C), 3.34 (2H, s, CH2), 2.25 (3H, s, 
C(O)CH3), 1.72 (6H, s, C(CH3)2). 13C NMR (101 MHz, CDCl3) δ: 200.8, 164.3, 160.6, 
107.2, 96.7, 50.0, 30.2, 25.0. Mpt: 51-53 °C {Et2O}. 
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6-(5-(2-((1E,3Z)-4-((2R,3R)-3-((R)-2-((tert-butyldiphenylsilyl)oxy)propyl)oxiran-2-
yl)buta-1,3-dien-1-yl)-1,3-dioxolan-2-yl)-4-hydroxy-2-oxopentyl)-2,2-dimethyl-4H-1,3-
dioxin-4-one 235 
 
n-BuLi (2.5 M in hexanes, 0.72 mL, 1.81 mmol) was added to a solution of i-Pr2NH 
(0.25 mL, 1.81 mmol) in THF (7.4 mL) at −78 °C. The reaction was left to stir for 20 min 
after which time keto-dioxinone 117 (160 mg, 0.860 mmol) in THF (1.5 mL) was added 
dropwise. The solution was allowed to warm to −40 °C over 1 hour, when aldehyde 179 
(220 mg, 0.430 mmol) in THF (0.7 mL) was added. After a further 3 h at this temperature, 
formic acid (0.072 mL, 1.94 mmol) in THF (0.7 mL) was added and the solution allowed to 
warm to rt. The organic phase was washed with sat. aqueous NH4Cl (15 mL) which was 
acidified to pH 3-4 with a 10% aqueous AcOH. The aqueous phase was extracted with 
EtOAc (2 x 15 mL) and the combined organic phases were washed with brine (15 mL), dried 
(MgSO4) and concentrated in vacuo. Chromatography (2:1 then 1:1 hexanes/EtOAc) yielded 
keto-dioxinone 235 (220 mg, 0.318 mmol, 73%) as an orange gum containing an inseparable 
mixture of epimers. 
1H NMR (400 MHz, CDCl3) δ: 7.68-7.65 (4H, m, CArH), 7.44-7.34 (6H, m, CArH), 
6.77-6.71 (1H, m, H8), 6.23 (1H, t, J = 11.3 Hz, H7), 5.63 (1H, d, J = 15.2 Hz, H9), 5.34 (1H, 
s, H18), 5.11 (1H, t, J = 10.0 Hz, H6), 4.42-4.35 (1H, m, H13), 4.08 (1H, app. sex, J = 5.8 Hz, 
H1), 4.03-3.83 (4H, m, H11), 3.54 (1H, d, J = 5.9 Hz, OH), 3.43-3.41 (1H, partially hidden 
under H16 peak, H5), 3.41 (2H, s, H16), 3.05-3.01 (1H, m, H4), 2.69 (1H, ddd, J = 15.8, 8.2, 
2.5 Hz, H12 or 14), 2.35 (1H, dd, J = 15.8, 4.2 Hz, H12 or 14), 1.93-1.91 (2H, m, H12 or 14), 
1.81-1.68 (2H, m, H3), 1.71 (6H, s H21), 1.15 (3H, d, J = 6.2 Hz, H2), 1.05 (9H, s, CCH3). 
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13C NMR (101 MHz, CDCl3) δ: 202.4, 164.4, 160.7, 135.8 (2C), 135.7 (2C), [134.3, 134.3], 
134.0, [132.4, 132.3], 130.1, 129.6, 129.5, 127.6 (2C), 127.5 (2C), [125.7, 125.6], 108.6, 
107.1, 96.7, 67.4, [64.8, 64.6], [64.3, 64.2], [64.1, 64.1], [57.6, 57.6], [53.8, 53.8], [49.8, 
49.7], 48.0, 43.7, 41.5, 26.9 (3C), 25.0, 24.9, 23.2, 19.1. NB: carbon missing due to overlap 
and carbons in square brackets due to epimers. HRMS: (ES+) Calculated for C39H50O9NaSi 
[M+Na]+: 713.3122; Found: 713.3122. IR νmax/cm-1 (neat): 3490 br, 1727, 1638, 1428, 
1376, 1273, 1203, 1111, 1016. 
 
  
   190 
6-(4-hydroxy-5-(2-((1E,3Z)-4-((2R,3R)-3-((R)-2-hydroxypropyl)oxiran-2-yl)buta-1,3-
dien-1-yl)-1,3-dioxolan-2-yl)-2-oxopentyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 245 
 
TBAF (1.0 M in THF, 0.28 mL, 0.280 mmol) was added to a solution of keto-dioxinone 235 
(97 mg, 0.140 mmol) and 4 Å MS (100 mg) in THF (3.0 mL) at rt and stirred for 40 hr. The 
reaction mixture was filtered and the filtrate was concentrated in vacuo, without heating, to 
leave the crude material dissolved in THF (0.5 mL) which was chromatographed (100 % 
EtOAc) to afford keto-dioxinone 245 (50 mg 0.111 mmol, 79%) as a colourless gum 
containing an inseparable mixture of epimers. 
1H NMR (400 MHz, CDCl3) δ: 6.78-6.71 (1H, m, H8), 6.22 (1H, t, J = 11.3 Hz, H7), 5.63 
(1H, dd, J = 15.2, 4.8 Hz, H9), 5.32 (1H, s, H18), 5.14 (1H, dd, J = 10.0, 9.6 Hz, H6), 
4.39-4.31 (1H, m, H13), 4.10-4.05 (1H, m, H1), 4.05-3.85 (4H, m, H11), 3.59-3.51 (2H, m, H5 
and OH), 3.39 (2H, s, H16), 3.04-3.00 (1H, m, H4), 2.72-2.65 (1H, m, H12 or 14), 2.37-2.50 
(1H, m, H12 or 14), 1.92-1.90 (2H, m, H12 or 14), 1.85 (1H, dt, J = 14.2, 4.4 Hz, H3a), 1.69 (6H, 
s, H21), 1.69-1.60 (1H, hidden under H21, H3b), 1.24  (3H, d, J = 6.3 Hz, H2). NB: one OH 
peak missing due to overlap. 13C NMR (101 MHz, CDCl3) δ: 202.3, [164.4, 164.4], 160.7, 
[134.5, 134.3], 132.5, [129.8, 129.7], [125.7, 125.6], [108.6, 108.5], 107.2, 96.7, 66.2, [64.8, 
64.6], 64.3, [64.1, 64.1], 58.3, 53.8, 49.7, 48.0, [43.7, 43.6], 40.7, 25.0, 24.9, 23.4. 
NB: carbons in square brackets due to epimers. HRMS: (ES+) Calculated for C23H33O9 
[M+H]+: 453.2125; Found: 453.2146. IR νmax/cm-1 (neat): 3475 br, 1718, 1634, 1392, 1376, 
1274, 1203, 1016. 
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(4R,5R)-5-(((tert-butyldimethylsilyl)oxy)methyl)-N-methoxy-N,2,2-trimethyl-1,3-
dioxolane-4-carboxamide 288 
 
AlMe3 (2.0 M in hexanes, 35 mL, 70.2 mmol) was added slowly to a mixture of 
N,O-dimethylhydroxylamine hydrochloride (6.8 g, 70.2 mmol) in CH2Cl2 (130 mL) at 0 °C 
and then stirred at rt for 15 min. Following this, the solution was cooled to 0 °C and a 
solution of (−)-2,3-O-isopropylidene-D-erythronolactone (5.6 g, 35.1 mmol) in CH2Cl2 
(130 mL) was added. After 25 min, the reaction was quenched with aqueous HCl (0.5 M, 
170 mL) and allowed to warm to rt. The phases were separated and the aqueous phase was 
extracted with CH2Cl2 (3 x 200 mL). The combined organic layers were dried (Na2SO4) and 
concentrated in vacuo. The crude, unprotected alcohol was dissolved in CH2Cl2 (34 mL) and 
imidazole (3.7 g, 54.9 mmol) and TBSCl (5.5 g, 36.6 mmol) were sequentially added. The 
mixture was stirred at rt for 16 h and then washed with sat. aqueous NH4Cl (150 mL). The 
aqueous layer was extracted with CH2Cl2 (3 x 200 mL) and the organic layers were dried 
(Na2SO4), concentrated in vacuo and chromatography (5:1 hexanes/EtOAc) gave Weinreb 
amide 288 (7.2 g, 21.6 mmol, 71%) as a white solid. 
1H NMR (400 MHz, CDCl3) δ: 5.00 (1H, d, J = 6.6 Hz, H1), 4.44 (1H, app. q, J = 6.1 Hz, 
H2), 3.73 (3H, s, CH3), 3.72 (1H, dd, J = 10.4, 6.1 Hz, CHaHbOSi), 3.61 (1H, dd, J = 10.4, 
5.8 Hz, CHaHbOSi), 3.19 (3H, s, CH3), 1.60 (3H, s, CH3), 1.42 (3H, s, CH3), 0.90 (9H, s, 
SiC(CH3)3), 0.07 (3H, s, CH3), 0.06 (3H, s, CH3). 13C NMR (126 MHz, CDCl3) δ: 169.3, 
109.9, 78.2, 73.9, 62.6, 61.3, 32.4, 27.5, 26.0 (3C), 25.6, 18.5, −5.3 (2C). HRMS: (ES+) 
Calculated for C15H31NO5SiNa [M+Na]+: 356.1869; Found: 356.1878. IR νmax/cm-1 (neat): 
1697, 1463, 1380, 1255, 1213, 1091, 992. [α]30D: +40.7 (c = 1.2, CHCl3).  Mpt: 54-56 °C 
{CHCl3}. 
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(4R,5R)-5-(((tert-butyldimethylsilyl)oxy)methyl)-2,2-dimethyl-1,3-dioxolane-4-
carbaldehyde 285 
 
DIBALH (1.0 M in toluene, 60 mL, 59.7 mmol) was added over 20 min to a solution of 
amide 288 (10 g, 29.8 mmol) in THF (270 mL) at −78 °C. After 30 min sat. aqueous 
Rochelle’s salt (300 mL) was added and the mixture warmed to rt. The two phases were 
separated and the aqueous phase was extracted with Et2O (2 x 250 mL). The combined 
organic layers were washed with brine (250 mL), dried (MgSO4) and concentrated in vacuo. 
Chromatography (9:1 hexanes/EtOAc) gave aldehyde 285 (7.8 g, 28.9 mmol, 97%) as a 
colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 9.68 (1H, d, J = 2.0 Hz, C(O)H), 4.49-4.45 (1H, m, H2), 4.43 
(1H, dd, J = 7.8, 2.0 Hz, H1), 3.78 (1H, dd, J = 11.4, 8.3 Hz, CHaHbOSi), 3.69 (1H, dd, 
J = 11.4, 2.8 Hz, CHaHbOSi), 1.57 (3H, s, CH3), 1.38 (3H, s, CH3), 0.88 (9H, s, SiC(CH3)3), 
0.05 (3H, s, CH3), 0.04 (3H, s, CH3). 13C NMR (125 MHz, CDCl3) δ: 200.2, 110.6, 80.8, 
79.8, 60.5, 26.8, 25.7 (3C), 25.0, 18.2, −5.5, −5.7. HRMS: (CI+) Calculated for 
C13H30NO4Si [M+NH4]+: 292.1944; Found: 292.1953. IR νmax/cm-1 (neat): 1733, 1473, 
1463, 1381, 1252, 1214, 1144, 1086, 1004. [α]28D: +39.8 (c = 1.2, CHCl3). 
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tert-butyl(((4R,5R)-5-((S)-1-((tert-butyldimethylsilyl)oxy)but-3-en-1-yl)-2,2-dimethyl-
1,3-dioxolan-4-yl)methoxy)dimethylsilane 289 
 
Aldehyde 285 (7.9 g, 28.7 mmol) in Et2O (72 mL) was added to a solution of 
(−)-Ipc2B(allyl)borane (1.0 M in pentane, 35 mL, 34.4 mmol) in Et2O (200 mL) at −100 °C. 
After 3 h, aqueous NaOH (2.0 M, 19 mL) and H2O2 (50% wrt in H2O, 8.7 mL) were added 
and the solution allowed to warm to rt overnight. The mixture was diluted with water 
(200 mL), the phases were separated and the aqueous phase extracted with Et2O (2 x 
200 mL). The organic layers were washed with brine (200 mL), dried (MgSO4) and 
concentrated in vacuo. Chromatography (95:5 hexanes/Et2O) gave the alcohol as an 
inseparable mixture with side products. The crude material was dissolved in CH2Cl2 
(100 mL) at 0 °C and 2,6-lutidine (7.6 mL, 65.4 mmol) and TBSOTf (7.5 mL, 32.7 mmol) 
were sequentially added. The solution was stirred at 0 °C for 1 h and rt for 30 min, when it 
was diluted with CH2Cl2 (150 mL) and washed with sat. aqueous NaHCO3 (200 mL). The 
aqueous layer was extracted with CH2Cl2 (2 x 200 mL) and the combined organic layers 
were dried (Na2SO4) and concentrated in vacuo. Chromatography (98:2 hexanes/EtOAc) 
afforded olefin 289 (7.9 g, 24.1 mmol, 84% over 2 steps) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 5.85 (1H, tdd, J = 17.3, 10.2, 7.1 Hz, CH2=CH), 5.13-5.06 
(2H, m, CH2=CH), 4.16 (1H, ddd, J = 7.4, 5.9, 3.8 Hz, H2), 4.06 (1H, app. t, J = 4.9 Hz, H1), 
4.05-4.02 (1H, m, CHOSi), 3.87 (1H, dd, J = 10.9, 3.8 Hz, CHaHbOSi), 3.68 (1H, dd, 
J = 11.0, 7.4 Hz, CHaHbOSi), 2.44-2.29 (2H, m, CCH2C), 1.45 (3H, s, CH3), 1.32 (3H, s, 
CH3), 0.91 (9H, s, SiC(CH3)3), 0.89 (9H, s, SiC(CH3)3), 0.09 (6H, s, CH3), 0.07 (3H, s, 
CH3), 0.07 (3H, s, CH3). 13C NMR (101 MHz, CDCl3) δ: 134.3, 117.5, 107.7, 78.7, 78.5, 
70.3, 63.4, 38.8, 27.8, 26.0 (3C), 25.9 (3C) 25.5, 18.4, 18.1, −3.9, −4.5, −5.1, −5.2. HRMS: 
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(ES+) Calculated for C22H47O4Si2 [M+H]+: 431.3013; Found: 431.3015. IR νmax/cm-1 (neat): 
1473, 1255, 1095, 836. [α]25D: +24.3 (c = 1.1, CHCl3). 
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(R)-1-((4S,5R)-5-(((tert-butyldimethylsilyl)oxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-
yl)but-3-en-1-ol 290 
 
Aldehyde 285 (120 mg, 0.434 mmol) in Et2O (3.0 mL) was added to a solution of 
(+)-Ipc2B(allyl)borane (1.0 M in pentane, 0.52 mL, 0.520 mmol) in Et2O (1.1 mL) at −78 °C 
and stirred at this temperature for 3 h. Following this aqueous NaOH (2.0 M, 0.3 mL) and 
H2O2 (50% wrt in H2O, 0.13 mL) were added and the solution allowed to warm to rt over 
night. The mixture was diluted with water (5 mL), the phases were separated and the 
aqueous phase extracted with Et2O (2 x 10 mL). The organic layers were washed with brine 
(5 mL), dried (MgSO4) and concentrated in vacuo. Chromatography (95:5 hexanes/Et2O) 
gave alcohol 290 (82 mg, 0.259 mmol, 60%) as the separable diastereoisomer and a 
colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 5.87 (1H, tdd, J = 17.2, 10.2, 7.1 Hz, CH2=CH), 5.16-5.08 
(2H, m, CH2=CH), 4.16-4.12 (1H, m, H2), 4.06 (1H, dd, J = 6.3, 3.5 Hz, H1), 3.90-3.84 (1H, 
m, CHOH), 3.91 (1H, dd, J = 10.8, 7.3 Hz, CHaHbOSi), 3.72 (1H, dd, J = 10.4, 4.1 Hz, 
CHaHbOSi), 2.87 (1H, d, J = 5.0 Hz, OH), 2.43-2.31 (2H, m, CCH2C) 1.47 (3H, s, CH3), 
1.35 (3H, s, CH3), 0.89 (9H, s, SiC(CH3)3), 0.08 (6H, s, CH3). 13C NMR (101 MHz, CDCl3) 
δ: 134.9, 117.3, 108.0, 78.8, 77.1, 68.4, 61.7, 38.9, 27.3, 25.8 (3C), 25.1, 18.3, −5.5 (2C). 
HRMS: (ES+) Calculated for C16H32O4Si [M+H]+: 317.2148; Found: 317.2148. 
IR νmax/cm-1 (neat): 3483 br, 1374, 1380, 1252, 1215, 1078. [α]25D: −7.94 (c = 1.2, CHCl3). 
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(S,E)-methyl 5-((tert-butyldimethylsilyl)oxy)-5-((4R,5R)-5-(((tert-butyldimethylsilyl)oxy) 
methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)pent-2-enoate 290 
 
Alkene 289 (6.0 g, 13.9 mmol), methyl acrylate (3.7 mL, 41.6 mmol) and Grubbs second-
generation catalyst (590 mg, 0.695 mmol) were added to CH2Cl2 (250 mL) and heated to 
40 °C for 3 h. The solution was then concentrated in vacuo and chromatography (8:1 
hexanes/Et2O) yielded enoate 290 (5.3 g, 10.8 mmol, 78%) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ: 7.01 (1H, td, J = 15.4, 7.5 Hz, H2), 5.89 (1H, td, J = 15.6, 
1.3 Hz, H1), 4.17-4.10 (2H, m, H6 and H4), 4.04-4.01 (1H, m, H5), 3.83 (1H, dd, J = 10.9, 4.3 
Hz, H7a), 3.72 (3H, s, CH3), 3.68 (1H, dd, J = 10.9, 6.7 Hz, H7b), 2.61-2.53 (1H, m, H3a), 
2.49-2.42 (1H, m, H3b), 1.43 (3H, s, CH3), 1.31 (3H, s, CH3), 0.90 (9H, s, SiC(CH3)3), 0.88 
(9H, s, SiC(CH3)3), 0.08 (6H, s, CH3), 0.07 (3H, s, CH3), 0.06 (3H, s, CH3). 
13C NMR (101 MHz, CDCl3) δ: 166.7, 145.4, 123.4, 108.0, 79.0, 78.1, 69.8, 62.9, 51.4, 
37.0, 27.6, 26.0 (3C), 25.9 (3C), 25.3, 18.4, 18.1, −3.9, −4.5, −5.2, −5.3. HRMS: (ES+) 
Calculated for C24H49O6Si2 [M+H]+: 489.3068; Found: 489.3072. IR νmax/cm-1 (neat): 1729, 
1256, 1171, 1094, 837. [α]25D: +18.1 (c = 1.6, CHCl3). 
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S,E)-methyl 5-((tert-butyldimethylsilyl)oxy)-5-((4R,5R)-5-(hydroxymethyl)-2,2-dimethyl 
-1,3-dioxo-lan-4-yl)pent-2-enoate 291 
 
CSA (500 mg, 2.16 mmol) in MeOH (110 mL) was added slowly to enoate 290 (5.3 g, 
10.8 mmol) in CH2Cl2 (110 mL) at 0 °C. After 2 h, the solution was washed with sat. 
aqueous NaHCO3 (250 mL) and the aqueous phase was extracted with CH2Cl2 (2 x 200 mL). 
The combined organic layers were dried (Na2SO4) and chromatography (1:1 hexanes/Et2O) 
gave alcohol 291 (3.1 g, 8.35 mmol, 77%) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ: 6.97 (1H, td, J = 15.4, 7.5 Hz, H2), 5.91 (1H, td, J = 15.6, 
1.3 Hz, H1), 4.20-4.16 (2H, m, H6 and H4), 4.00 (1H, t, J = 5.6 Hz, H5), 3.74-3.68 (1H, m, 
H7a), 3.73 (3H, s, CH3), 3.58 (1H, td, J = 13.6, 4.2 Hz, H7b), 2.68 (1H, t, J = 6.9 Hz, OH), 
2.62-2.50 (2H, m, H3), 1.44 (3H, s, CH3), 1.33 (3H, s, CH3), 0.89 (9H, s, SiC(CH3)3), 0.14 
(3H, s, CH3), 0.12 (3H, s, CH3). 13C NMR (101 MHz, CDCl3) δ: 166.5, 144.2, 123.9, 108.0, 
78.3, 77.1, 69.8, 61.5, 51.5, 37.4, 28.0, 25.8 (3C), 25.7, 18.1, −4.2, −4.5. HRMS: (ES+) 
Calculated for C18H35O6Si [M+H]+: 375.2203; Found: 375.2212. IR νmax/cm-1 (neat): 3504 
br, 1726, 1659, 1256, 1219, 1171, 1080, 1039. [α]28D: +33.51 (c = 1.9, CHCl3). 
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(S,E)-methyl-5-((tert-butyldimethylsilyl)oxy)-5-((4R,5S)-5-formyl-2,2-dimethyl-1,3-
dioxolan-4-yl)pent-2-enoate 292 
 
Dess-Martin periodinane (1.7 g, 3.96 mmol) was added to alcohol 291 (1.2 g, 3.30 mmol) in 
CH2Cl2 (20 mL) at rt. After 2 h, the mixture was filtered through Celite® and concentrated 
in vacuo. Chromatography (2:1 hexanes/Et2O) afforded aldehyde 292 (1.1 g, 3.00 mmol, 
91%) as a colourless oil.  
1H NMR (400 MHz, CDCl3) δ: 9.62-9.61 (1H, m, H7), 6.93 (1H, td, J = 15.4, 7.6 Hz, H2), 
5.95 (1H, td, J = 15.6, 1.3 Hz, H1), 4.35-4.34 (2H, m, H6 and H5), 4.20 (1H, app. t, J = 6.7 
Hz, H4), 3.77 (3H, s, CH3), 2.52-2.48 (2H, m, H3), 1.61 (3H, s, CH3), 1.40 (3H, s, CH3), 0.90 
(9H, s, SiC(CH3)3), 0.12 (3H, s, CH3), 0.09 (3H, s, CH3). 13C NMR (101 MHz, CDCl3) 
δ: 199.5, 166.4, 143.9, 123.9, 110.3, 82.3, 80.3, 70.1, 51.5, 37.2, 27.0, 25.7 (3C), 25.0, 18.1, 
−4.4, −4.8. HRMS: (ES+) Calculated for C18H33O6Si [M+H]+: 373.2046; Found: 373.2053. 
IR νmax/cm-1 (neat): 1726, 1727, 1255, 1215, 1170, 1138, 1071. [α]28D: +37.05 (c = 1.4, 
CHCl3). 
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(S,E)-methyl5-((tert-butyldimethylsilyl)oxy)-5-((4R,5R)-2,2-dimethyl-5-vinyl-1,3-
dioxolan-4-yl) pent-2-enoate 293 
 
Methyltriphenylphosphonium bromide (86 mg, 0.242 mmol) and potassium t-butoxide 
(27 mg, 0.242 mmol) were heated in toluene (1.5 mL) at 105 °C for 1 h. The mixture was 
then cooled to 0 °C and aldehyde 292 (30 mg, 80.5 µmol) in toluene (0.5 mL) was added 
drop wise and stirred for 10 min. Following this, sat. aqueous NH4Cl (5 mL) was added and 
the phases were separated. The aqueous phase was extracted with EtOAc (3 x 5 mL) and the 
organic layers were combined, washed with brine (5 mL), dried (Na2SO4) and concentrated 
in vacuo. Chromatography (8:1 hexanes/Et2O,) furnished alkene 293 (16 mg, 43.2 µmol, 
54%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.07-7.00 (1H, m, H2), 6.97-5.88 (2H, m, H1 and H7), 5.35 
(1H, d, J = 17.1 Hz, H8trans), 5.25 (1H, d, J = 10.4 Hz, H8cis), 4.57 (1H, t, J = 6.7 Hz, H6), 
4.05 (1H, t, J = 6.6 Hz, H5), 3.95-3.91 (1H, m, H4), 3.73 (3H, s, CH3), 2.60-2.44 (2H, m, H3), 
1.47 (3H, s, CH3), 1.34 (3H, s, CH3), 0.87 (9H, s, SiC(CH3)3), 0.08 (3H, s, CH3), 0.05 (3H, s, 
CH3). 13C NMR (101 MHz, CDCl3) δ: 166.7, 145.2, 134.4, 123.5, 118.3, 108.3, 79.7, 78.7, 
69.9, 51.4, 36.8, 27.7, 25.9 (3C), 25.3, 18.0, −3.5, −4.4. HRMS: (CI+) Calculated for 
C19H38NO5Si [M+NH4]+: 388.2519; Found: 388.2510. IR νmax/cm-1 (neat): 1726, 1435, 
1371, 1253, 1216, 1169, 1078, 1035. [α]26D: +21.0 (c = 0.7, CHCl3). 
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(S,E)-5-((tert-butyldimethylsilyl)oxy)-5-((4R,5R)-5-(((tert-butyldimethylsilyl)oxy) 
methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)pent-2-en-1-ol 296 
 
DIBALH (1.0 M in toluene, 1.0 mL, 0.990 mmol) was added to enoate 290 (220 mg, 
0.450 mmol) in CH2Cl2 (3.7 mL) at −20 °C. After 1 h, the solution was warmed to rt and 
stirred for a further 1 h when it was quenched with sat. aqueous NH4Cl (0.4 mL) and stirred 
for a further 15 min. Et2O (7.0 mL) and MgSO4 (150 mg) were added and the mixture was 
filtered through Celite®, washing with Et2O. The filtrate was concentrated in vacuo and 
chromatography (2:1 pentane/Et2O) afforded alcohol 296 (200 mg, 0.428 mmol, 95%) as a 
colourless oil.  
1H NMR (400 MHz, CDCl3) δ: 5.79-5.68 (2H, m, H2 and H3), 4.17-4.02 (5H, m, H1, H5, H6 
and H7), 3.88 (1H, dd, J = 11.0, 3.7 Hz, H8a), 3.67 (1H, dd, J = 11.1, 7.3 Hz, H8b), 2.43-2.30 
(2H, m, H4), 1.45 (3H, s, CH3), 1.33 (3H, s, CH3), 0.90 (9H, s, SiC(CH3)3), 0.89 (9H, s, 
SiC(CH3)3), 0.08 (6H, s, CH3), 0.07 (3H, s, CH3), 0.07 (3H, s, CH3). 13C NMR (101 MHz, 
CDCl3) δ: 132.0, 128.2, 107.7, 78.7, 78.5, 70.3, 63.5, 63.4, 37.0, 27.7, 26.0 (3C), 25.8 (3C), 
25.4, 18.4, 18.0, −4.0, −4.5, −5.2, −5.3. HRMS: (ES+) Calculated for C23H49O5Si2 [M+H]+: 
461.3119; Found: 461.3109. IR νmax/cm-1 (neat): 3392 br, 1473, 1463, 1380, 1253, 1094, 
1005. [α]26D: +32.0 (c = 4.5, CHCl3). 
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((2R,3R)-3-((S)-2-((tert-butyldimethylsilyl)oxy)-2-((4R,5R)-5-(((tert-butyldimethyl 
silyl)oxy) methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethyl)oxiran-2-yl) methanol 297 
 
t-Butyl hydroperoxide (5.5 M in decane, 1.3 mL, 7.04 mmol) was added to a solution of allyl 
alcohol 296 (1.0 g, 2.20 mmol) and VO(acac)2 (41 mg, 0.154 mmol) in CH2Cl2 (22 mL) at 
−10 °C and left stirring at this temperature for 16 h. The reaction was quenched with sat. 
aqueous Na2SO3 (30 mL) and the aqueous phase was extracted with CH2Cl2 (3 x 30 mL). 
The combined organic layers were dried (MgSO4) concentrated in vacuo and 
chromatography (2:1 pentane/Et2O) gave epoxide 297 (500 mg, 10.5 mmol, 48%) as a 
yellow oil. 
1H NMR (400 MHz, CDCl3) δ: 4.23-4.16 (2H, m, H5 and H7), 4.12 (1H, dd, J = 6.3, 4.9 Hz, 
H6), 3.90 (1H, m, H1a), 3.81 (1H, dd, J = 10.9, 4.6 Hz, H8a), 3.68 (1H, dd, J = 10.9, 6.6 Hz, 
H8b), 3.66-3.60 (1H, m, H1b), 3.13 (1H, td, J = 6.0, 2.2 Hz, H3), 2.98 (1H, dt, J = 4.5, 2.4 Hz, 
H2), 1.93-1.87 (1H, m, H4a), 1.80-1.73 (1H, m, H4b), 1.43 (3H, s, CH3), 1.34 (3H, s, CH3), 
0.9  (18H, s, SiC(CH3)3), 0.12 (3H, s, CH3), 0.11 (3H, s, CH3), 0.07 (6H, s, CH3). 13C NMR 
(101 MHz, CDCl3) δ: 108.0, 79.5, 78.71, 68.6, 62.8, 61.5, 59.0, 52.8, 36.4, 27.4, 26.0 (3C), 
25.9 (3C), 25.3, 18.4, 18.1, −4.2, −4.5, −5.3, −5.2. HRMS: (ES+) Calculated for C23H49O6Si2 
[M+H]+: 477.3068; Found: 477.3069. IR νmax/cm-1 (neat): 3460 br, 1473, 1380, 1254, 1215, 
1097. [α]25D: +5.38 (c = 1.5, CH2Cl2). 
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(2S,3R)-3-((S)-2-((tert-butyldimethylsilyl)oxy)-2-((4R,5R)-5-(((tert-butyldimethylsilyl) 
oxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethyl)oxirane-2-carbaldehyde 300 
 
Dess-Martin periodinane (1.2 g, 2.86 mmol) was added to alcohol 297 (1.1 g, 2.38 mmol) in 
CH2Cl2 (44 mL) at rt and stirred for 1 h. The mixture was then filtered through Celite® and 
the filtrate was washed with sat. aqueous NaHCO3 (50 mL). The aqueous layer was 
extracted with CH2Cl2 (2 x 50 mL) and the combined organic layers were dried (Na2SO4), 
concentrated in vacuo and chromatography (7:1 pentane/Et2O) gave aldehyde 300 as a white 
solid. Recrystallisation from CH2Cl2 gave aldehyde 300 (1.0 g, 2.35 mmol, 88%) as white 
crystals. The absolute structure was unambiguously determined by X-ray crystallography 
(Appendix 1). 
1H NMR (400 MHz, CDCl3) δ: 9.02 (1H, d, J = 6.4 Hz, H1), 4.32-4.23 (1H, m, H5), 
4.23-4.08 (2H, m, H6 and H7), 3.78 (1H, dd, J = 11.0, 4.9 Hz, H8a), 3.69 (1H, dd, J = 10.8, 
5.8 Hz, H8b), 3.43 (1H, td, J = 5.8, 1.9 Hz, H3), 3.22 (1H, dd, J = 6.5, 2.0 Hz, H2), 2.02 (1H, 
dt, J = 14.5, 5.8 Hz, H4a), 1.92-1.83 (1H, m, H4b), 1.44 (3H, s, CH3), 1.36 (3H, s, CH3), 0.92  
(9H, s, SiC(CH3)3), 0.91 (9H, s, SiC(CH3)3), 0.14 (3H, s, CH3), 0.15 (3H, s, CH3), 0.09 (6H, 
s, CH3). 13C NMR (101 MHz, CDCl3) δ: 198.2, 108.2, 79.5, 77.7, 68.3, 62.4, 59.6, 53.7, 
35.9, 27.3, 25.9 (3C), 25.8 (3C), 25.1, 18.3, 18.0, −4.1, −4.5, −5.3 (2C). HRMS: (ES+) 
Calculated for C23H46O6Si2 [M+H]+: 475.2911; Found: 475.2915. IR νmax/cm-1 (neat): 1732, 
1473, 1381, 1257, 1215, 1095, 1006, 836. [α]25D: +63.4 (c = 1.3, CH2Cl2). Mpt: 84-86 °C 
{CH2Cl2}.  
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(2S,3R)-3-((S)-2-((tert-butyldimethylsilyl)oxy)-2-((4R,5R)-5-(((tert-butyldimethylsilyl) 
oxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethyl)oxirane-2-carboxylic acid 303 
 
A solution of NaClO2 (580 mg, 6.36 mmol) and NaH2PO4H2O (880 mg, 6.36 mmol) in 
water (12 mL) was added to a solution of aldehyde 300 (500 mg, 1.06 mmol) in 
2-methyl-2-butene (6.8 mL) and t-BuOH (12 mL) and stirred at rt. After 1 h, the mixture was 
diluted with water (25 mL) and Et2O (30 mL) and the two phases were separated. The 
aqueous phase was extracted with Et2O (2 x 30 mL) and the combined organic phases were 
washed with water (30 mL), brine (2 x 30 mL), dried (MgSO4) and concentrated in vacuo. 
Excess t-BuOH was azeotropically removed with toluene to give acid 303 (520 mg, 
1.06 mmol, 100%) as a colourless, thick syrup. 
1H NMR (400 MHz, CDCl3) δ: 4.24 (1H, q, J = 5.4 Hz, H5), 4.21-4.13 (2H, m, H6 and H7), 
3.77 (1H, dd, J = 10.9, 4.5 Hz, H8a), 3.68 (1H, dd, J = 10.9, 5.8 Hz, H8b), 3.39-3.36 (2H, m, 
H2 and H3), 2.00-1.94 (1H, m, H4a), 1.90-1.84 (1H, m, H4b), 1.43 (3H, s, OC(CH3)), 1.36 
(3H, s, OC(CH3)), 0.90  (18H, s, SiC(CH3)3), 0.13 (3H, s, Si(CH3)2), 0.12 (3H, s, SiCH3), 
0.07 (6H, s, SiCH3). 13C NMR (101 MHz, CDCl3) δ: 174.2, 108.3, 79.2, 77.8, 68.3, 62.5, 
55.7, 53.1, 36.2, 27.3, 25.9 (3C), 25.8 (3C), 25.1, 18.3, 18.0, −4.1, −4.6, −5.3 (2C). HRMS: 
(ES+) Calculated for C23H47O7Si2 [M+H]+: 491.2869; Found: 491.2871. IR νmax/cm-1 (neat): 
3158 br, 1729, 1463, 1275, 1096. [α]25D: +3.07 (c = 2.3, CH2Cl2). 
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(2S,3R)-3-((S)-2-((tert-butyldimethylsilyl)oxy)-2-((4R,5R)-5-(((tert-butyldimethylsilyl) 
oxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethyl)-N-methoxy-N-methyloxirane-2-
carboxamide 308 
 
CDI (16 mg, 97.3 µmol) was added to acid 303 (42 mg, 88.5 µmol) in CH2Cl2 (0.8 mL) at 
0 °C, stirred at this temperature for 45 min and then at rt. After 45 min, 
N,O-dimethylhydroxylamine hydrochloride (10 mg, 97.3 µmol) was added and the mixture 
stirred for 16 h at rt. The reaction was then diluted with EtOAc (10 mL) and washed 
sequentially with aqueous HCl (1.0 M, 10 mL), sat. aqueous NaHCO3 (10 mL) and brine 
(10 mL), dried (MgSO4) and concentrated in vacuo to give Weinreb amide 308 (42 mg, 
78.8 µmol, 89%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 4.23-4.14 (3H, m, H5, H6 and H7), 3.83 (1H, dd, J = 10.9, 
4.5 Hz, H8a), 3.77 (3H, s, CH3), 3.70-3.65 (2H, m, H2 and H8b), 3.35-3.32 (1H, m, H3), 3.23 
(3H, s, CH3), 2.07-2.00 (1H, m, H4a), 1.79-1.73 (1H, m, H4b), 1.42 (3H, s, CH3), 1.32 (3H, s, 
CH3), 0.89  (18H, s, SiC(CH3)3), 0.13 (3H, s, CH3), 0.11 (3H, s, CH3), 0.07 (6H, s, CH3). 
13C NMR (101 MHz, CDCl3) δ: 168.4, 107.9, 79.5, 78.2, 68.7, 62.7, 62.0, 55.0, 52.4, 36.4, 
32.6, 27.5, 26.0 (3C), 25.9 (3C), 25.2, 18.4, 18.0, −4.2, −4.5, −5.3 (2C). HRMS: (ES+) 
Calculated for C25H51NNaO7Si2 [M+Na]+: 556.3102; Found: 556.3093. IR νmax/cm-1 (neat): 
1679, 1464, 1381, 1255, 1215, 1095, 1005. [α]27D: +4.20 (c = 2.0, CH2Cl2). 
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6-(4-((2R,3R)-3-((R)-2-((tert-butyldiphenylsilyl)oxy)propyl)oxiran-2-yl)-4-hydroxy-2-
oxobutyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 311 
 
n-BuLi (2.5 M in hexanes, 1.2 mL, 2.88 mmol) was added to a solution of i-Pr2NH 
(0.40 mL, 2.88 mmol) in THF (16 mL) at −78 °C. The reaction was left to stir for 20 min 
after which time keto-dioxinone 55 (260 mg, 1.39 mmol) in THF (3.2 mL) was added 
dropwise. The solution was allowed to warm to −40 °C over 1 h, then cooled back to −78 °C 
when aldehyde 171 (340 mg, 0.928 mmol) in THF (3.2 mL) was added. After a 20 min at 
this temperature, formic acid (0.12 mL, 3.25 mmol) in THF (3.2 mL) was added and the 
solution allowed to warm to rt. The organic phase was washed with sat. aqueous NH4Cl 
(50 mL) which was acidified to pH 3-4 with a 10% aqueous sol. of AcOH. The aqueous 
phase was extracted with EtOAc (2 x 50 mL) and the combined organic phases were washed 
with brine (50 mL), dried (MgSO4) and concentrated in vacuo. Chromatography (1:1 
hexanes/EtOAc) yielded keto-dioxinone 311 as an inseparable mixture of the two epimers 
with impurities (200 mg, 0.371 mmol, ~40% conversion). A small quantity was isolable for 
characterisation and was obtained as a colourless oil and containing an inseparable mixture 
of the epimers. 
1H NMR (400 MHz, CDCl3) δ: 7.68-7.66 (4H, m, ArH), 7.45-7.36 (6H, m, ArH), 5.34 (1H, 
s, H9), 4.08-3.99 (2H, m, H2 and H6), 3.38 (1H, d, J = 16.6 Hz, H8a), 3.33 (1H, d, J = 16.6 
Hz, H8b), 3.03 (1H, td, J = 5.8, 2.1 Hz, H4), 2.71 (1H, dd, J = 4.7, 2.2 Hz, H5), 2.68-2.66 
(2H, m, H7), 2.48 (1H, d, J = 3.6 Hz, OH), 1.74-1.66 (2H, m, H3), 1.71 (6H, s, CH3), 1.16 
(3H, d, J = 6.3 Hz, H1), 1.06 (9H, s, CH3). 13C NMR (101 MHz, CDCl3) δ: 202.4, 163.8, 
160.5, 135.8 (4C), 134.2, 134.1, 129.7, 129.7, 127.6 (2C), 127.5 (2C), 107.3, 96.9, 67.4, 
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66.7, 59.2, 53.7, 47.9, 46.0, 41.0, 27.0 (3C), 25.1 (2C), 23.1, 19.2. HRMS: (ES+) Calculated 
for C31H41O7Si [M+H]+: 553.2622; Found: 553.2637. IR νmax/cm-1 (neat): 3463 br, 1726, 
1637, 1428, 1376, 1274, 1205, 1111, 1015. 
  
   207 
(2S,3R)-3-((R)-2-((tert-butyldiphenylsilyl)oxy)propyl)oxirane-2-carboxylic acid 313 
 
A solution of NaClO2 (440 mg, 4.88 mmol) and NaH2PO4H2O (670 mg, 4.88 mmol) in 
water (9.2 mL) was added to a solution of aldehyde 171 (300 mg, 0.814 mmol) in 
2-methyl-2-butene (5.2 mL) and t-BuOH (9.2 mL) and stirred at rt for 1 h. The reaction was 
diluted with water (20 mL) and Et2O (20 mL) and the two phases were separated. The 
aqueous phase was extracted with Et2O (2 x 20 mL) and the combined organic phases were 
washed with water (20 mL) and brine (2 x 20 mL), dried (MgSO4) and concentrated in 
vacuo. Excess t-BuOH was azeotropically removed with toluene to give acid 313 (300 mg, 
0.814 mmol, 100%) as a colourless, viscous syrup. 
1H NMR (400 MHz, CDCl3) δ: 7.68-7.65 (4H, m, ArH), 7.46-7.36 (6H, m, ArH), 4.08 (1H, 
sex, J = 5.8 Hz, H2), 3.35 (1H, td, J = 5.8, 1.8 Hz, H4), 3.20 (1H, d, J = 1.9 Hz, H5), 
1.79-1.72 (2H, m, H3), 1.17 (3H, d, J = 6.2 Hz, H1), 1.05 (9H, s, C(CH3)3). 13C NMR 
(101 MHz, CDCl3) δ: 174.8, 135.8 (2C), 135.7 (2C), 134.0, 133.7, 129.7, 129.6, 127.7 (2C), 
127.5 (2C), 67.1, 56.1, 52.2, 40.8, 26.9 (3C), 23.1, 19.1. HRMS: (CI+) Calculated for 
C22H32NO4Si [M+NH4]+: 402.2101; Found: 402.2112. IR νmax/cm-1 (neat): 3202 br, 1722, 
1462, 1428, 1126, 1111, 997. [α]24D: +23.2 (c = 4.0, CH2Cl2). 
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(2S,3R)-3-((R)-2-((tert-butyldiphenylsilyl)oxy)propyl)-N-methoxy-N-methyloxirane-2-
carboxamide 314 
 
CDI (94 mg, 0.579 mmol) was added to acid 313 (200 mg, 0.527 mmol) in CH2Cl2 (2.6 mL) 
at 0 °C and stirred at this temperature for 45 min and then at rt for a further 45 min. 
Following this N,O-dimethylhydroxylamine hydrochloride (56 mg, 0.579 mmol) was added 
and the mixture stirred for 16 h at rt. The reaction was diluted with EtOAc (25 mL) and 
washed with aqueous HCl (1.0 M, 25 mL), sat. aqueous NaHCO3 (25 mL) and brine 
(25 mL), dried (MgSO4) and concentrated in vacuo to give Weinreb amide 314 (170 mg, 
0.411 mmol, 78%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.68-7.66 (4H, m, ArH), 7.44-7.34 (6H, m, ArH), 4.12-4.05 
(1H, m, H2), 3.71 (3H, s, CH3), 3.57 (1H, s, H5), 3.32 (1H, ddd, J = 6.6, 5.0, 1.8 Hz, H4), 
3.23 (3H, s, CH3), 1.84-1.70 (2H, m, H3), 1.18 (3H, d, J = 6.2 Hz, H1), 1.05 (9H, s, 
C(CH3)3). 13C NMR (101 MHz, CDCl3) δ: 168.5, 135.8 (4C), 134.2, 134.0, 129.6, 129.6, 
127.6 (2C), 127.5 (2C), 67.3, 61.9, 55.0, 51.5, 41.2, 32.6, 26.9 (3C), 23.1, 19.1. 
HRMS: (ES+) Calculated for C24H33NNaO4Si [M+Na]+: 450.2077; Found: 450.2072. 
IR νmax/cm-1 (neat): 1674, 1462, 1428, 1383, 1125, 1110, 997. [α]24D: +10.4 (c = 4.8, 
CH2Cl2). 
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(1R,2R,3S,4R)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triyl triacetate 323 
 
p-Toluenesulfonyl chloride (160 g, 833 mmol) in pyridine (300 mL) was added dropwise to 
(D)-glucose (100 g, 555 mmol) in pyridine (1.0 L) with a dropping funnel, ensuring the 
internal temperature was maintained between 18-22 °C with the aid of an ice bath. The 
mixture was stirred for 90 min when it was raised to pH 9 and maintained at this pH by the 
addition of aqueous NaOH (3M). On doing so, the solution turned from yellow to orange to 
a dark red and all solids were dissolved indicating that the correct pH was reached. After a 
further 1 h the pH was lowered to pH 7 by the addition of aqueous HCl (3 M). Solvents were 
then removed in vacuo and excess pyridine azeotroped with toluene (3 x 300 mL) to give the 
crude anhydro-glucose. EtOAc (300 mL), acetic anhydride (320 mL, 3.33 mol) and DMAP 
(6.8 g, 56.0 mmol) were added to the crude material at rt and stirred for 3 h, following which 
time the product began to dissolve. The mixture was quenched with EtOH (130 mL) and 
solid NaHCO3 was added until CO2 evolution ceased, when further EtOAC (300 mL) was 
added. The mixture was filtered through florosil and dissolved in MeOtBu causing the 
DMAP to precipitate and this could then be removed through filtration. The filtrate was 
concentrated to give the crude sugar, which was recrystallised from Et2O to give the acetyl 
protected 1,6-anhydro sugar 323 (10 g, 34.7 mmol, 6%) as large colourless cyrstals which 
were separated from the solvent. The mother liquors were concentrated and chromatography 
(2:1 pentane/EtOAc) followed by recrystallisation (Et2O) gave triacetyl 323 (14 g, 
48.6 mmol, 8%). The purification steps were repeated to give further 323 (11 g, 39.2 mmol, 
7%) as large colourless crystals. The experimental data is consistent with that reported in the 
literature.158 
OO
OAcAcO
OAc
1
2
5
6
4
3
   210 
1H NMR (400 MHz, CDCl3) δ: 5.47 (1H, s, H1), 4.87 (1H, s, H5), 4.65-4.61 (3H, m, H2, H3 
and H4), 4.10 (1H, d, J = 7.8 Hz, H6a), 3.81 (1H, dd, J = 7.8, 5.7 Hz, H6b), 2.18 (3H, s, 
OCH3), 2.15 (3H, s, OCH3), 2.12 (3H, s, OCH3). 13C NMR (101 MHz, CDCl3) δ: 170.0, 
169.6, 169.0, 99.3, 73.8, 70.5, 69.7, 69.2, 65.4, 21.0, 20.9, 20.9. HRMS: (ES+) Calculated 
for C12H16O8Na [M+Na]+: 311.0743; Found: 311.0746. IR νmax/cm-1 (neat): 1757, 1731, 
1367, 1217, 1150, 1119, 1044, 1030, 1011.  [α]24D: −63.5 (c =1.0, CHCl3) {lit: = −60.0, 
c = 1.0, CHCl3). Mpt: 107-108 °C {Et2O} (literature 107-109 °C).158  
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(1R,2S,3S,4R)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol 321 
 
Triacetyl 323 (14 g, 48.6 mmol) was dissolved in MeOH (1.4 L) and NaOMe (130 mg, 
2.43 mmol) was added. After 3 h, the solution was concentrated in vacuo. The crude material 
was washed with EtOH to give the anhydro-sugar 321 (5.4 g, 36.0 mmol, 74%) as a white 
solid. The experimental data is consistent with that reported in the literature.159  
1H NMR (400 MHz, CD3OD) δ: 5.28 (1H, s, H1), 4.45 (1H, d, J = 5.6 Hz, H5), 4.06 (1H, d, 
J = 7.3 Hz, H6a), 3.65 (1H, dd, J = 7.3, 5.6 Hz, H6b), 3.61 (1H, s, H2 or H3 or H4), 3.48 (1H, 
s, H2 or H3 or H4), 3.36 (1H, s, H2 or H3 or H4). 13C NMR (101 MHz, CD3OD) δ: 103.8, 
78.1, 74.9, 73.2, 72.7, 66.5. HRMS: (CI+) Calculated for C6H14NO5 [M+NH4]+: 180.0872; 
Found: 180.0876. IR νmax/cm-1 (neat):  3370 br, 3337 br, 3258 br, 1363, 1290, 1138, 1075, 
1038, 1011, 987. [α]24D: −62.9 (c =1.0, H2O); {lit: = −66.0, c = 2.0, H2O). Mpt: 178-179 °C 
{MeOH} (literature 178 °C). 
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(1R,2S,3S,4R)-2,4-bis((4-chlorobenzyl)oxy)-6,8-dioxabicyclo[3.2.1]octan-3-ol 325 
 
A mixture of triol 321 (10 g, 61.7 mmol), para-chlorobenzyl bromide (50.7 g, 247 mmol) 
and BaO (28 g, 185 mmol) in DMF (250 mL) was heated at 60 °C for 3 h when it was 
cooled to rt, quenched with MeOH (130 mL) and stirred for 30 min. The mixture was diluted 
with CHCl3 (500 mL) and filtered through Celite®. The filtrate was concentrated in vacuo 
and chromatography (2:1 pentane/EtOAc) gave sugar 325 (17 g, 42.1 mmol, 68%) as an 
off-white, amorphous solid.  
1H NMR (400 MHz, CDCl3) δ: 7.30-7.27 (8H, m, ArH), 5.45 (1H, s, H1), 4.65 (2H, s, H7 or 
H8), 4.63 (2H, s, H7 or H8), 4.58 (1H, d, J = 5.1 Hz, H5), 3.85-3.83 (2H, m, H3 and H6a), 3.68 
(1H, dd, J = 7.5, 5.3 Hz, H6b), 3.32 (1H, d, J = 4.0 Hz, H4), 3.24 (1H, d, J = 3.7 Hz, H2), 2.33 
(1H, d, J = 4.9 Hz, OH). 13C NMR (101 MHz, CDCl3) δ: 136.3, 136.2, 133.7, 133.6, 129.1 
(2C), 129.0 (2C), 128.6 (4C), 101.1, 79.7, 79.4, 75.0, 71.3, 70.9, 70.4, 66.4. HRMS: (ES+) 
Calculated for C22H23Cl2NNaO5 [M+CH3CN+Na]+: 474.0851; Found: 474.0831. 
IR νmax/cm-1 (neat): 3474 br, 1492, 1089, 1015, 892, 807. [α]24D: −24.6 (c = 1.1, CHCl3). 
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(1R,2R,3S,4R)-2,4-bis((4-chlorobenzyl)oxy)-6,8-dioxabicyclo[3.2.1]octan-3-yl 4-methyl 
benzenesulfonate 326 
 
Alcohol 325 (300 mg, 0.730 mmol) and TsCl (280 mg, 1.46 mmol) were heated in pyridine 
(0.3 mL) at 35 °C for 24 h after which time the solution was cooled to rt. The reaction was 
dissolved in EtOAc (20 mL) and washed sequentially with aqueous HCl (1 M, 3 x 15 mL), 
sat. aqueous NaHCO3 (15 mL) and brine (15 mL). The organic phase was dried (MgSO4) 
and concentrated in vacuo. Chromatography (4:1 to 3:1 pentane/EtOAc) gave 1,6-anhydro 
sugar 326 (320 mg, 0.601 mmol, 82%) as a colorless gum. 
1H NMR (400 MHz, CDCl3) δ: 7.47-7.72 (2H, m, ArH), 7.35-7.24 (8H, m, ArH), 7.14-7.12 
(2H, m, ArH), 5.34 (1H, s, H1), 4.61-4.50 (4H, m, H3, H5 and H7 or H8), 4.41 (1H, 
d, J = 12.6 Hz, H7 or H8), 4.29 (1H, d, J = 12.6 Hz, H7 or H8), 3.89 (1H, d, J = 7.7 Hz, H6a), 
3.68 (1H, dd, J = 7.7, 5.7 Hz, H6b), 3.43 (1H, d, J = 1.6 Hz, H2 or H4), 3.23 (1H, s, H2 or H4), 
2.46 (3H, s, CH3). 13C NMR (101 MHz, CDCl3) δ: 145.4, 135.8, 135.7, 133.8, 133.3, 133.0 
(2C), 129.2 (2C), 129.0 (2C), 128.6 (2C), 128.6 (2C), 128.6 (2C), 127.9 (2C), 19.7, 75.4, 
74.9, 74.7, 74.1, 71.0, 70.6, 66.9, 21.7. N.B: One carbon missing due to overlap. HRMS: 
(ES+) Calculated for C29H29Cl2NNaO7S [M+CH3CN+Na]+: 628.0939; Found: 628.0931. 
IR νmax/cm-1 (neat): 1598, 1492, 1360, 1189, 1176, 1149, 1089, 1014, 943. [α]28D: +7.1 
(c = 4.1, CHCl3). 
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O-((1R,2R,3S,4R)-2,4-bis((4-chlorobenzyl)oxy)-6,8-dioxabicyclo[3.2.1]octan-3-yl) 1H-
imidazole -1-carbothioate 329 
 
Alcohol 325 (2.0 g, 4.87 mmol) and 1,1-thiocarbonyldiimidazole (1.3 g, 7.30 mmol) were 
heated at reflux in toluene (47 mL) for 6 h. The solution was then concentrated in vacuo and 
chromatography (1:2 pentane/EtOAc) gave thioester 329 (2.5 g, 4.68 mmol, 96%) as a 
yellow solid.  
1H NMR (400 MHz, CDCl3) δ: 8.26 (1H, s, ArH), 7.53 (1H, s, ArH), 7.34-7.26 (8H, m, 
ArH), 7.02 (1H, s, ArH), 5.69 (1H, s, H3), 5.47 (1H, s, H1), 4.79-4.62 (5H, m, H5, H7 and 
H8), 3.84-3.76 (2H, m, H6), 3.39 (1H, s, H2 or H4), 3.35 (1H, s, H2 or H4). 13C NMR 
(101 MHz, CDCl3) δ: 182.0, 136.9, 135.5, 135.5, 133.9, 133.9, 131.3, 129.2 (4C), 128.7 
(4C), 117.8, 99.9, 75.9, 74.1, 73.7, 73.6, 71.5, 70.7, 65.1. HRMS: (ES+) Calculated for 
C24H23Cl2N2O5S [M+H]+: 521.0705; Found: 521.0714. IR νmax/cm-1 (neat): 1738, 1465, 
1492, 1391, 1332, 1295, 1284, 1228, 1091, 1014, 986. [α]24D: −62.0 (c = 1.3, CHCl3). Mpt: 
96-98 °C {CHCl3}. 
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(1R,2S,4R)-2,4-bis((4-chlorobenzyl)oxy)-6,8-dioxabicyclo[3.2.1]octane 327 
 
A solution of AIBN (1.8 g, 11.0 mmol) and Bu3SnH (15 mL, 55.0 mmol) in toluene (35 mL) 
was added over an h to a refluxing solution of thioester 329 (5.8 g, 11.0 mmol) in toluene 
(340 mL). After a further 30 min of heating the solution was cooled to rt and the solvent 
evaporated in vacuo. Chromatography (9:1 silica gel/KF by weight; 10:1 CH2Cl2/Et2O) gave 
tetrahydropyran 327 (3.8 g, 9.60 mmol, 87%) as a colourless, viscous syrup. 
1H NMR (400 MHz, CDCl3) δ: 7.32-7.26 (8H, m, ArH), 5.46 (1H, s, H1), 4.63-4.53 (5H, m, 
H5, H7 and H8), 3.78 (1H, dd, J = 7.7, 5.5 Hz, H6a), 3.68 (1H, d, J = 7.7 Hz, H6b), 3.34-3.20 
(2H, m, H2 and H4), 2.01 (1H, dt, J = 15.8, 1.8 Hz, H3a), 1.88-1.82 (1H, m, H3b). 13C NMR 
(101 MHz, CDCl3) δ: 136.9, 136.8, 133.5 (2C), 129.0 (2C), 128.9 (2C), 128.5 (2C), 
128.5  (2C), 100.7, 74.5, 72.3, 72.2, 70.5, 69.8, 65.4, 24.7. HRMS: (ES+) Calculated for 
C20H20Cl2NaO4 [M+Na]+: 417.0636; Found: 417.0645. IR νmax/cm-1 (neat): 1492, 1144, 
1121, 1090, 1016, 922, 906. [α]26D: −35.9 (c =1.0, CHCl3).  
 
  
OO
OO
1
2
5
6
43
Cl Cl
78
   216 
((2R,3S,5R)-6-acetoxy-3,5-bis((4-chlorobenzyl)oxy)tetrahydro-2H-pyran-2-yl)methyl 
acetate 331 
 
A mixture of tetrahydropyran 327 (6.6 g, 16.8 mmol), acetic anhydride (22 mL, 235 mmol) 
and BF3OEt2 (1.0 mL, 8.40 mmol) were stirred at 0 °C for 30 min. The mixture was then 
poured on to sat. aqueous NaHCO3 (300 mL) and stirred until gas evolution ceased. If it was 
required, further solid NaHCO3 was added. The aqueous phase was extracted with CHCl3 (3 
x 300 mL) and the combined organic phases were dried (MgSO4) and concentrated in vacuo. 
Chromatography (4:1 pentane/EtOAc) gave diacetate 331 (8.1 g, 16.3 mmol, 97%) as a 
colorless, thick syrup and an inseparable mixture of diastereoisomers 3.3:1.0 α/β.  
α-anomer: 1H NMR (400 MHz, CDCl3) δ: 7.33-7.22 (8H, m, ArH), 6.31 (1H, d, J = 3.2 Hz, 
H1), 4.62-4.38 (4H, m, H7 and H8), 4.31-4.22 (2H, m, H6), 3.86 (1H, ddd, J = 9.8, 4.5, 2.4 
Hz, H5), 3.56 (1H, dt, J = 12.2, 4.2 Hz, H2), 3.47-3.40 (1H, m, H4), 2.39 (1H, dt, J = 11.7, 
4.7 Hz, H3a), 2.15 (3H, s, CH3) 1.85 (3H, s, CH3), 1.85 (1H, app. q, J = 11.8 Hz, H3b). 
13C NMR (101 MHz, CDCl3) δ: 170.7, 169.4, 136.1, 136.0, 133.8, 133.8, 129.2 (2C), 129.1 
(2C), 128.7 (4C), 88.6, 72.6, 71.2, 71.0, 70.7, 69.9, 62.8, 30.2, 21.1, 20.8.  
β-anomer: 1H NMR (400 MHz, CDCl3) δ: 7.34-7.20 (8H, m, ArH), 5.59 (1H, d, J = 7.9 Hz, 
H1), 4.62-4.22 (6H, m, H6, H7 and H8), 3.68 (1H, ddd, J = 9.4, 4.6, 2.8 Hz, H) 3.47-3.37 (2H, 
m, H2 and H4), 2.58 (1H, dt, J = 12.4, 4.8 Hz, H3a), 2.11 (3H, s, CH3) 2.01 (3H, s, CH3), 1.60 
(1H, app. q, J = 11.4 Hz, H3b). 13C NMR (101 MHz, CDCl3) δ: 170.7, 169.1, 136.5, 136.0, 
133.8, 133.6, 129.1 (2C), 128.8 (2C), 128.7 (2C), 128.6 (2C), 95.4, 77.0, 74.0, 71.5, 71.1, 
70.3, 62.8, 34.2, 21.1, 20.8.  
HRMS: (ES+) Calculated for C24H26Cl2NaO7 [M+Na]+: 519.0953; Found: 519.0947. 
IR νmax/cm-1 (neat): 1740, 1370, 1492, 1225, 1152, 1083, 970. 
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((2R,3S,5R,6S)-3,5-bis((4-chlorobenzyl)oxy)-6-cyanotetrahydro-2H-pyran-2-yl)methyl 
acetate 332 and ((2R,3S,5R,6R)-3,5-bis((4-chlorobenzyl)oxy)-6-cyanotetrahydro-2H-
pyran-2-yl)methyl acetate 333 
 
TMSOTf (1.1 mL, 6.18 mmol) was added to a solution of diacetate 331 (5.1 g, 10.3 mmol) 
and TMSCN (3.4 mL, 33.9 mmol) in CH3CN (51 mL) at 0 °C and stirred for 45 min. The 
solution was diluted with CH2Cl2 (200 mL) and washed with ice-cold sat. aqueous NaHCO3 
(100 mL). The organic phase was washed a further 3 times with sat. aqueous NaHCO3 
(100 mL) and dried (MgSO4). The solvent was concentrated and chromatography (5:1 to 3:1 
pentane/EtOAc) give the β-anomer 332 (2.0 g, 4.32 mmol, 42%) as a white amorphous solid 
and the α-anomer 331 (2.0 mg, 4.32 mmol, 42%) as a colourless oil.  
332: 
1H NMR (400 MHz, CDCl3) δ: 7.37-7.19 (8H, m, ArH), 4.71 (1H, d, J = 11.6 Hz, H7 or H8), 
4.66 (1H, d, J = 11.6 Hz, H7 or H8), 4.55 (1H, d, J = 11.6 Hz, H7 or H8), 4.38 (1H, d, 
J = 11.6 Hz, H7 or H8), 4.33 (1H, dd, J = 12.2, 2.0 Hz, H6a), 4.17 (1H, dd, J = 12.2, 5.4 Hz, 
H6b), 4.03 (1H, d, J = 9.7 Hz, H1), 3.66-3.57 (1H, m, H2), 3.48-3.41 (1H, m, H5), 3.39-3.30 
(1H, m, H4), 2.65 (1H, dt, J = 12.3, 4.5 Hz, H3a), 2.04 (3H, s, CH3), 1.45 (1H, app. q, 
J = 11.2 Hz, H3b). 13C NMR (101 MHz, CDCl3) δ: 170.6, 135.6, 135.3, 134.1, 134.0, 129.3 
(2C), 129.1 (2C), 128.8 (2C), 128.7 (2C), 116.8, 78.8, 73.6, 71.6, 70.6, 70.3, 69.0, 62.7, 
35.3, 20.7.  HRMS: (ES+) Calculated for C23H24Cl2NO5 [M+H]+: 464.1032; Found: 
464.1037. IR νmax/cm-1 (neat): 1736, 1492, 1368, 1352, 1232, 1085, 1043, 1015, 807. 
[α]26D: +43.2 (c =1.5, CHCl3). 
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333: 
1H NMR (400 MHz, CDCl3) δ: 7.36-7.21 (8H, m, ArH), 4.79 (1H, d, J = 5.4 Hz, H1), 
4.62-4.54 (3H, m, H7 and H8), 4.39 (1H, d, J = 11.7 Hz, H7 or H8), 4.34-4.24 (2H, m, H6), 
3.82 (1H, ddd, J = 9.6, 4.8, 2.3 Hz, H5), 3.60 (1H, ddd, J = 11.8, 5.3, 4.5 Hz, H2), 3.34 (1H, 
ddd, J = 11.1, 9.7, 4.6 Hz, H4), 2.62-2.50 (1H, m, H3a), 2.03 (3H, s, CH3), 1.80 (1H, app. q, 
J = 11.9 Hz, H3b). 13C NMR (101 MHz, CDCl3) δ: 170.6, 135.7, 135.4, 134.1, 133.9, 129.1 
(2C), 129.0 (2C), 128.9 (2C), 128.7 (2C), 114.9, 74.9, 71.4, 70.9, 70.3, 69.9, 67.2, 62.4, 
32.3, 20.7.  HRMS: (ES+) Calculated for C23H24Cl2NO5 [M+H]+: 464.1032; Found: 
464.1038. IR νmax/cm-1 (neat): 1737, 1491, 1366, 1232, 1086, 1016, 807. [α]26D: +107.5 
(c =1.4, CHCl3). 
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(2R,3R,5S,6R)-3,5-bis((4-chlorobenzyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-2-
carbonitrile 337 
 
Nitrile 333 (89 mg, 0.192 mmol) and K2CO3 (27 mg, 0.192 mmol) were stirred in MeOH (15 
mL) for 30 min. The solution was washed with sat. aqueous NH4Cl (25 mL) and the aqueous 
phase was extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried 
(MgSO4) and concentrated in vacuo. Chromatography (3:2 pentane/EtOAc) afforded alcohol 
337 (50 mg, 0.119 mmol, 62%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.35-7.23 (8H, m, ArH), 4.79 (1H, d, J = 5.1 Hz, H1), 
4.62-4.45 (4H, m, H7 and H8), 3.88-3.76 (2H, m, H6), 3.66 (1H, dt, J = 9.6, 3.2 Hz, H5), 3.58 
(1H, dt, J = 11.9, 4.6 Hz, H2), 3.48 (1H, ddd, J = 11.1, 9.6, 4.5 Hz, H4), 2.54 (1H, dt, 
J = 11.4, 3.9 Hz, H3a), 1.79 (1H, app. q, J = 11.8 Hz, H3b). 13C NMR (101 MHz, CDCl3) 
δ: 136.0, 135.5, 134.0, 133.7, 129.0 (4C), 128.8 (2C), 128.7 (2C), 115.1, 77.0, 71.6, 70.8, 
70.4, 70.3, 67.2, 61.3, 32.4.  HRMS: (ES+) Calculated for C21H22Cl2NO4 [M+H]+: 422.0926; 
Found: 422.0923 IR νmax/cm-1 (neat): 3458 br, 1491, 1358, 1085, 1015, 807. [α]26D: +61.1 
(c =1.7, CHCl3).  
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(2S,3R,5S,6R)-3,5-bis((4-chlorobenzyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-2-
carbonitrile 334 
 
Nitrile 332 (690 mg, 1.49 mmol) and K2CO3 (205 mg, 1.49 mmol) were stirred in MeOH 
(130 mL) for 30 min. The solution was washed with sat. aqueous NH4Cl (200 mL) and the 
aqueous phase was extracted with CHCl3 (5 x 100 mL). The organic layers were dried 
(MgSO4) and concentrated in vacuo. Chromatography (5:2 pentane/EtOAc) afforded alcohol 
334 (540 mg, 1.29 mmol, 86%) as an off-white oil. 
1H NMR (400 MHz, CDCl3) δ: 7.36-7.21 (8H, m, ArH), 4.67 (2H, s, H7 or H8), 4.57 (1H, d, 
J = 11.6 Hz, H7 or H8), 4.45 (1H, d, J = 11.7 Hz, H7 or H8), 4.05 (1H, d, J = 9.7 Hz, H1), 
3.89 (1H, dd, J = 12.4, 2.6 Hz, H6a), 3.72 (1H, dd, J = 12.4, 4.5 Hz, H6b), 3.60 (1H, ddd, 
J = 11.2, 9.6, 4.6 Hz, H2), 3.47 (1H, ddd, J = 11.0, 9.2, 4.5 Hz, H4), 3.32-3.28 (1H, m, H5), 
2.62 (1H, dt, J = 12.2, 4.6 Hz, H3a), 1.46 (1H, app. q, J = 11.4 Hz, H3b). 13C NMR (101 
MHz, CDCl3) δ: 135.9, 135.3, 134.1, 133.9, 129.3 (2C), 129.0 (2C), 128.8 (2C), 128.7 (2C), 
116.9, 81.2, 73.9, 71.5, 70.7 (2C), 69.0, 61.6, 32.5. HRMS: (ES−) Calculated for 
C22H22Cl2NO6 [M+CO2H]: 466.0824; Found: 466.0814. IR νmax/cm-1 (neat): 3443 br, 1492, 
1351, 1087, 1015, 807. [α]26D: +19.3 (c =1.0, CHCl3). 
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((2R,3S,5R,6S)-3,5-bis((4-chlorobenzyl)oxy)-6-cyanotetrahydro-2H-pyran-2-yl)methyl 
3,5-dinitro benzoate 336 
 
3,5-Dinitrobenzoyl chloride (45 mg, 0.195 mmol), DMAP (1.1 mg, 9.7 µmol) and NEt3 
(30 µL, 0.195 mmol) were added to alcohol 334 (41 mg, 0.0974 mmol) in CH2Cl2 (1.7 mL) 
and stirred at rt for 2 h. CH2Cl2 (20 mL) was added and the solution was washed with 
aqueous HCl (1.0 M, 20 mL). The aqueous layer was extracted with CH2Cl2 (2 x 20 mL) and 
the combined organic phases were dried (MgSO4), concentrated in vacuo and 
chromatography (4:1 pentane/EtOAc) gave ester 336 (45 mg, 0.0728 mmol, 75%) as a white 
solid. Recrystallisation from CH2Cl2/pentane gave the dinitro-ester as small, white needles. 
The absolute structure was unambiguously determined by X-ray crystallography (Appendix 
1). 
1H NMR (400 MHz, CDCl3) δ: 9.22 (1H, t, J = 2.0 Hz, ArH), 8.98 (2H, d, J = 2.0 Hz, ArH), 
7.37-7.16 (8H, m, ArH), 4.76-4.62 (4H, m, H6 and/or H7 and/or H8), 4.52 (1H, dd, J = 12.1, 
5.1 Hz, H6 or H7 or H8), 4.37 (1H, d, J = 11.9 Hz, H6 or H7 or H8), 4.11 (1H, d, J = 9.8 Hz, 
H1), 3.77-3.56 (2H, m, H2 and H5), 3.45 (1H, ddd, J = 10.8, 9.5, 4.5 Hz, H4), 2.78 (1H, dt, 
J = 12.3, 4.5 Hz, H3a), 1.53 (1H, app. q, J = 11.5 Hz, H3b). 13C NMR (101 MHz, CDCl3) 
δ: 162.1, 148.6 (2C), 135.4, 135.3, 134.1, 134.0, 133.1, 129.3 (6C), 128.8 (2C), 128.7 (2C), 
122.6, 116.6, 78.2, 73.7, 71.8, 70.2, 69.8, 69.1, 64.8, 35.1. HRMS: (ES+) Calculated for 
C29H24Cl2N3O11 [M−H+HCO2H]: 660.0788; Found: 660.0801. IR νmax/cm-1 (neat): 1736, 
1545, 1492, 1345, 1281, 1167, 1090, 1015. [α]21D: +83.1 (c =1.0, CHCl3). Mpt: 132-134 °C 
{CH2Cl2/pentane}.  
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(2S,3R,5S,6R)-6-(((4-bromobenzyl)oxy)methyl)-3,5-bis((4-chlorobenzyl)oxy) tetrahydro 
-2H-pyran-2-carbonitrile 350 
 
Sodium hydride (60% w.r.t dispersion in oil; 71 mg, 1.76 mmol) and 4-bromobenzyl 
bromide (440 mg, 1.76 mmol) were added to a solution of alcohol 334 (500 mg, 1.12 mmol) 
in DMF (9 mL) at rt and stirred for 30 min. The solution was diluted with CHCl3 (50 mL), 
washed with water (4 x 50 mL), dried (MgSO4) and concentrated in vacuo. Chromatography 
(2:1 pentane/Et2O) furnished nitrile 350 (610 mg, 1.00 mmol, 93%) as a white amorphous 
solid. 
1H NMR (400 MHz, CDCl3) δ: 7.47-7.11 (12H, m, ArH), 4.70 (1H, d, J = 11.6 Hz, H7 or H8 
or H9), 4.66 (1H, d, J = 11.6 Hz, H7 or H8 or H9), 4.55-4.33 (4H, H7 and/or H8 and/or H9), 
4.01 (1H, d, J = 9.7 Hz, H1), 3.71-3.58 (3H, m, H6 and H2), 3.48 (1H, ddd, J = 11.1, 9.4, 4.6 
Hz, H4), 3.35 (1H, ddd, J = 9.7, 4.1, 2.0 Hz, H5), 2.60 (1H, dt, J = 12.2, 4.5 Hz, H3a), 1.43 
(1H, app. q, J = 11.4 Hz, H3b). 13C NMR (101 MHz, CDCl3) δ: 136.8, 135.9, 135.4, 134.1, 
133.8, 135.6 (2C), 129.4 (2C), 129.3 (2C), 128.9 (2C), 128.8 (2C), 128.7 (2C), 121.6, 116.9, 
80.9, 73.8, 72.8, 71.5, 70.6, 70.6, 69.1, 68.3, 35.7. HRMS: (ES+) Calculated for 
C28H27BrCl2NO4 [M+H]+: 590.0501; Found: 590.0521. IR νmax/cm-1 (neat): 1492, 1462, 
1348, 1088, 1048, 1011, 972. [α]23D: +25.2 (c =1.0, CHCl3).  
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(2R,3R,5S,6R)-methyl 6-(((4-bromobenzyl)oxy)methyl)-3,5-bis((4-chlorobenzyl) oxy) 
tetrahydro-2H-pyran-2-carboxylate 351 
 
Acetyl chloride (0.50 mL) was added to nitrile 350 (290 mg, 0.496 mmol) in MeOH (10 mL) 
at 0 °C and then heated at 65 °C. After 24 h, the solution was cooled to 0 °C and further 
acetyl chloride (0.20 mL) was added. After additional heating at 65 °C for 24 h the solution 
was evaporated and purified by chromatography (2:1 pentane/Et2O) to give methyl ester 351 
(310 mg, 0.492 mmol, 99%) as a white solid. 
1H NMR (400 MHz, CDCl3) δ: 7.45-7.12 (12H, m, ArH), 4.56-4.33 (6H, m, H7, H8 and H9), 
3.84 (1H, d, J = 9.6 Hz, H1), 3.76 (3H, s, OCH3), 3.73-3.62 (3H, m, H6 and H2), 3.50-3.41 
(2H, m, H4 and H5), 2.63 (1H, dt, J = 12.2, 4.3 Hz, H3a), 1.50 (1H, app. q, J = 11.2 Hz, H3b). 
13C NMR (101 MHz, CDCl3) δ: 169.9, 137.2, 136.2 (2C), 133.7, 131.4 (2C), 129.4 (2C), 
129.0 (2C), 128.9 (2C), 128.6 (4C), 121.5, 80.4, 79.8, 74.0, 72.7, 71.6, 70.8, 70.4, 68.9, 52.3, 
35.2. N.B.: One carbon missing due to overlap of peaks.  HRMS: (ES+) Calculated for 
C31H32BrCl2NNaO6 [M+CH3CN+Na]+: 686.0688; Found: 686.0681. IR νmax/cm-1 (neat): 
1748, 1491, 1365, 1216, 1088, 1015. [α]23D: +12.5 (c =1.0, CHCl3).  
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(2R,3R,5S,6R)-6-(((4-bromobenzyl)oxy)methyl)-3,5-bis((4-chlorobenzyl)oxy) tetrahydro 
-2H-pyran-2-carboxylic acid 355 
 
Ester 351 (460 mg, 0.740 mmol) and LiOHH2O (62 mg, 1.48 mmol) were stirred in MeOH 
and water (20:1; 14 mL) for 24 h. The solution was diluted with CHCl3 (100 mL) and 
washed with aqueous citric acid (10%, 100 mL). The phases were separated and the organic 
phase was dried (MgSO4) and concentrated in vacuo to give the clean acid 355 (440 mg, 
0.729 mmol, 98%) as a colourless oil, which was used in subsequent reactions without 
further purification. 
1H NMR (400 MHz, CDCl3) δ: 7.44-7.12 (12H, m, ArH), 4.56-4.45 (5H, m, H7, H8 and H9), 
4.34 (1H, d, J = 11.6 Hz, H7or H8 or H9), 3.89 (1H, d, J = 9.3 Hz, H1), 3.75-3.62 (3H, m, H6 
and H2), 3.50-3.44 (2H, m, H4 and H5), 2.62 (1H, dt, J = 12.0, 4.0 Hz, H3a), 1.57 (1H, app. q, 
J = 11.2 Hz, H3b). 13C NMR (101 MHz, CDCl3) δ: 172.5, 136.7, 136.1, 136.0, 133.7 (2C), 
131.5 (2C), 129.5 (2C), 129.1 (2C), 128.9 (2C), 128.6 (4C), 121.7, 79.8, 79.0, 73.7, 72.6, 
71.4, 70.8, 70.3, 68.8, 35.1. HRMS: (ES+) Calculated for C28H28BrCl2O6 [M+H]+: 
609.0446; Found: 609.0420 IR νmax/cm-1 (neat): 3101 br, 1746, 1491, 1220, 1088, 1014. 
[α]22D: +18.8 (c =1.0, CHCl3). 
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(2R,3R,5S,6R)-6-(((4-bromobenzyl)oxy)methyl)-3,5-bis((4-chlorobenzyl)oxy)-N-
methoxy-N-methyltetrahydro-2H-pyran-2-carboxamide 356 
 
Acid 355 (110 mg, 0.178 mmol) was dissolved in CH2Cl2 (3.0 mL) and CDI (39 mg, 0.241) 
was added at 0 °C and stirred for 30 min, followed by 45 min at rt. N,O-
dimethylhydroxylamine hydrochloride (28 mg, 0.289 mmol) was added and stirred for 16 h. 
The mixture was washed sequentially with aqueous HCl (1.0 M, 10 mL), sat. aqueous 
NaHCO3 (10 mL) and brine (10 mL), dried (MgSO4) and concentrated in vacuo. 
Chromatography (1:2 pentane/Et2O) afforded amide 356 (90 mg, 0.138 mmol, 78%) as a 
colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.44-7.42 (2H, m, ArH), 7.30-7.13 (10H, m, ArH), 4.56-4.28 
(7H, m, H1, H7, H8 and H9), 3.86 (1H, ddd, J = 11.3, 9.3, 4.6 Hz, H2), 3.74-3.69 (1H, m, H6a), 
3.69 (3H, s, CH3), 3.61 (1H, dd, J = 10.8, 5.3 Hz, H6b), 3.51-3.40 (2H, m, H4 and H5), 3.28 
(3H, s, CH3), 2.62 (1H, dt, J = 11.8, 4.5 Hz, H3a), 1.52 (1H, app. q, J = 11.3 Hz, H3b). 13C 
NMR (101 MHz, CDCl3) δ: 169.1, 137.3, 136.8, 136.4, 133.6, 133.4, 131.4 (2C), 129.3 
(2C), 129.1 (2C), 128.9 (2C), 128.6 (2C), 128.5 (2C), 121.4, 80.6, 75.5, 73.4, 72.6, 72.0, 
71.3, 70.2, 69.5, 62.0, 35.5, 32.1. HRMS: (ES+) Calculated for C30H33BrCl2NO6 [M+H]+: 
652.0868; Found: 652.0888. IR νmax/cm-1 (neat): 1668, 1490, 1086, 1014. [α]23D: +20.4 (c 
=1.0, CHCl3). 
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3-(allyloxy)-3-oxopropanoic acid 362 
 
Meldrum’s acid (10 g, 69.4 mmol) and allyl alcohol (24 mL, 347 mmol) were heated to 
90 °C for 8 h. Removal of excess allyl alcohol in vacuo gave acid 362 (10 g, 69.4 mmol, 
100%) as a yellow oil, which was used in subsequent reactions without further purification. 
The experimental data is consistent with that reported in the literature.160 
1H NMR (400 MHz, CDCl3) δ: 11.4 br, (1H, s, OH), 5.90 (1H, ddd, J = 16.5, 10.9, 5.7 Hz, 
H3), 5.41-5.20 (2H, m, H4 and H5), 4.66 (2H, d, J = 5.7 Hz, H2), 3.45 (2H, s, H1). 13C NMR 
(101 MHz, CDCl3) δ: 171.7, 166.2, 131.2, 119.2, 66.4, 40.8. 
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allyl 4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-oxobutanoate 363 
 
Oxalyl chloride (1.5 mL, 18.1 mmol) and DMF (2 drops, cat.) were added to acid 362 (2.0 g, 
13.9 mmol) in CH2Cl2 (28 mL) at 0 °C. The solution was stirred at this temperature for 
30 min followed by 3 h at rt. Following this, the solution was concentrated in vacuo to give 
the acid chloride. Alongside this reaction n-BuLi (2.5 M in hexanes, 19 mL, 47.3 mmol) was 
added to HMDS (9.9 mL, 47.3 mmol) in THF (70 mL) at 0 °C and stirred for 1 h when the 
solution was cooled to −78 °C. Dioxinone 55 (5.9 g, 41.6 mmol) was added to this solution 
and stirred for 1 h at −78 °C. The acid chloride in THF (5 mL) was added to the mixture and 
stirred for a further 2 h when it was quenched with sat. aqueous NH4Cl (50 mL) and warmed 
to rt. Et2O (100 mL) was added and aqueous HCl (1.0 M) until pH 2 was reached. The 
phases were separated and the aqueous phase washed with Et2O (2 x 100 mL). The 
combined organic layers were dried (MgSO4) and concentrated in vacuo to give the crude 
material. Chromatography (3:1 to 2:1 to 1: 2 pentane/Et2O) gave keto-dioxinone 363 (1.7 g, 
6.24 mmol, 45%) as a yellow oil. The experimental data is consistent with that reported in 
the literature.55 
1H NMR (400 MHz, CDCl3) δ: 5.91 (1H, ddt, J = 16.4, 10.5, 6.0 Hz, H5), 5.40-5.27 (2H, m, 
H6 and H7), 5.37 (1H, s, H1), 4.65 (2H, d, J = 6.0 Hz, H4), 3.55 (2H, s, H2 or H3), 3.50 (2H, s, 
H2 or H3), 1.71 (6H, s, H8). 13C NMR (101 MHz, CDCl3) δ: 195.4, 166.0, 163.4, 160.4, 
131.2, 119.4, 107.4, 97.2, 66.3, 49.0, 47.0, 25.0. 
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tetrahydro-2H-pyran-2-carboxylic acid 368 
 
TEMPO (1.3 g, 8.38 mmol) was added to tetrahydropyran-2-methanol (4.9 g, 41.9 mmol) 
and (diacetoxyiodo)benzene (30 g, 92.2 mmol) in CH3CN/H2O (1:1, 100 mL) at 0 °C, then 
stirred at rt for 3 h. Aqueous NaOH (1.0 M, 200 mL) was added and the aqueous phase was 
extracted with EtOAc (3 x 200 mL). The aqueous layer was then re-acidified with aqueous 
HCl (1.0 M) to pH 2 where it was then extracted with EtOAc (6 x 100 mL). The combined 
organic layers were dried (MgSO4) and concentrated in vacuo to give acid 368 (5.1 g, 
39.5 mmol, 94%) as an orange oil, which was used in subsequent steps without further 
purification. The experimental data is consistent with that reported in the literature.161 
1H NMR (400 MHz, CDCl3) δ: 4.12 (1H, d, J = 11.9 Hz, OCHaHbC), 3.99 (1H, d, J = 9.4 
Hz, OCHCC), 3.58-3.52 (1H, m, OCHaHbC), 2.11-1.94 (3H, m, CH2), 1.65-1.55 (3H, m, 
CH2). 13C NMR (101 MHz, CDCl3) δ: 175.5, 75.4, 68.3, 28.6, 25.1, 22.8. 
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allyl 3-oxo-3-(tetrahydro-2H-pyran-2-yl)propanoate 370 
 
Acid 368 (280 mg, 2.15 mol) in CH2Cl2 (1.0 mL) was added to a solution of Meldrum’s acid 
(330 mg, 2.32), DCC (470 mg, 2.23 mmol) and DMAP (80 mg, 0.645 mmol) in CH2Cl2 (11 
mL) at rt. After 16 h, the reaction was diluted with Et2O (200 mL), filtered and washed with 
aqueous HCl (1.5 M, 100 mL), H2O (100 mL) and brine (100 mL). The organic phase was 
dried (MgSO4) and concentrated to give the acylated Meldrum’s acid 369. 369 was then 
heated in toluene (3.5 mL) with allyl alcohol (350 mL, 5.08 mmol) at 90 °C for 16 h and 
evaporated to give allyl ester 370 (210 mg, 0.995 mmol, ~46% conversion over two steps) as 
a orange oil. A sample of which was purified by chromatography (5:1 pentane/Et2O) for 
analysis, otherwise allyl ester 370 was used in subsequent reactions without further 
purification. 
1H NMR (400 MHz, CDCl3) δ: 5.92 (1H, ddt, J = 17.3, 10.3, 5.8 Hz, H5), 5.37-5.32 (1H, m, 
H6a), 5.27-5.23 (1H, m, H6b), 4.66-4.62 (2H, m, H4), 4.05-4.01 (1H, m, H1a), 3.85 (1H, dd, 
J = 11.0, 2.4 Hz, H2), 3.66 (1H, d, J = 16.4 Hz, H3a), 3.59 (1H, d, J = 16.4 Hz, H3b), 3.46 
(1H, td, J = 11.2, 3.1, H1b), 1.95-1.88 (2H, m, CH2), 1.60-1.45 (4H, m, CH2). 13C NMR 
(101 MHz, CDCl3) δ:  204.0, 167.2, 131.7, 118.5, 82.1, 68.4, 65.8, 45.1, 27.8, 25.4, 22.9. 
HRMS: (CI+) Calculated for C11H20NO4 [M+NH4]+: 230.1392; Found: 230.1392. 
IR νmax/cm-1 (neat): 1741, 1719, 1645, 1315, 1207, 1091, 1147, 1047, 988. 
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benzyl 2-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)acetate 371 
 
Dioxinone 55 (5.6 mL, 42.2 mmol) was added to freshly prepared LiHMDS (1.0 M, 
44.3 mmol) at −78 °C. After 30 min, benzyl chloroformate (3.3 mL, 23.2 mmol) was added 
and the mixture was warmed to rt over 2 h. The reaction was quenched with aqueous HCl 
(1.0 M, 200 mL) and the aqueous phase was extracted with EtOAC (3 x 200mL). The 
combined organic layers were dried (MgSO4), concentrated in vacuo and chromatography 
(4:1 to 2:1 pentane/Et2O) gave benzyl ester 371 (2.6 g, 9.24 mmol, 40%) as a yellow oil. The 
data is consistent with that reported in the literature.162 
1H NMR (400 MHz, CDCl3) δ: 7.39-7.34 (5H, m, ArH), 5.39 (1H, s, CH=C), 5.17 (2H, s, 
OCH2), 3.31 (2H, s, CCH2), 1.63 (6H, s, CH3). 13C NMR (101 MHz, CDCl3) δ: 166.9, 
163.5, 160.7, 135.0, 128.7 (2C), 128.7, 128.6 (2C), 107.3, 96.5, 67.4, 39.4, 24.8 (2C).  
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2-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)acetic acid 372 
 
Benzyl ester 371 (1.1g, 4.09 mmol) and Pd/C (10% by wt, 110 mg) were stirred in EtOAc 
(40 mL) while hydrogen was bubbled through the suspension for 5 min. The mixture was 
stirred for a further 45 min under a hydrogen atmosphere (balloon) when it was filtered 
through Celite® and concentrated in vacuo to give 372 (610 mg, 3.25 mmol, 80%) as a 
white solid which was used in subsequent reactions without further purification. 
1H NMR (400 MHz, CDCl3) δ: 5.44 (1H, s, CH=C), 3.33 (2H, s, CH2), 1.72 (6H, s, CH3). 
13C NMR (125 MHz, CDCl3) δ: 171.5, 162.9, 160.7, 107.4, 96.7, 38.8, 24.9 (2C). HRMS: 
(CI+) Calculated for C8H14NO5 [M+NH4]+: 204.0872; Found: 204.0870. IR νmax/cm-1 (neat): 
3193 br, 1734, 1701, 1647, 1393, 1373, 1247, 1235, 1200, 1014, 948, 903. Mpt: 97-99 °C 
{CHCl3} 
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2-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-N-methoxy-N-methylacetamide 376 
 
CDI (91 mg, 0.562 mmol) was added to acid 372 (95 mg, 0.511 mmol) in THF/CH2Cl2 1:1 
(2.0 mL) at 0 °C and stirred for 30 min., followed by 30 min at rt. 
N,O-dimethylhydroxylamine hydrochloride (55 mg, 0.562 mmol) was then added and the 
reaction stirred for 2 days. The mixture was washed sequentially with aqueous HCl (1.0 M, 
10 mL), sat. aqueous NaHCO3 (10 mL) and brine (10 mL), dried (MgSO4) and concentrated 
in vacuo. Chromatography (Et2O) afforded amide 376 (80 mg, 0.347 mmol, 68%) as a white 
solid. 
1H NMR (400 MHz, CDCl3) δ: 5.38 (1H, s, CH=C), 3.72 (3H, s, CH3) 3.40 (2H, s, CH2), 
3.21 (3H, s, CH3), 1.72 (6H, s, CH3). 13C NMR (125 MHz, CDCl3) δ: 167.6, 165.1, 160.9, 
107.2, 96.4, 61.4, 37.4, 32.2, 25.0 (2C). HRMS: (CI+) Calculated for C10H16NO5 [M+H]+: 
230.1025; Found: 230.1028. IR νmax/cm-1 (neat): 1726, 1661, 1645, 1424, 1394, 1372, 1273, 
1260, 1198, 1167, 993, 907. Mpt: 88-90 °C {Et2O/pentane} 
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1-((2R,3R,5S,6R)-6-(((4-bromobenzyl)oxy)methyl)-3,5-bis((4-chlorobenzyl)oxy) 
tetrahydro-2H-pyran-2-yl)ethanone 377 
 
MeMgBr (3.0 M in THF, 50 µL, 0.146 mmol) was added to a solution of Weinreb amide 356 
(60 mg, 92.1 µmol) in THF (1.0 mL) at 0 °C and stirred for 30 min when it was quenched 
with sat. aqueous NH4Cl (5.0 mL). The aqueous layer was extracted with CH2Cl2 (10 mL) 
and the organic phase was dried (MgSO4), concentrated in vacuo and chromatography (1:1 
pentane/Et2O) gave ketone 377 (51 mg, 83.8 µmol, 91%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.46-7.14 (12H, m, ArH), 4.57-4.35 (6H, m, H7, H8 and H9), 
3.77 (1H, d, J = 9.3 Hz, H1), 3.71-3.63 (2H, m, H6), 3.56-3.50 (1H, m, H2), 3.47-3.41 (2H, 
m, H4 and H5), 2.65 (1H, dt, J = 12.0, 4.1 Hz, H3a), 2.22 (3H, s, H10), 1.56-1.47 (1H, m, H3b). 
13C NMR (101 MHz, CDCl3) δ: 205.2, 137.1, 136.2, 136.1, 133.7, 133.6, 131.5 (2C), 129.3 
(2C), 129.2 (2C), 128.9 (2C), 128.6 (4C), 121.5, 83.9, 80.2, 73.3, 72.6, 71.7, 70.4, 70.3, 
69.1, 35.2, 27.8. HRMS: (ES+) Calculated for C31H32BrCl2NNaO5 [M+CH3CN+Na]+: 
670.0739; Found: 670.0746. IR νmax/cm-1 (neat): 1725, 1490, 1353, 1086, 1014, 805. [α]24D: 
+25.7 (c =1.0, CHCl3). 
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(S)-pent-4-en-2-yl 2-((2S,3R,5S,6R)-6-(((4-bromobenzyl)oxy)methyl)-3,5-bis((4-chloro 
benzyl) oxy)tetrahydro-2H-pyran-2-yl)-6-hydroxy-4-methoxybenzoate 380 
 
Thionyl chloride (0.22 mL, 2.91 mmol) was added to a solution of acid 355 (220 mg, 
0.363 mmol) in CH2Cl2 (3.5 mL) at room temperature and stirred for 16 h. Further thionyl 
chloride (0.12 mL, 1.46 mmol) was added and after another 1 h the reaction was 
concentrated in vacuo and excess thionyl chloride was removed by azeotroping with dry 
toluene (3 x 1.0 mL) to give the acid chloride 364. While acid chloride 364 was drying under 
reduced pressure, allyl ester 363 (97 mg, 0.363 mmol) was dissolved in THF (3.5 mL) at 
0 °C and i-PrMgBr (0.8 M in THF, 0.43 mL, 0.345 mmol) was added. After 30 min the acid 
chloride 364 was added to this solution in CH2Cl2 (0.5 mL) at 0 °C and the reaction was left 
stirring at this temperature for 1 h. The reaction was then concentrated in vacuo, redissolved 
in CH2Cl2 (8.0 mL) and the mixture was purged with argon. To this, a degassed solution of 
Pd(PPh3)4 (42 mg, 36.3 µmol) and morpholine (63 µL, 0.726 mmol) in CH2Cl2 (1.0 mL) was 
added and the reaction stirred for 30 min at 0 °C. The reaction was washed with aqueous 
10% citric acid (25 mL) and extracted with CHCl3 (3 x 25 mL). The organic phase was dried 
(MgSO4) and concentrated in vacuo to give the crude diketo-dioxinone 359 which was used 
in the subsequent reaction without further purification. Diketo-dioxinone 359 was heated in 
toluene (10 mL) with (S)-4-penten-2-ol (0.30 mL, 2.90 mmol) at 110 °C for 1 h. The 
solution was concentrated in vacuo and redissolved in CH2Cl2/i-PrOH 1:1 (16 mL) and 
CsOAc (210 mg, 1.09 mmol) was added at room temperature. After stirring for 2 h, HCl 
(1.25 M in MeOH, 2.9 mL, 3.63 mmol) was added and the reaction was stirred for a further 
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16 h. The reaction was then washed with sat. aqueous NaHCO3 (50 mL), extracted with Et2O 
(3 x 50 mL) and the combined organic phases were dried (MgSO4) and concentrated in 
vacuo. Chromatography returned resorcylate 379 and methyl ester 351 as an inseparable 
mixture of products in approximate ratio of 5:1 respectively, which were used directly in the 
next step without isolation. Methyl iodide (90 µL, 1.45 mmol) in acetone (1.2 mL) was 
added to the mixture of resorcylate 379, methyl ester 351 and potassium carbonate (100 mg, 
0.726 mmol) in acetone (15 mL) and heated to 45 °C for 2 h. The reaction was then washed 
with H2O (25 mL) and the aqueous phase was extracted with Et2O (3 x 25 mL). The 
combined organic phases were dried (MgSO4), concentrated in vacuo and chromatography 
(2:1 pentane/Et2O) gave the methylated resorcylate 380 (92 mg, 0.115 mmol, 32% over 3 
steps) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ: 11.50 (1H, s, OH), 7.46-7.16 (10H, m, ArH), 6.88-6.86 (2H, 
m, ArH), 6.71 (1H, d, J = 2.6 Hz, H7 or H8), 6.44 (1H, d, J = 2.6 Hz, H7 or H8), 5.78 (1H, 
ddt, J = 17.2, 10.2, 7.0 Hz, H12), 5.49 (1H, d, J = 9.1 Hz, H1), 5.21-5.08 (3H, m, H9, H13 and 
H14), 4.60 (1H, d, J = 11.7 Hz, OCH2), 4.58 (1H, d, J = 12.7 Hz, OCH2), 4.50 (1H, d, J = 
12.7 Hz, OCH2), 4.42 (1H, d, J = 11.7 Hz, OCH2), 4.18 (1H, d, J = 11.8 Hz, OCH2), 3.97 
(1H, d, J = 11.8 Hz, OCH2), 3.81 (3H, s, OCH3), 3.76-3.71 (2H, m, H6), 3.58-3.51 (2H, m, 
H4 and H5), 3.06 (1H, ddd, J = 11.3, 8.8, 4.1 Hz, H2),  2.64 (1H, dt, J = 12.1, 4.1 Hz, H3a), 
2.49-2.32 (2H, m, H11), 1.60 (1H, app q, J = 11.2 Hz, H3b), 1.26 (3H, d, J = 6.2 Hz, H10). 13C 
NMR (101 MHz, CDCl3) δ: 170.9, 164.0, 164.0, 143.9, 137.4, 136.5, 136.2, 133.6, 133.3, 
133.3, 131.5 (2C), 129.2 (2C), 129.2 (2C), 129.0 (2C), 128.6 (2C), 128.3 (2C), 121.4, 118.3, 
106.9, 106.1, 100.1, 80.7, 79.2, 78.1, 72.6 (2C), 72.0, 71.0, 70.5, 69.4, 55.3, 40.3, 36.4, 19.2. 
HRMS: (ES+) Calculated for C40H42BrCl2O8 [M+H]+: 799.1440; Found: 799.1460. IR 
νmax/cm-1 (neat): 1646, 1615, 1578, 1491, 1357, 1318, 1254, 1204, 1160, 1087, 1013. [α]25D: 
+37.7 (c =1.0, CHCl3). 
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(S)-pent-4-en-2-yl 2-((2S,3R,5S,6R)-6-(((4-bromobenzyl)oxy)methyl)-3,5-bis((4-chloro 
benzyl) oxy)tetrahydro-2H-pyran-2-yl)-4,6-dihydroxybenzoate 379 
 
For the characterisation of resorcylate 379 a sample of the two compounds 379 and 351 
(13 mg) was stirred in MeOH (0.6 mL) and H2O (0.12 mL) with LiOHH2O (1.0 mg, 23.8 
µmol) for 2 days. The reaction was then washed with sat. aqueous NaHCO3 (5 mL), 
extracted with Et2O (3 x 5 mL) and the combined organic phases were dried (MgSO4) and 
concentrated in vacuo. Chromatography (1:1 pentane/Et2O) gave resorcylate 379 (8 mg, 10.2 
µmol) as a yellow oil.  
1H NMR (400 MHz, CDCl3) δ: 11.41 (1H, s, OH), 7.46-7.16 (10H, m, ArH), 6.89-6.86 (2H, 
m, ArH), 6.62 (1H, d, J = 2.7 Hz, H7 or H8), 6.36 (1H, d, J = 2.7 Hz, H7 or H8), 5.78 (1H, 
ddt, J = 17.2, 10.2, 7.0 Hz, H12), 5.52 (1H, s, OH), 5.49 (1H, d, J = 8.9 Hz, H1), 5.19-5.08 
(3H, m, H9, H13 and H14), 4.60 (1H, d, J = 11.6 Hz, OCH2), 4.58 (1H, d, J = 12.6 Hz, OCH2), 
4.49 (1H, d, J = 12.6 Hz, OCH2), 4.40 (1H, d, J = 11.6 Hz, OCH2), 4.16 (1H, d, J = 11.8 Hz, 
OCH2), 3.97 (1H, d, J = 11.8 Hz, OCH2), 3.77-3.70 (2H, m, H6), 3.55-3.51 (2H, m, H4 and 
H5), 3.05 (1H, ddd, J = 11.2, 8.9, 4.0 Hz, H2),  2.64 (1H, dt, J = 11.7, 4.0 Hz, H3a), 2.49-2.32 
(2H, m, H11), 1.54 (1H, app q, J = 11.3 Hz, H3b), 1.25 (3H, d, J = 6.2 Hz, H10). 13C NMR 
(101 MHz, CDCl3) δ: 170.6, 163.8, 160.3, 144.5, 137.2, 136.4, 136.1, 133.7, 133.4, 133.2, 
131.5 (2C), 129.4 (2C), 129.2 (2C), 129.0 (2C), 128.6 (2C), 128.3 (2C), 121.5, 118.4, 106.6, 
106.5, 102.8, 80.4, 79.0, 78.1, 72.6, 72.5, 72.1, 71.0, 70.5, 69.3, 40.2, 36.4, 19.1. HRMS: 
(ES+) Calculated for C39H40BrCl2O8 [M+H]+: 785.1284; Found: 785.1280. IR νmax/cm-1 
(neat): 3317 br, 1647, 1491, 1356, 1316, 1259, 1088, 1014. [α]25D: +14.6 (c =0.4, CHCl3).  
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(S)-pent-4-en-2-yl 2-((2S,3R,5S,6R)-3,5-bis((4-chlorobenzyl)oxy)-6-(((4-(methyl(phenyl) 
amino)benzyl)oxy)methyl)tetrahydro-2H-pyran-2-yl)-6-hydroxy-4-methoxybenzoate 
401 
 
Resorcylate 380 (50 mg, 62.7µmol) was azeotropically dried with toluene (3 x 1 mL), 
dissolved in toluene (0.60 mL) and to this N-methylaniline (8.0 µL, 75.2 µmol) was added. 
Tris(dibenzylideneacetone)dipalladium(0) (2.9 mg, 3.14 µmol), (o-biphenyl)P(t-Bu)2 
(1.9 mg, 6.27 µmol) and sodium tertbutoxide (8.0 mg, 87.8 µmol) were added to a Schlenk 
flask which was then evacuated and back filled with argon. To this the solution of 
resorcylate 380 and the amine was added and the reaction was heated for 2 h at 80 °C. The 
reaction was cooled to rt, diluted with Et2O (10 mL) and the mixture filtered through 
Celite®. The filtrate was concentrated in vacuo and chromatography gave aniline 401 
(40 mg, 48.3 µmol, 77%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 11.49 (1H, s, OH), 7.31-7.17 (10H, m, ArH), 7.05-6.95 (5H, 
m, ArH), 6.89-6.87 (2H, m, ArH), 6.76 (1H, d, J = 2.7 Hz, H7 or H8), 6.43 (1H, d, J = 2.7 
Hz, H7 or H8), 5.79 (1H, ddt, J = 17.2, 10.2, 7.0 Hz, H12), 5.50 (1H, d, J = 9.1 Hz, H1), 
5.21-5.08 (3H, m, H9, H13 and H14), 4.62-4.43 (4H, m, OCH2), 4.18 (1H, d, J = 11.8 Hz, 
OCH2), 3.98 (1H, d, J = 11.8 Hz, OCH2), 3.81-3.77 (2H, m, H6), 3.77 (3H, s, CH3), 
3.64-3.53 (2H, m, H4 and H5), 3.31 (3H, s, CH3), 3.08 (1H, ddd, J = 11.2, 8.9, 4.0 Hz, H2),  
2.63 (1H, dt, J = 11.8, 4.3 Hz, H3a), 2.50-2.33 (2H, m, H11), 1.57 (1H, app. q, J = 11.3 Hz, 
H3b), 1.27 (3H, d, J = 6.3 Hz, H10). 13C NMR (101 MHz, CDCl3) δ: 170.8, 164.0, 163.9, 
148.9, 148.5, 144.0, 136.6, 136.2, 133.5, 133.3, 130.6, 129.2 (2C), 129.2 (2C), 129.1 (2C), 
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129.0 (2C), 128.6 (2C), 128.2 (2C), 121.6, 121.0 (2C), 119.6 (2C), 118.3, 106.7, 106.1, 
100.2, 80.8, 79.2, 78.2, 73.1, 72.6, 72.0, 71.0, 70.6, 68.9, 55.3, 40.3, 40.2, 36.5, 19.2. 
N.B: one CAr missing due to overlap. HRMS: (ES+) Calculated for C47H50Cl2O8N [M+H]+: 
826.2913; Found: 826.2916. IR νmax/cm-1 (neat): 1644, 1613, 1595, 1578, 1513, 1493, 1345, 
1317, 1252, 1203, 1159, 1114, 1083, 1015. [α]26D: +36.2 (c =1.0, CHCl3). 
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(S)-pent-4-en-2-yl 2-((2S,3R,5S,6R)-3,5-bis((4-chlorobenzyl)oxy)-6-(hydroxymethyl) 
tetrahydro-2H-pyran-2-yl)-6-hydroxy-4-methoxybenzoate 402 
 
Tin(IV) chloride (1.0 M in heptane, 49 µL, 48.5 µmol) was added to a solution of aniline 401 
(40 mg, 48.5 µmol) in CH2Cl2 (1.0 mL) and stirred at rt for 30 min. The reaction was then 
diluted with CH2Cl2 (10 mL) and washed successively with water (10 mL), sat. aqueous 
NaHCO3 (10 mL) and brine (10 mL). The organic phase was dried (MgSO4) and 
concentrated in vacuo. Chromatography (2:1 to 1:1 pentane/Et2O) gave alcohol 402 (22 mg, 
35 µmol, 73%) as a colourless oil.  
1H NMR (400 MHz, CDCl3) δ: 11.51 (1H, s, OH), 7.36-7.26 (4H, m, ArH), 7.20-7.16 (2H, 
m, ArH), 6.89-6.86 (2H, m, ArH), 6.60 (1H, d, J = 2.8 Hz, H7 or H8), 6.44 (1H, d, J = 2.8 
Hz, H7 or H8), 5.79 (1H, ddt, J = 17.2, 10.4, 7.1 Hz, H12), 5.52 (1H, d, J = 9.0 Hz, H1), 
5.24-5.10 (3H, m, H9, H13 and H14), 4.64 (1H, d, J = 11.8 Hz, OCH2), 4.48 (1H, d, J = 11.8 
Hz, OCH2), 4.20 (1H, d, J = 11.8 Hz, OCH2), 3.98 (1H, d, J = 11.8 Hz, OCH2), 3.95-3.92 
(1H, m, H6a), 3.81 (3H, s, CH3), 3.77-3.72 (1H, m, H6b), 3.54-3.46 (2H, m, H4 and H5), 3.10 
(1H, ddd, J = 11.0, 9.0, 4.1 Hz, H2),  2.66 (1H, dt, J = 12.0, 4.1 Hz, H3a), 2.50-2.34 (2H, m, 
H11), 2.02 (1H, br s, OH), 1.58 (1H, app. q, J = 11.2 Hz, H3b), 1.28 (3H, d, J = 6.1 Hz, H10). 
13C NMR (101 MHz, CDCl3) δ: 170.6, 164.1, 163.9, 143.6, 136.4, 136.1, 133.7, 133.4, 
133.2, 129.2 (2C), 129.0 (2C), 128.7 (2C), 128.3 (2C), 118.4, 106.9, 106.1, 100.1, 80.9, 
79.0, 78.0, 73.0, 72.1, 70.9, 70.4, 62.7, 55.4, 40.2, 36.2, 19.2. HRMS: (ES+) Calculated for 
C33H37Cl2O8 [M+H]+: 631.1865; Found: 631.1860. IR νmax/cm-1 (neat): 3497 br, 1644, 
1614, 1578, 1492, 1356, 1316, 1253, 1203, 1160, 1084, 1015. [α]25D: +41.8 (c =1.0, CHCl3). 
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(S)-pent-4-en-2-yl 2-acetoxy-6-((2S,3R,5S,6R)-3,5-bis((4-chlorobenzyl)oxy)-6-(((4-( 
methyl(phenyl)amino)benzyl)oxy)methyl)tetrahydro-2H-pyran-2-yl)-4-methoxy 
benzoate 404 
 
 
DMAP (1.4 mg, 11.6 µmol) was added to a solution of resorcylate 401 (48 mg, 58.2 µmol) 
and acetic anhydride (10 µL, 0.175 mmol) in THF (0.8 mL) at rt. After 30 min the solution 
was washed with sat. aqueous NaHCO3 (10 mL) and the aqueous phase was extracted with 
Et2O (3 x 10 mL). The combined organic phases were dried (MgSO4), concentrated in vacuo 
and chromatography (1:1 pentane/Et2O) gave aniline 404 (47 mg, 54.1 µmol, 93%) as a 
colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.30-7.15 (10H, m, ArH), 7.04-6.92 (7H, m, ArH), 6.89 (1H, 
d, J = 2.5 Hz, H7 or H8), 6.58 (1H, d, J = 2.5 Hz, H7 or H8), 5.75 (1H, ddt, J = 17.2, 10.3, 7.0 
Hz, H12), 5.17-5.03 (3H, m, H9, H13 and H14), 4.80 (1H, d, J = 9.1 Hz, H1), 4.57 (1H. d, J = 
11.8 Hz, OCH2), 4.50-4.37 (3H, m, OCH2), 4.16 (1H, d, J = 12.4 Hz, OCH2), 4.12 (1H, d, J 
= 12.4 Hz, OCH2), 3.78-3.71 (2H, m, H6), 3.73 (3H, s, CH3), 3.63-3.54 (1H, m, H4), 3.54-
3.48 (1H, m, H5), 3.30 (3H, s, CH3), 3.19 (1H, ddd, J = 11.0, 9.1, 4.3 Hz, H2),  2.58 (1H, dt, 
J = 11.8, 4.5 Hz, H3a), 2.41-2.32 (1H, m, H11a), 2.29 (3H, s, CH3), 2.24-2.17 (1H, m, H11b), 
1.52 (1H, app. q, J = 11.4 Hz, H3b), 1.28 (3H, d, J = 6.3 Hz, H10). 13C NMR (101 MHz, 
CDCl3) δ: 169.0, 165.3, 161.1, 149.7, 148.9, 148.5, 141.3, 136.7, 136.3, 133.5, 133.4, 133.2, 
130.7, 129.5 (2C), 129.2 (2C), 129.0 (4C), 128.5 (2C), 128.2 (2C), 121.6, 121.0 (2C), 
119.7 (2C), 119.3, 117.9, 110.5, 108.1, 80.7, 78.8, 77.2, 73.1, 72.2, 71.1, 70.5, 70.5, 68.8, 
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55.5, 40.2, 40.0, 36.2, 21.0, 19.2. HRMS: (ES+) Calculated for C49H52Cl2O9N [M+H]+: 
631.1865; Found: 631.1860. IR νmax/cm-1 (neat): 1771, 1717, 1613, 1596, 1513, 1493, 1262, 
1203, 1191, 1153, 1083. [α]26D: +27.8 (c =1.0, CHCl3).  
   242 
(S)-pent-4-en-2-yl 2-acetoxy-6-((2S,3R,5S,6R)-3,5-bis((4-chlorobenzyl)oxy)-6-(hydroxy 
methyl)tetrahydro-2H-pyran-2-yl)-4-methoxybenzoate 405 
 
Tin(IV) chloride (1.0 M in heptane, 25 µL, 25.4 µmol) was added to a solution of aniline 404 
(20 mg, 23.1 µmol) in CH2Cl2 (0.8 mL) and stirred at −78 °C for 30 min. The reaction was 
then diluted with CH2Cl2 (10 mL) and washed successively with water (10 mL), sat. aqueous 
NaHCO3 (10 mL) and brine (10 mL). The organic phase was dried (MgSO4) and 
concentrated in vacuo. Chromatography (1:2 pentane/Et2O) gave alcohol 405 (14 mg, 
20.8 µmol, 90%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.34-7.31 (2H, m, ArH), 7.26-7.24 (2H, m, ArH), 7.19-7.16 
(2H, m, ArH), 6.98-6.94 (2H, m, ArH), 6.77 (1H, d, J = 2.5 Hz, H7 or H8), 6.61 (1H, d, 
J = 2.5 Hz, H7 or H8), 5.76 (1H, ddt, J = 17.3, 10.4, 7.1 Hz, H12), 5.14-5.07 (3H, m, H9, H13 
and H14), 4.68 (1H, d, J = 9.1 Hz, H1), 4.61 (1H, d, J = 11.7 Hz, OCH2), 4.46 (1H, d, 
J = 11.7 Hz, OCH2), 4.22 (1H, d, J = 12.2 Hz, OCH2), 4.13 (1H, d, J = 12.2 Hz, OCH2), 3.89 
(1H, dd, J = 11.8, 2.5 Hz, H6a), 3.76 (3H, s, CH3), 3.69 (1H, dd, J = 11.8, 4.3 Hz, H6b), 
3.50-3.41 (2H, m, H4 and H5), 3.33 (1H, ddd, J = 11.1, 9.2, 4.4 Hz, H2),  2.62 (1H, dt, 
J = 12.2, 4.2 Hz, H3a), 2.47-2.36 (1H, m, H11a), 2.28 (3H, s, CH3), 2.28-2.21 (1H, m, H11b), 
1.54 (1H, app. q, J = 11.2 Hz, H3b), 1.27 (3H, d, J = 6.2 Hz, H10). 13C NMR 
(101 MHz, CDCl3) δ: 168.8, 165.8, 160.7, 149.6, 140.2, 136.4, 136.1, 133.7, 133.3, 
129.4 (2C), 129.0 (2C), 128.7 (2C), 128.3 (2C), 125.5, 119.4, 118.1, 111.2, 108.0, 80.7, 
79.4, 76.7, 72.3, 71.5, 70.6, 70.3, 62.4, 55.6, 40.0, 35.8, 30.0, 19.2. HRMS: (ES+) 
Calculated for C35H39Cl2O9 [M+H]+: 673.1971; Found: 673.1971. IR νmax/cm-1 (neat): 3517 
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br, 1772, 1717, 1614, 1491, 1367, 1320, 1264, 1192, 1153, 1086, 1041, 1015. [α]26D: +24.9 
(c =1.0, CHCl3). 
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5. APPENDIX 
  Crystal Data for Epoxide 300 5.1
 
Crystal data and structure refinement for 300 
 
Identification code AB1402b 
Formula C23H46O6Si2 
Formula weight 474.78 
Temperature 173 K 
Diffractometer, wavelength Agilent Xcalibur PX Ultra A, 1.54184 Å 
Crystal system, space group Orthorhombic, P 21 21 21 
Unit cell dimensions a = 7.48688(17) Å α = 90° 
 b = 11.5710(2) Å β = 90° 
 c = 32.0894(8) Å γ = 90° 
Volume, Z 2779.92(10) Å3, 4 
Density (calculated) 1.134 Mg/m3 
Absorption coefficient 1.419 mm-1 
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F(000) 1040 
Crystal colour / morphology Colourless plates 
Crystal size 0.30 x 0.12 x 0.02 mm3 
θ range for data collection 2.754 to 71.677° 
Index ranges -9<=h<=6, -14<=k<=14, -39<=l<=36 
Reflns collected / unique 15730 / 5310 [R(int) = 0.0620] 
Reflns observed [F>4σ(F)] 4877 
Absorption correction Analytical 
Max. and min. transmission 0.972 and 0.753 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5310 / 0 / 280 
Goodness-of-fit on F2 1.123 
Final R indices [F>4σ(F)] R1 = 0.1565, wR2 = 0.4272 
R indices (all data) R1 = 0.1620, wR2 = 0.4299 
Absolute structure parameter 0.08(5) 
Largest diff. peak, hole 2.480, -0.924 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
 
Table 1. Bond lengths [Å] and angles [°] for 300 
 
Bond                                               Length  L 
O(1)-C(1) 1.18(2) 
C(1)-C(2) 1.51(3) 
C(2)-O(3) 1.45(2) 
C(2)-C(4) 1.45(2) 
O(3)-C(4) 1.439(19) 
C(4)-C(5) 1.50(2) 
C(5)-C(6) 1.53(2) 
C(6)-O(21) 1.427(17) 
C(6)-C(7) 1.54(2) 
C(7)-O(8) 1.433(16) 
C(7)-C(11) 1.567(19) 
O(8)-C(9) 1.410(15) 
C(9)-O(10) 1.477(18) 
C(9)-C(29) 1.48(2) 
C(9)-C(30) 1.56(2) 
O(10)-C(11) 1.427(17) 
C(11)-C(12) 1.52(2) 
C(12)-O(13) 1.480(19) 
O(13)-Si(14) 1.605(10) 
Si(14)-C(15) 1.818(17) 
Si(14)-C(16) 1.90(2) 
Si(14)-C(17) 1.917(16) 
C(17)-C(20) 1.52(2) 
C(17)-C(19) 1.52(2) 
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C(17)-C(18) 1.56(3) 
O(21)-Si(22) 1.656(11) 
Si(22)-C(25) 1.77(2) 
Si(22)-C(24) 1.836(19) 
Si(22)-C(23) 1.844(16) 
C(25)-C(26) 1.55(3) 
C(25)-C(28) 1.61(2) 
C(25)-C(27) 1.62(3) 
Bond                                           Angle 
O(1)-C(1)-C(2) 122.7(16) 
O(3)-C(2)-C(4) 59.4(10) 
O(3)-C(2)-C(1) 112.5(14) 
C(4)-C(2)-C(1) 118.8(14) 
C(4)-O(3)-C(2) 60.4(10) 
O(3)-C(4)-C(2) 60.3(10) 
O(3)-C(4)-C(5) 117.0(14) 
C(2)-C(4)-C(5) 119.8(15) 
C(4)-C(5)-C(6) 113.6(13) 
O(21)-C(6)-C(5) 111.8(12) 
O(21)-C(6)-C(7) 105.6(11) 
C(5)-C(6)-C(7) 110.2(12) 
O(8)-C(7)-C(6) 108.8(10) 
O(8)-C(7)-C(11) 101.4(10) 
C(6)-C(7)-C(11) 115.5(13) 
C(9)-O(8)-C(7) 107.2(10) 
O(8)-C(9)-O(10) 104.2(11) 
O(8)-C(9)-C(29) 107.4(11) 
O(10)-C(9)-C(29) 109.7(13) 
O(8)-C(9)-C(30) 114.2(12) 
O(10)-C(9)-C(30) 104.0(11) 
C(29)-C(9)-C(30) 116.6(14) 
C(11)-O(10)-C(9) 109.6(10) 
O(10)-C(11)-C(12) 108.6(12) 
O(10)-C(11)-C(7) 102.8(10) 
C(12)-C(11)-C(7) 116.9(13) 
O(13)-C(12)-C(11) 110.6(13) 
C(12)-O(13)-Si(14) 124.8(10) 
O(13)-Si(14)-C(15) 114.0(7) 
O(13)-Si(14)-C(16) 102.1(8) 
C(15)-Si(14)-C(16) 111.2(9) 
O(13)-Si(14)-C(17) 106.8(6) 
C(15)-Si(14)-C(17) 113.2(8) 
C(16)-Si(14)-C(17) 108.7(9) 
C(20)-C(17)-C(19) 119.5(19) 
C(20)-C(17)-C(18) 105.5(17) 
C(19)-C(17)-C(18) 107.1(18) 
C(20)-C(17)-Si(14) 110.4(12) 
C(19)-C(17)-Si(14) 108.3(13) 
C(18)-C(17)-Si(14) 105.1(13) 
C(6)-O(21)-Si(22) 129.1(9) 
O(21)-Si(22)-C(25) 100.6(6) 
O(21)-Si(22)-C(24) 112.4(8) 
C(25)-Si(22)-C(24) 112.4(9) 
O(21)-Si(22)-C(23) 112.8(7) 
C(25)-Si(22)-C(23) 113.3(9) 
C(24)-Si(22)-C(23) 105.6(10) 
C(26)-C(25)-C(28) 108.3(16) 
C(26)-C(25)-C(27) 106.9(18) 
C(28)-C(25)-C(27) 101.8(16) 
C(26)-C(25)-Si(22) 114.9(14) 
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C(28)-C(25)-Si(22) 113.3(14) 
C(27)-C(25)-Si(22) 110.6(11) 
 
 
 
 
  Crystal Data for Dinitro 336 5.2
 
Crystal data and structure refinement for 336 
Identification code  s14msh10 
Empirical formula  C28H23Cl2N3O9 
Formula weight  616.39 
Temperature  150(2) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  I2 
Unit cell dimensions a = 21.625(2) Å α= 90°. 
 b = 7.435(6) Å β= 93.267(9)°. 
 c = 17.6998(17) Å γ = 90°. 
Volume 2841(2) Å3 
Z 4 
Density (calculated) 1.441 Mg/m3 
Absorption coefficient 2.572 mm-1 
F(000) 1272 
Crystal size 0.250 x 0.040 x 0.020 mm3 
Theta range for data collection 5.006 to 71.871°. 
Index ranges -26<=h<=26, -8<=k<=9, -17<=l<=21 
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Reflections collected 12826 
Independent reflections 5252 [R(int) = 0.0764] 
Completeness to theta = 67.684° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.60323 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5252 / 37 / 685 
Goodness-of-fit on F2 1.025 
Final R indices [I>2sigma(I)] R1 = 0.0642, wR2 = 0.1459 
R indices (all data) R1 = 0.1071, wR2 = 0.1723 
Absolute structure parameter -0.02(3) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.207 and -0.178 e.Å-3 
 
The structure shows the whole molecule to be slightly disordered and in close proximity to a 
crystallographic C2 axis, and as a result the two identified orientations must be 50% 
occupancy. 
 
Table 1. Bond lengths [Å] and angles [°] for 336 
 
Bond                                                Length 
C(1)-O(1)  1.430(18) 
C(1)-C(11)  1.50(3) 
C(1)-C(2)  1.53(2) 
C(1)-H(1)  1.0000 
C(2)-O(2)  1.430(19) 
C(2)-C(3)  1.51(2) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.53(2) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-O(3)  1.41(2) 
C(4)-C(5)  1.530(19) 
C(4)-H(4)  1.0000 
C(5)-O(1)  1.43(2) 
C(5)-C(51)  1.52(2) 
C(5)-H(5)  1.0000 
C(11)-N(1)  1.11(4) 
C(21)-O(2)  1.427(19) 
C(21)-C(22)  1.50(2) 
C(21)-H(21A)  0.9900 
C(21)-H(21B)  0.9900 
C(22)-C(23)  1.3900 
C(22)-C(27)  1.3900 
C(23)-C(24)  1.3900 
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C(23)-H(23)  0.9500 
C(24)-C(25)  1.3900 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.3900 
C(25)-Cl(2)  1.732(9) 
C(26)-C(27)  1.3900 
C(26)-H(26)  0.9500 
C(27)-H(27)  0.9500 
C(31)-O(3)  1.46(2) 
C(31)-C(32)  1.53(2) 
C(31)-H(31A)  0.9900 
C(31)-H(31B)  0.9900 
C(32)-C(33)  1.3900 
C(32)-C(37)  1.3900 
C(33)-C(34)  1.3900 
C(33)-H(33)  0.9500 
C(34)-C(35)  1.3900 
C(34)-H(34)  0.9500 
C(35)-C(36)  1.3900 
C(35)-Cl(1)  1.719(12) 
C(36)-C(37)  1.3900 
C(36)-H(36)  0.9500 
C(37)-H(37)  0.9500 
C(51)-O(4)  1.46(3) 
C(51)-H(51A)  0.9900 
C(51)-H(51B)  0.9900 
C(52)-O(5)  1.22(4) 
C(52)-O(4)  1.39(4) 
C(52)-C(53)  1.52(4) 
C(53)-C(54)  1.3900 
C(53)-C(58)  1.3900 
C(54)-C(55)  1.3900 
C(54)-H(54)  0.9500 
C(55)-C(56)  1.3900 
C(55)-N(3)  1.415(14) 
C(56)-C(57)  1.3900 
C(56)-H(56)  0.9500 
C(57)-C(58)  1.3900 
C(57)-N(2)  1.471(15) 
C(58)-H(58)  0.9500 
N(2)-O(7)  1.217(19) 
N(2)-O(6)  1.228(19) 
N(3)-O(9)  1.204(17) 
N(3)-O(8)  1.22(2) 
O(7)-O(7)#1  1.20(2) 
Bond                                           Angle 
O(1)-C(1)-C(11) 108.6(13) 
O(1)-C(1)-C(2) 109.6(12) 
C(11)-C(1)-C(2) 109.6(16) 
O(1)-C(1)-H(1) 109.7 
C(11)-C(1)-H(1) 109.7 
C(2)-C(1)-H(1) 109.7 
O(2)-C(2)-C(3) 113.8(12) 
O(2)-C(2)-C(1) 105.3(11) 
C(3)-C(2)-C(1) 111.1(16) 
O(2)-C(2)-H(2) 108.8 
C(3)-C(2)-H(2) 108.8 
C(1)-C(2)-H(2) 108.8 
C(2)-C(3)-C(4) 109.4(12) 
C(2)-C(3)-H(3A) 109.8 
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C(4)-C(3)-H(3A) 109.8 
C(2)-C(3)-H(3B) 109.8 
C(4)-C(3)-H(3B) 109.8 
H(3A)-C(3)-H(3B) 108.2 
O(3)-C(4)-C(5) 105.0(15) 
O(3)-C(4)-C(3) 111.6(13) 
C(5)-C(4)-C(3) 110.2(12) 
O(3)-C(4)-H(4) 110.0 
C(5)-C(4)-H(4) 110.0 
C(3)-C(4)-H(4) 110.0 
O(1)-C(5)-C(51) 109.9(13) 
O(1)-C(5)-C(4) 108.7(14) 
C(51)-C(5)-C(4) 112.3(14) 
O(1)-C(5)-H(5) 108.6 
C(51)-C(5)-H(5) 108.6 
C(4)-C(5)-H(5) 108.6 
N(1)-C(11)-C(1) 178(2) 
O(2)-C(21)-C(22) 109.1(11) 
O(2)-C(21)-H(21A) 109.9 
C(22)-C(21)-H(21A) 109.9 
O(2)-C(21)-H(21B) 109.9 
C(22)-C(21)-H(21B) 109.9 
H(21A)-C(21)-H(21B) 108.3 
C(23)-C(22)-C(27) 120.0 
C(23)-C(22)-C(21) 120.0(8) 
C(27)-C(22)-C(21) 120.0(8) 
C(24)-C(23)-C(22) 120.0 
C(24)-C(23)-H(23) 120.0 
C(22)-C(23)-H(23) 120.0 
C(25)-C(24)-C(23) 120.0 
C(25)-C(24)-H(24) 120.0 
C(23)-C(24)-H(24) 120.0 
C(24)-C(25)-C(26) 120.0 
C(24)-C(25)-Cl(2) 119.5(6) 
C(26)-C(25)-Cl(2) 120.5(6) 
C(27)-C(26)-C(25) 120.0 
C(27)-C(26)-H(26) 120.0 
C(25)-C(26)-H(26) 120.0 
C(26)-C(27)-C(22) 120.0 
C(26)-C(27)-H(27) 120.0 
C(22)-C(27)-H(27) 120.0 
O(3)-C(31)-C(32) 112.6(12) 
O(3)-C(31)-H(31A) 109.1 
C(32)-C(31)-H(31A) 109.1 
O(3)-C(31)-H(31B) 109.1 
C(32)-C(31)-H(31B) 109.1 
H(31A)-C(31)-H(31B) 107.8 
C(33)-C(32)-C(37) 120.0 
C(33)-C(32)-C(31) 117.9(15) 
C(37)-C(32)-C(31) 122.1(15) 
C(34)-C(33)-C(32) 120.0 
C(34)-C(33)-H(33) 120.0 
C(32)-C(33)-H(33) 120.0 
C(33)-C(34)-C(35) 120.0 
C(33)-C(34)-H(34) 120.0 
C(35)-C(34)-H(34) 120.0 
C(34)-C(35)-C(36) 120.0 
C(34)-C(35)-Cl(1) 119.4(10) 
C(36)-C(35)-Cl(1) 120.6(10) 
C(37)-C(36)-C(35) 120.0 
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C(37)-C(36)-H(36) 120.0 
C(35)-C(36)-H(36) 120.0 
C(36)-C(37)-C(32) 120.0 
C(36)-C(37)-H(37) 120.0 
C(32)-C(37)-H(37) 120.0 
O(4)-C(51)-C(5) 109.0(16) 
O(4)-C(51)-H(51A) 109.9 
C(5)-C(51)-H(51A) 109.9 
O(4)-C(51)-H(51B) 109.9 
C(5)-C(51)-H(51B) 109.9 
H(51A)-C(51)-H(51B) 108.3 
O(5)-C(52)-O(4) 117(3) 
O(5)-C(52)-C(53) 127(3) 
O(4)-C(52)-C(53) 115(2) 
C(54)-C(53)-C(58) 120.0 
C(54)-C(53)-C(52) 131.8(14) 
C(58)-C(53)-C(52) 108.0(14) 
C(55)-C(54)-C(53) 120.0 
C(55)-C(54)-H(54) 120.0 
C(53)-C(54)-H(54) 120.0 
C(56)-C(55)-C(54) 120.0 
C(56)-C(55)-N(3) 119.4(10) 
C(54)-C(55)-N(3) 120.5(10) 
C(57)-C(56)-C(55) 120.0 
C(57)-C(56)-H(56) 120.0 
C(55)-C(56)-H(56) 120.0 
C(56)-C(57)-C(58) 120.0 
C(56)-C(57)-N(2) 120.0(9) 
C(58)-C(57)-N(2) 120.0(9) 
C(57)-C(58)-C(53) 120.0 
C(57)-C(58)-H(58) 120.0 
C(53)-C(58)-H(58) 120.0 
O(7)-N(2)-O(6) 125.3(14) 
O(7)-N(2)-C(57) 117.1(13) 
O(6)-N(2)-C(57) 117.5(13) 
O(9)-N(3)-O(8) 122.6(12) 
O(9)-N(3)-C(55) 119.5(13) 
O(8)-N(3)-C(55) 117.5(12) 
C(1)-O(1)-C(5) 113.7(13) 
C(21)-O(2)-C(2) 112.3(12) 
C(4)-O(3)-C(31) 112.6(15) 
C(52)-O(4)-C(51) 117(2) 
O(7)#1-O(7)-N(2) 132.5(11) 
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